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Abstract 
Chronic fatigue syndrome (CFS) is a common, debilitating condition.  Although 
existing research has largely focused on adult patients, CFS is similarly prevalent in 
adolescents.  The aetiology of the illness remains poorly understood, and treatments 
typically focus on the alleviation of symptoms rather than cure.  One of the most 
debilitating and frequently reported symptoms of CFS is cognitive impairment.  
Despite the potentially severe educational, functional, and developmental 
consequences of cognitive impairment in young people, neuropsychological 
performance had not been investigated in this population until very recently.  In a 
recent study by some members of the current research team, no differences in 
cognitive function were found between adolescent CFS patients and healthy controls.  
Given that these findings were inconsistent previous research and theory, the we 
hypothesised that motivation or perfectionism might have accounted for the 
nonsignificant results.  The current research group designed a study to investigate 
cognitive function in adolescents and young adults with CFS.  Building on the 
previous study, we examined the effects of motivation and perfectionism on 
cognitive performance in young CFS patients.  The sample included 23 CFS patients 
aged between 12 and 21 years, and 23 age and sex matched healthy controls.  
Participants completed a self-report measure of perceived cognitive impairment as 
well as a range of cognitively demanding tests on a computerised assessment tool 
and a written academic achievement test.  A measure of intelligence was included to 
allow for differences in intellectual capacity to be statistically controlled.  The 
participants also completed self-report measures of perfectionism, test motivation, 
sleep disturbance, fatigue, and psychological adjustment.  Compared to controls, the 
CFS patients reported significantly higher levels of cognitive impairment and 
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performed less well on measures of executive function, attention, and working 
memory.  However, there were no between-group differences in processing speed, 
and the CFS patients achieved higher scores on the academic tests than controls.  
Although test motivation was higher in the CFS group, there were no between-group 
differences in perfectionism, and motivation and perfectionism were not significant 
predictors of neuropsychological function or academic achievement.  Compared to 
healthy controls, the young CFS group also reported higher levels of fatigue, sleep 
disturbance, and psychological distress, however these factors were not significant 
predictors of perceived cognitive disturbance, neuropsychological performance, or 
academic achievement.  The CFS group reported higher rates of school absenteeism, 
although no correlation was identified between school absenteeism and academic 
performance.  To investigate whether the cognitive impairment observed in young 
people with CFS is similar to that found in adult patients, neuropsychological 
performance was compared between the young participants and adult CFS patients 
from a concurrent study.  The young CFS group achieved higher scores on measures 
of executive function, but performed similarly on measures of attention and working 
memory.  These findings are discussed with reference to the study limitations and the 
implications for managing cognitive impairment in young CFS patients.   
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Chapter 1: Historical Perspective of CFS 
To provide a context for understanding Chronic Fatigue Syndrome (CFS), 
this chapter presents an historical account of the major events that have influenced 
how the illness is currently conceptualised.  The ongoing changes and recent 
developments in the conceptualisation of CFS have resulted in inconsistent research 
findings and a poor understanding of the nature of the condition.  The beginning of 
the chapter includes a description of how Neurasthenia briefly came to prominence 
in the late 19th Century, followed by an investigation of epidemics of fatigue, post-
viral syndromes, and chronic infectious illnesses throughout the 20th Century.  The 
rise of CFS as a contemporary diagnosis will then be discussed, along with the 
development of modern case definitions for adults and paediatric patients. 
 
Neurasthenia 
Although CFS is often considered to be a modern condition, fatiguing 
illnesses were documented centuries ago.  Early accounts of illnesses characterised 
by unexplained debilitating fatigue accompanied by a myriad of somatic symptoms 
bear a close resemblance to the current conceptualisation of CFS.  In 1869, George 
Miller Beard described and termed one of the earliest known such illness, 
Neurasthenia (Beard, 1869).  He classified the condition as an organic illness defined 
by a fatigued body and mind associated with a collection of other symptoms, such as 
malaise, debilitated function, poor appetite, weakness in the back and spine, pain, 
hysteria, insomnia, hyperchondriases, avoidance of mental effort, nausea, and 
headache.  Beard believed that Neurasthenia was most common in civilised, 
intellectual communities and was associated with the increasing intellectual and 
occupational pressures of a modern society.  He noted that Neurasthenia appeared to 
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have a hereditary component and could be provoked by physical or mental stressors 
(Beard, 1869). 
In the same year, Edward Van Deusen (1869) identified a similar illness, also 
labelling it Neurasthenia.  He described the condition as characterised by profound 
exhaustion, physical sensitivity, neuralgias, depression, irritability, excessive 
perspiration, sleeplessness, and cognitive and intellectual disturbance (Van Deusen, 
1869).  Unlike Beard however, he attributed the cause of Neurasthenia to 
psychological factors, including excessive mental labour, depression, grief, domestic 
discord, and prolonged anxiety.  Van Deusen believed that farmers’ wives were the 
most commonly affected patients due to excessive isolation and boredom, and he 
prescribed physical exercise, mental activity, and sufficient sleep and nutrition. 
Beard’s (1869) description of Neurasthenia quickly became popular among 
high social positions of American and Western European society.  It was commonly 
diagnosed and formed the focus of immense public and professional interest until 
early in the 20th century, when medical professionals and patients lost interest in the 
condition.  This change could be accounted for by a combination of factors, such as 
inadequate evidence for an organic cause, ineffective medical treatments, and 
indicators of equally high prevalence rates in lower economic classes (Wessely, 
Hotopf, & Sharpe, 1998).  At this time, psychological explanations for Neurasthenia 
began to emerge, along with an inevitable social stigma (Demitrack & Abbey, 1996).  
After the illness was reconceptualised as a psychiatric condition, diagnoses were 
made less frequently and Neurasthenia was eventually removed from the Diagnostic 
and Statistical Manual of Mental Disorders, Third Edition (American Psychiatric 
Association, 1980; Friedberg & Leonard, 1998). 
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Epidemic Outbreaks of Fatigue 
Towards the middle of the 20th century, epidemic outbreaks of CFS-like 
illnesses were observed in several localised regions around the world.  Although 
these illnesses differ somewhat from the modern characterisation of CFS, the 
epidemics provide evidence for the existence of a specific medical entity that could 
be directly related to CFS (Jenkins, 1991).  Based on a review of 12 epidemics 
occurring between 1934 and 1961, common symptoms in these illnesses included 
myalgia, mood disturbance, memory and concentration impairment, headaches, and 
muscle weakness (Sabin & Dawson, 1993). 
Particular attention has been given to two significant outbreaks that affected 
the medical staff at hospitals in Los Angeles in 1934 (Lippincott, Williams, & 
Wilkins, 1937) and London in 1955 (The Medical Staff of the Royal Free Hospital, 
1957).  In the Los Angeles outbreak, 198 hospital staff members presented with an 
illness characterised by pain, headaches, muscle tenderness and weakness, fatigue, 
irritability, emotional lability, depression, sleep disturbance, and impaired memory 
and concentration.  Most sufferers reported significant functional impairment, and 
staff members missed an average of 13.6 weeks of work during the epidemic 
(Gilliam, 1938; Wessely, 2001).  The outbreak coincided with a poliomyelitis 
epidemic, and as such, it was initially believed to be a version of poliomyelitis 
despite clear differences in presentation and course (Smallman-Raynor & Trevelyan, 
2006).  In the 1955 epidemic, 70 medical staff members at a London hospital were 
admitted over a two-week period following the rapid onset of an illness characterised 
by headaches, sore throat, malaise, fatigue, vertigo, and limb pain (Lippincott et al., 
1937).  In the subsequent months, 292 staff members and 12 hospital patients had 
developed the illness.  Laboratory assessment results were generally unremarkable, 
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and the illness was particularly prevalent among female resident nursing staff 
(Compston, 1978; The Medical Staff of the Royal Free Hospital, 1957).  
Although such epidemics were rare in young people, children and adolescents 
were not immune.  Following reports of a few isolated poliomyelitis cases in 1948, 
488 people in Iceland presented with symptoms of fever, pain, muscle weakness, and 
irritability.  Of these patients, 194 were under 19 years old.  Laboratory 
investigations were predominantly unremarkable.  Seven years later, 39 patients were 
re-examined, and 75% of those who had been severely affected reported residual 
symptoms (Parish, 1978). 
Various explanations for these outbreaks have been proposed.  Some argued 
that hysteria or other emotional disturbances were responsible for the outbreaks.  
Both the London and Los Angeles outbreaks occurred in the context of intense fear 
over contracting poliomyelitis, and the selectivity of affected patients along with an 
absence of physiological markers points towards a psychological explanation in at 
least some cases (McEvedy & Beard, 1970).  In contrast, others suggested that the 
staff of the Los Angeles hospital were exposed to a modified infection of 
poliomyelitis (Sabin & Dawson, 1993).  Acheson (1959) argued that the consistency 
of symptoms and illness course among patients from diverse communities is 
indicative of an infectious illness spread through interpersonal contact.  He also 
suggested that genuine cases of poliomyelitis might have acted as a trigger for 
hysterical cases among other staff members.  To date, the trigger for these epidemics 
remains unclear, and both an infectious process and a psychological response provide 
feasible aetiological explanations. 
Following an editorial published in the Lancet in 1956, Benign Myalgic 
Encephalomyelitis became the term used to describe a new clinical entity that might 
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account for the epidemic outbreaks.  The symptom criteria included central nervous 
system damage, muscle pain, emotional disturbance, normal cerebrospinal fluid, 
reticuloendothelial system involvement, chronic course, and frequent relapses.  The 
diagnosis allowed for unknown aetiology, and the illness was differentiated from 
known viral infections and hysteria.   
 
Postinfectious Fatigue Syndromes 
An association between infection and chronic fatiguing illnesses has long 
been recognised.  In 1934, Alice Evens argued that many cases of Neurasthenia were 
actually misdiagnosed brucellosis infections (Evans, 1934).  Evans believed that the 
animal infection could also affect humans, and noted that it is inherently difficult to 
detect through serum analysis.  Although this theory was initially built on anecdote 
and generalisations from animal studies (Demitrack & Abbey, 1996), Spink (1951) 
later found that 74 of 120 people with brucellosis continued to exhibit symptoms 
after one year despite the absence of a clear organic cause or evidence for an 
infectious illness. 
Spink’s (1951) findings sparked interest in the role of psychological factors in 
cases of prolonged recovery from infectious illnesses.  This interest heightened 
further following a study by Cluff, Trever, Imboden, and Canter (1959) who 
conducted assessments at several six-month intervals in 24 people who had 
contracted brucellosis.  After one year, 16 patients remained symptomatic, and 10 
continued to exhibit symptoms at a two-year follow-up.  Laboratory findings 
revealed no evidence of an active brucella infection or central nervous system 
damage.  Compared to those who recovered quickly, the chronically ill patients 
scored higher on measures of psychological impairment, were more resistant to 
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discussing personal issues, and were more likely to attribute their symptoms to 
organic factors.  Biographical assessment also revealed that 11 of the chronically ill 
patients had experienced traumatic childhood events compared to two of the 
recovered patients.  In addition, 11 of those in the chronic group and none of those in 
the recovered group reported significant stress in the year preceding the infection.  
Based on these findings, the authors argued that prolonged postinfectious illnesses 
were caused by psychological factors (Imboden et al., 1959). 
Imboden, Canter, and Cluff (1961) later designed a prospective study to 
assess whether psychological symptoms exist prior to the development of prolonged 
postinfectious illnesses.  In anticipation of a flu epidemic at a US army base, 600 
employees were recruited for psychological assessment.  At a three- to six-week 
follow-up, 12 of the 26 people who contracted the illness reported ongoing 
symptoms of fatigue, headaches, sleep disturbance, and depressed mood.  No 
differences were observed between the recovered and the symptomatic patients in 
symptom presentation during the acute phase of the flu and in the laboratory results 
at onset and at follow-up.  However, the symptomatic patients scored higher on 
measures of morale loss and depression prior to contracting the illness.  Imboden et 
al. (1961) suggested that an infectious illness might trigger a depressive episode in 
people who are predisposed to psychological disturbances.  Following this research, 
interest in chronic brucellosis rapidly declined in public and medical domains 
(Wessely et al., 1995).  This is perhaps indicative of a bias against illnesses 
associated with psychological phenomena. 
Despite ongoing research efforts, organic explanations for chronic fatiguing 
illnesses remained unsubstantiated, and accurate diagnosis had become enormously 
challenging.  The clinical symptoms were variable, nonspecific, and common to 
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many organic and psychological disorders (Henderson, 1994; Holt, 1965; Levine, 
1994).  To facilitate the development of a unified, operationally defined case 
definition, a symposium was held at the Royal Society of Medicine in 1978.  The 
group argued that the Los Angeles outbreak was an organic illness primarily 
characterised by encephalomyelitis and myalgia, and as such, Myalgic 
Encephalomyelitis (ME) was affirmed as the correct diagnostic term (Compston, 
1978; Jenkins, 1991).  In the absence of epidemic outbreaks in the following two 
decades, sporadic cases formed the primary focus for research (Wessely et al., 1998).  
Currently, ME is conceptualised as a noncontagious, chronic, illness with no 
neurological symptoms that is generally preceded by an infectious illness (Wessely et 
al., 1998). 
Interest in fatiguing illnesses expanded in the 1980’s in response to intense 
media attention surrounding Epstein-Barr virus (EBV) epidemics across North 
America (Wessely et al., 1999).  At this time, three separate reports were published 
describing patients suffering from persistent symptoms of ME, as well as 
immunological disturbances and abnormal antibody responses to EBV (Jones et al., 
1985; Straus et al., 1985; Tobi et al., 1982).  Many patients had also developed the 
condition following episodes of infectious mononucleosis.  These factors led 
researchers to propose that the persistent illness was caused by chronic EBV 
(Wessely et al., 1998).  Despite subsequent evidence that EBV was often unrelated to 
this symptom presentation, media focus, public demand, and patient lobbyists 
suggested that the symptoms and disability associated with EBV were genuine 
(Wessely et al., 1998).  In response, the Centers for Disease Control (CDC) 
formulated a group of infectious diseases specialists, clinicians, and researchers to 
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develop a specific case definition for this chronic illness in 1987.  This resulted in the 
birth of the term Chronic Fatigue Syndrome (Holmes et al., 1988). 
Chronic Fatigue Syndrome 
The aim of the CDC working group was to develop appropriate nomenclature 
and form a set of operational criteria without attributing the illness to a specific 
causative agent.  By identifying a homogenous collection of people suffering from 
the same condition, the group hoped to promote consistent research investigating 
underlying aetiological processes (Holmes et al., 1988).  The working group arrived 
at the term CFS, describing it as a disabling condition characterised by fatigue lasting 
at least six months that was accompanied by a range of signs and symptoms.  All 
other physical and psychological explanations for the illness had to be ruled out 
before a diagnosis was made, and psychiatric illnesses were considered exclusory. 
The CDC criteria were largely unsuccessful in promoting research to 
determine aetiological factors.  Fukuda et al. (1994) argued that disagreement among 
medical professionals and researchers regarding the exclusion of cases with a 
psychiatric diagnosis and the stringency of the criteria generated inconsistent 
diagnostic approaches.  In 1994, a revision of the case definition was made with the 
goal of promoting international agreement on a comprehensive and systematic 
approach to the evaluation, diagnosis, and study of CFS (Fukuda et al., 1994).  The 
new criteria omitted several exclusory psychiatric illnesses, such as somatoform 
disorders, anxiety disorders, and nonpsychotic or nonmelancholic forms of 
depression.  There was also a reduction in number of somatic symptoms required, 
and all physical diagnostic signs were removed (Fukuda et al., 1994).  The revised 
criteria are presented in Figure 1.1.  
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Hickie et al. (2009) measured the construct validity of the 1994 CFS case 
definition based on 33 studies across 21 countries.  The final sample included 2,013 
Figure 1.1. The 1994 CDC Revised Case Criteria for CFS 
A thorough medical history, physical examination, mental status examination, 
and laboratory tests are recommended to identify underlying or contributing 
conditions that require treatment. Diagnosis or classification cannot be made 
without such an evaluation. Clinically evaluated, unexplained chronic fatigue 
cases can be classified as CFS if the patient meets both of the following criteria: 
 
1. The individual has severe chronic fatigue for 6 or more consecutive 
months that is not due to ongoing exertion or other medical conditions 
associated with fatigue (these other conditions need to be ruled out by a 
doctor after diagnostic tests have been conducted) 
2. The fatigue significantly interferes with daily activities and work 
3. The individual concurrently has four or more of the following symptoms: 
x post-exertion malaise lasting more than 24 hours 
x unrefreshing sleep 
x significant impairment of short-term memory or concentration 
x muscle pain 
x pain in the joints without swelling or redness 
x headaches of a new type, pattern, or severity 
x tender lymph nodes in the neck or armpit 
x a sore throat that is frequent or recurring 
These symptoms persisted or recurred during 6 or more consecutive months of 
illness and they cannot have first appeared before the fatigue. 
 
Exclusionary Criteria 
1. Any active medical condition that may explain the presence of chronic 
fatigue, such as untreated hypothyroidism, sleep apnoea and narcolepsy, 
and iatrogenic conditions such as side effects of medication 
2. Any previously diagnosed medical condition whose resolution has not 
been documented beyond reasonable doubt and whose continued activity 
may explain the chronic fatiguing illness.  Such conditions may include 
previously treated malignancies and unresolved cases of hepatitis B or C. 
3. Any past or current diagnosis of Major Depressive Disorder with 
psychotic or melancholic features; Bipolar Affective Disorders; 
Schizophrenia of any subtype; delusional disorders of any subtype; 
dementias of any subtype; Anorexia Nervosa; or Bulimia Nervosa. 
4. Alcohol or other substance abuse within 2 years before the onset of 
chronic fatigue and at any time afterward. 
5. Severe obesity as defined by a body mass index [body mass index = 
weight in kilograms/(height in meters) 2] equal to or greater than 45. 
6. Any unexplained physical examination finding or laboratory or imaging 
test abnormality that strongly suggests the presence of an exclusionary 
criteria must be resolved before further classification. 
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participants with chronic fatigue and 1,958 with CFS.  An exploratory factor analysis 
revealed a five-factor solution for symptoms, including musculoskeletal pain or 
fatigue, neurocognitive difficulties, inflammation, sleep disturbance or fatigue, and 
mood disturbance.  The solution could distinguish CFS from prolonged fatigue and 
was remarkably consistent across a wide range of cultures and healthcare settings.  
However, some argued that although the revised criteria increased the sensitivity of 
the diagnosis, the specificity was compromised, leading to considerable homogeneity 
in the presentation of patients with CFS (De Becker, McGregor, & De Meirleir, 
2001; Jason et al., 1997).  As a result, findings among much of the research are often 
inconsistent. 
Ongoing dissatisfaction with the conceptualisation of CFS led to another 
collaboration of international experts at the beginning of the 21st century.  This effort 
gave rise to what is now known as the Canadian case definition (Carruthers et al., 
2003).  Rather than relying on a set of specific criteria, the new diagnostic approach 
involves a flexible combination of primary and secondary symptoms.  This allows 
for greater scope in identifying individual patients and enables researchers to clearly 
define their research sample.  The aim of the definition was to create a clinically 
relevant and inclusive diagnostic approach by using criteria that encompassed a 
range of grouped symptoms (Carruthers et al., 2003; Carruthers, 2007).  Figure 1.2 
outlines the Canadian Clinical Working Case Definition. 
Using a factor-analytic approach, Jason, Corradi, and Torres-Harding, (2007) 
investigated symptom profiles derived from the Canadian criteria in 114 patients.  
Four patient groups were identified: patients with infectious symptoms, patients with 
inflammatory symptoms, patients with prominent cognitive problems, and patients 
who were less severely impaired.  The data suggest that CFS patients may be  
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Figure 1.2. Adapted From the Canadian Clinical Working Case Definition 
for CFS 
A patient with CFS will meet criteria for symptoms 1-4; have two or more 
neurological/cognitive manifestations; have one or more symptoms from two of 
the categories of autonomic, neuroendocrine and immune manifestations; and 
adhere to item 7.  The symptoms must have begun or changed after the onset of 
this illness.  Confirmation of an active disease process that explains most of the 
major symptoms is grounds for exclusion. 
 
1. Fatigue: Significant, new onset, unexplained, persistent, or recurrent 
physical and mental fatigue that substantially reduces activity level. 
2. Post-Exertional Malaise and/or Fatigue: An inappropriate loss of stamina 
(physical and mental), rapid fatiguability (muscular and cognitive), post 
exertional malaise, fatigue, and/or pain and a tendency for associated 
symptoms to worsen  with fatigue. Recovery is slow (>24 hours). 
3. Sleep Dysfunction: Unrefreshing sleep, poor sleep quantity, or circadian 
rhythm disturbance. 
4. Pain: Significant myalgia, often with headaches. 
5. Neurological/Cognitive: Two or more of following difficulties: confusion, 
impaired concentration, short term memory difficulties; disorientation, 
difficulty with information processing, categorisation and word retrieval, 
perceptual and sensory disturbances, Ataxia; hypersensitivity to sensory 
overload. 
6. At least one symptom from two of the following: 
x Autonomic: Orthostatic intolerance, postural orthostatic tachycardia 
syndrome, delayed postural hypotension, light-headedness, pallor, 
nausea and irritable bowel syndrome, urinary frequency, heart 
palpitations, exertional dyspnea. 
x Neuroendocrine: Loss of thermostatic stability, sweating, feverishness 
and cold extremities, intolerance of temperature extremes, weight 
change, worsening symptoms with stress. 
x Immune: Tender lymph nodes, recurrent sore throat, recurrent flu-like 
symptoms, general malaise, new sensitivities to food, medications, 
chemical. 
7.  The illness persists for at least six months: It usually has a distinct onset, 
although it may be gradual.  Preliminary diagnosis may be 
possible earlier. Three months is appropriate for children. 
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differentiated according to clinically meaningful subgroups.  Preliminary research 
also suggests that compared to the 1994 criteria, the Canadian case definition is 
superior in distinguishing CFS from psychiatric illnesses.  The new definition also 
detects cases with a greater level of functional impairment and more symptoms of 
fatigue or weakness, and neuropsychiatric and neurological symptoms than earlier 
criteria (Jason, Torres-Harding, Jurgens, & Helgerson, 2004).  It is important to 
recognise however, that like previous case definitions, the Canadian criteria were 
established through a consensual theoretical approach rather than empirical research.  
Currently, both the 1994 criteria and the Canadian case definition are commonly 
used to diagnose CFS. 
Due to the heterogeneity of CFS, several authors have attempted to the illness 
categorise into subtypes.  With this aim, Nisenbaum, Reyes, Mawle, and Reeves 
(1998) conducted telephone surveys with 1,150 people who had suffered from severe 
fatigue for at least one month.  A principal components analysis of symptoms 
revealed a three-factor structure accounting for intercorrelations among 14 
symptoms.  The factors included fatigue, mood and cognition, flulike symptoms, and 
visual impairment.  This factor structure only applied for participants who had 
experienced fatigue for more than six months, and no interpretable factor solution 
could be identified for those who had suffered severe fatigue for less than six 
months.  Jason, Taylor et al. (2002) also identified subgroups in a community-based 
telephone study involving 780 CFS patients diagnosed according to the 1994 criteria.  
A four-factor solution emerged from a factor analysis: lack of energy, physical 
exertion, cognitive disturbance, and fatigue and rest.  Using a cluster analysis 
approach, several other researchers have also successfully grouped CFS patients into 
subtypes according to illness severity (Arroll & Senior, 2009; Jason & Taylor, 2002; 
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Nisenbaum, Reyes, Unger, & Reeves, 2004) and fatigue type (Gielissen, 2007; Jason 
et al., 2009; Libman et al., 2008; Smets, Garssen, Bonke, & De Haes, 1995). 
 
CFS in Young People 
In the early 1990s, it became increasingly evident that illnesses characterised 
by chronic and debilitating fatigue were also common in children and adolescents.  
However, in the absence of research in paediatric patients, there was considerable 
uncertainty regarding how to characterise and diagnose young people.  Some authors 
argued that CFS should not be diagnosed in paediatric patients due to insufficient 
epidemiological and diagnostic research (Harris & Taitz, 1989; Plioplys, 1997).  
Although several studies indicated that CFS-like illnesses could be identified in 
young people, many patients did not meet any diagnostic criteria (Bell, 1997; Carter, 
Edwards, Kronenberger, Michalczyk, & Marshall, 1995; Feder, Dworkin, & Orkin, 
1994; Krilov, Fisher, Friedman, Reitman, & Mandel, 1998).  Researchers initially 
attempted to account for this by reducing the stringency of the diagnosis and limiting 
the symptom duration requirement to three months (Carter et al., 1995; Carter, 
Kronenberger, Edwards, Michalczyk, & Marshall, 1996; Smith et al., 1991; Vereker, 
1992).  However, this diagnostic approach was ad hoc and had little basis in 
empirical research. 
The Canadian case definition was the first set of criteria to make an explicit 
reference to paediatric populations.  The criteria specified that three months of 
fatigue was sufficient for children.  The authors also advised that compared to adults, 
the severity of symptoms may be more variable (Carruthers et al., 2003).  Again 
however, this description was ad hoc and there was a continuing need for an 
empirical approach to defining CFS in young patients. 
16 
 
In 2006, the first case definition for paediatric CFS was published (Jason et 
al., 2006).   The aim was to arrive at a set of objective criteria that would promote 
consistent diagnostic approaches in research and practice, provide authenticity to 
paediatric CFS, and protect children from being perceived as malingering or 
somatising.  The authors took a dimensional approach to the paediatric definition and 
borrowed symptom categories from the Canadian criteria.  Many of the minor 
symptoms were derived from factor-analytic studies.  Figure 1.3 presents the recently 
revised Paediatric Case Definition for CFS (Jason et al., 2008; see Appendix A for 
the complete paediatric definition of CFS). 
Compared to the adult criteria, fewer secondary symptoms are required for 
diagnosis in order to emphasise the importance of fatigue and compensate for 
variations in symptom severity.  A preliminary diagnosis can be made following one 
to two months of fatigue, and CFS is diagnosed if fatigue continues for at least three 
months.  Many premorbid somatic, cognitive, and depressive symptoms are not cited 
as a basis for exclusion, however a careful assessment is recommended to ensure that 
an alternative diagnosis does not more accurately account for the symptom 
presentation.  Lifelong fatigue was also removed as a condition for exclusion due to 
the difficulty in determining reliable premorbid functioning during childhood 
development.  It was noted that fatigue may manifest as irritability, and that 
compared to adults, children are characteristically more capable of adapting and 
accommodating to symptom development.  Therefore, it was recommended that 
performance and involvement in educative and recreational activities provides a 
more reliable indicator of functional impairment in young people.  School refusal 
was identified as an important differential diagnosis (Jason et al., 2006). 
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Figure 1.3. Paediatric Case Definition for CFS 
I. Clinically evaluated, unexplained, persistent or relapsing chronic fatigue over the 
past three months that 
A. is not the result of ongoing exertion 
B. is not substantially alleviated by rest 
C. results in substantial reduction in previous levels of educational, social and 
personal activities 
D. must persist or reoccur for at least three months 
 
II. The concurrent occurrence of the following classic ME/CFS symptom clusters, 
which must have persisted or recurred during the past three months of illness 
(symptoms may predate that reported onset of fatigue) 
 
A: Post-exertional malaise and/or postexertional fatigue 
x A loss of physical or mental stamina 
x Rapid/sudden muscle or cognitive fatigability 
x Post exertional malaise and/or fatigue 
x A tendency for other associated symptoms to worsen 
x A slow recovery, usually taking longer than 24 hours 
 
B: Unrefreshing sleep or disturbance of sleep quantity or rhythm 
x Prolonged sleep (including frequent naps) 
x Disturbed sleep 
x Day/night reversal 
 
C: Pain or discomfort that is often widespread and migratory in nature. At least 
one symptom from any of the following; 
x Myofascial and/or joint pain 
x Abdominal and/or head pain 
 
D: Two or more neurocognitive manifestations; 
x Impaired memory 
x Difficulty focusing 
x Difficulty finding the right word 
x Frequently forgetting what wanted to say 
x Absent mindedness 
x Slowness of thought 
x Difficulty recalling information 
x Need to focus on one thing at a time 
x Trouble expressing thought 
x Difficulty comprehending information 
x Frequently losing train of thought 
x New trouble with math or other educational subjects 
 
E: One symptom from two of the following categories; 
1. Autonomic manifestations 
2. Neuroendocrine manifestations 
3. Immune manifestations 
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Chapter Summary 
Examination of the historical context for CFS reveals why the illness remains 
poorly understood.  CFS has undergone several conceptual transitions since the 
initial reports of similar conditions in the 19th century.  Although the 
conceptualisation of fatiguing illnesses was initially received with great interest, 
failure to identify a biological cause and the social stigma associated with subsequent 
psychogenic conceptualisations caused these diagnoses to fall into relative disuse, 
impeding research progress in this area. 
Since the first case definition of CFS in 1988, there has been much 
disagreement about how the condition should be defined and diagnosed.  The 
Canadian definition enabled CFS to be more reliably distinguished from psychiatric 
conditions, and recent research classifying CFS patients into subgroups allowed for 
the heterogeneity of the illness to be integrated into the conceptualisation of CFS.  In 
the last decade, the unique presentation of CFS in children and adolescents was 
acknowledged through the development of paediatric diagnostic criteria.  As a 
consequence of these ongoing changes and recent developments, research efforts 
have been inconsistent, and CFS remains poorly understood, particularly in young 
people. 
The historical pattern leading up to our current understanding of CFS has 
been enormously variable.  The only consistent theme is the continuing confusion, 
debate, and frustration surrounding the conceptualisation of CFS.  At present, 
researchers agree that CFS is an exceedingly important and pertinent illness for 
study.  This is particularly true for young patients, who experience unique and 
profound impairment and disability at a pivotal life stage.  Recent findings regarding 
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the prevalence of CFS in young people are especially concerning.  As such, the 
following chapter will involve an exploration of the prevalence and impact of CFS in 
young people. 
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Chapter 2: Epidemiology and Aetiology of CFS in Young People 
This chapter presents an analytic synopsis of the research examining the 
epidemiology and aetiology of CFS in young people.  First, the methodological 
problems associated with the current research are explored in order to contextualise 
the discussion of the studies that follow.  Research examining the prevalence, course, 
and impact of CFS in young people is then presented to provide an estimate of the 
magnitude of the problem that CFS represents for young people.  This is followed by 
a discussion of the major aetiological theories of CFS in order to highlight the need 
for interventions designed to address key symptoms, such as cognitive impairment.  
Efforts were made to incorporate research from paediatric populations where 
possible. 
 
Methodological Issues 
The epidemiology of CFS in clinical and community samples is exceptionally 
difficult to determine.  Fatigue is an intangible, vague construct that is resistant to 
operationalisation and objective measurement (Wessely et al., 1998).  The severity 
and impact of CFS symptomatology is typically determined using self-report 
measures.  Moreover, people with unremitting, severe fatigue present with similar 
symptom patterns to those with CFS, making the distinction between these patients 
somewhat arbitrary and difficult to determine (Chester, 1997; Fukuda et al., 1997).  
Similarly, fatigue is a common core symptom of many physical and psychological 
conditions, making it difficult to accurately diagnose CFS patients in the absence of a 
thorough medical assessment (Wessely, 2001).  Research has been further impeded 
by the evolving case criteria and inconsistent diagnostic procedures and 
nomenclature (Maquet, Demoulin, & Crielaard, 2006).  As such, there is immense 
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heterogeneity between samples, and it is difficult to make reliable comparisons 
between studies or form generalisations to the entire CFS population (Demitrack, 
1998; Jason et al., 2005; Levine, 1997; Wessely et al., 1998). 
Research is even more challenging in paediatric populations.  Of the few 
studies investigating the epidemiology of CFS in young people, most involve small, 
heterogenic samples, and there is little consistency in the diagnostic and assessment 
approaches used between studies.  Further, samples of paediatric patients are largely 
obtained from tertiary organisations.  Given that CFS patients in tertiary heath care 
settings typically report higher levels of impairment and symptom severity than those 
in the community (Jason, Plioplys, Torres-Harding, & Corradi, 2003), many current 
findings may be limited to describing patients who are most severely affected by 
CFS.  For these reasons, caution is warranted in forming conclusions regarding the 
epidemiology of CFS in paediatric patients. 
 
Epidemiology of CFS 
Prevalence.  Fatigue is a common complaint in clinical and community 
populations (Chen, 1986).  Estimates from worldwide community studies indicate 
that the prevalence of significantly elevated fatigue is approximately 20-25% 
(Kroenke & Price, 1993; Lorge, Ekeberg, & Kassa, 1998).  Similarly, 21-27% of 
people in clinical populations report prolonged, high levels of fatigue (Bates et al., 
1993; Buchwald, Sullivan, & Komaroff, 1987; Kroenke, Wood, Mangelsdorff, 
Meier, & Powell, 1988).  The incidence of fatigue is consistently higher among 
females, although the gender ratio varies considerably between studies (Kroenke et 
al., 1988).  Chronic fatigue is also common in nonclinical adolescent populations.  
Based on semistructured interviews in 8,580 randomly selected households,  14.9% 
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of those aged between 16 and 24 reported chronic fatigue lasting at least six months 
(Watanabe, Stewart, Jenkins, Bhugra, & Furukawa, 2008).  Similar results were 
found using a multidimensional questionnaire in 3,467 adolescents aged from 12 to 
18.  Notable differences were identified between boys and girls, with 20.5% of girls 
and 6.5% of boys scoring above the clinical cut-off for severe fatigue.  Of these 
participants, 80.0% of the girls and 61.5% of the boys reported severe fatigue for at 
least one month (ter Wolbeek, van Doornen, Kavelaars, & Heijnen, 2006). 
One of the earliest studies to investigate the prevalence of CFS in young 
people was conducted in Australia (Lloyd, Hickie, Boughton, Spencer, & Wakefield, 
1990).  General practitioners (GPs) were asked to detect possible cases of CFS in 
patients presenting at doctors’ clinics.  Following GP referral, patients completed a 
screening questionnaire, participated in interviews conducted by both a physician and 
a psychiatrist, and underwent a medical examination to exclude alternative 
diagnoses.  Point prevalence rates were estimated at 0.37% in adults, 0.47% in those 
aged between 10 and 19, and 0.05% in children aged under 10 years.  However, 
compared to similar research in adults, this estimate is moderately low (Cho, 
Menezes, Hotopf, Bhugra, & Wessely, 2009; Wessely, Chalder, Hirsch, Wallace, 
Wright, 1997).  A possible explanation for this discrepancy is that the probable CFS 
cases were detected through GPs.  Some patients with CFS may not have attended a 
GP clinic during the data collection period.  Further, many GPs are sceptical about 
the existence of CFS (Bowen, Pheby, Charlett, & McNulty, 2005; Raine, Carter, 
Sensky, & Black, 2004), and a follow-up of nearly half of the GPs in the original 
study revealed that 19 possible cases may have been undetected (Lloyd et al., 1990).  
Therefore, these results may underestimate the prevalence of CFS.  Nonetheless, it is 
interesting to note that the prevalence rates were highest in the adolescent group.  
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This could be attributable to extraneous factors such as the recruitment method.  For 
example, young people may have been more likely to attend a GP clinic.  However, 
it is also possible that CFS is most common in the adolescent age group. 
Due to their scope, community-based screening assessments capture a greater 
number of people presenting with severe chronic fatigue.  Using this approach, a 
screening of over 12,000 households was conducted in a sample of five- to 17-year 
olds.  Over 4% of respondents reported significant fatigue, and 2.05% were 
diagnosed with a CFS-like illness.  Higher rates of CFS-like illnesses were observed 
in adolescents (2.91%) compared to prepubescent children (1.96%), and the rates 
were similar between males (47.5%) and females (52.5%; Jordan et al., 2000). 
However, much lower prevalence estimates have been reported in other 
studies using the same approach.  In a large telephone-based screening of 8,004 
households containing 16,970 residents, participants were given a survey followed 
by a brief interview.  Respondents who appeared to meet the 1994 case definition 
accounted for 0.2% of adult respondents, and a further 1.8% were classified as 
idiopathic chronic fatigue-like cases.  Of the 2,343 residents under the age of 18, 15 
(0.77%) reported fatigue lasting more than one month.  However, eight (0.34%) of 
these participants reported fatigue lasting more than six months, of whom three were 
diagnosed with exclusionary conditions, four (0.17%) had idiopathic chronic fatigue, 
and one (0.04%) appeared to meet the 1994 criteria (Steele et al., 1998). 
Similar results were found in a screening of 10,438 mothers of children aged 
between five and 15 across the United Kingdom.  Chronic fatigue was defined as 
severe fatigue associated with functional impairment of at least six months' duration, 
for which rest did not alleviate.  CFS was defined according to the 1994 criteria.  
Although 34.1% of the 4,240 children aged between 11 and 15 endorsed feelings of 
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fatigue, 0.57% reported chronic fatigue and 0.19% met the criteria for CFS.  
Moreover, only 0.04% of parents reported that their child had been officially 
diagnosed with CFS or ME (Chalder, Goodman, Wessely, Hotopf, & Meltzer, 2003).  
The same research group later conducted a prospective study with 842 adolescents 
aged between 11 and 15.  Incidence rates over a period of four to six months were 
1.1% for chronic fatigue, and 0.5% for CFS (Rimes et al., 2007). 
A significant limitation of these community-based studies is that the data 
were derived from self-report questionnaires or basic interviews.  In the absence of a 
medical examination, excusatory conditions cannot be reliably ruled out in 
accordance with standard diagnostic procedures.  This limits diagnostic accuracy, 
potentially causing inflated prevalence estimates.  One group sought to overcome 
this problem by investigating nationwide prevalence and incidence rates using a 
similar approach to the study by Lloyd et al. (1990).  A representative sample of 354 
GPs in the Netherlands completed questionnaires regarding the prevalence of CFS in 
their patients aged 10 to 18 years.  In addition, paediatric hospital departments 
prospectively reported new cases of CFS in adolescent patients.  Prevalence was 
estimated at 0.11% and incidence was 0.01% (Nijhof et al., 2011).  Although this 
study relied on GP notifications, all Dutch citizens must be registered within a GP 
clinic, and GP referral is mandatory for patients to access hospital care.  Further, GPs 
are required to make detailed records of patient diagnoses, reducing the likelihood 
that GPs relied on retrospective recall to report cases. 
The prevalence studies discussed above each share the common problem of 
identifying CFS in young people according to adult case definitions.  It is widely 
recognised that the adult criteria are not equally applicable to paediatric patients, and 
the criterion that fatigue must be present for at least six months is generally 
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considered to be excessive for children and adolescents (Carter et al., 1995; Carter et 
al., 1996; Smith et al., 1991; Jason et al., 2006; Vereker, 1992).  As such, it is 
probable that these studies underestimate the prevalence of CFS in young people 
(Marshall, 1999). 
In seeking to account for this issue, Farmer, Fowler, Scourfield, and Thapar 
(2004) investigated the prevalence of chronic fatigue and CFS using a range of 
definitions.  The inhabitants of 1,468 households completed initial screening 
questionnaires, and follow-up telephone interviews were conducted in eight- to 17-
year-olds who reported disabling fatigue lasting several days or more.  The lifetime 
prevalence estimate of fatigue lasting more than three months was 2.34%, although 
this figure dropped to 1.9% when fatigue was accompanied by at least four of the 
minor criteria from the 1994 case definition.  The prevalence of fatigue lasting more 
than six months accompanied by at least four of the minor symptoms was 1.29%.  As 
expected, this suggests that a paediatric diagnostic approach produces somewhat 
higher prevalence estimates compared to when young patients are diagnosed 
according to adult criteria.  Note however, that although most other studies include 
point prevalence rates, these figures provide estimates of lifetime prevalence rates, 
which are almost certain to be higher. 
At present, prevalence estimates of CFS in young people are derived from a 
small number of studies that are limited by inconsistent diagnostic approaches and 
samples of patients who did not meet the full criteria for CFS.  Future research using 
the paediatric case definition is needed to gain a more accurate estimate of the 
prevalence of CFS in young populations.  To date, the literature suggests that CFS 
may be similarly common in adolescents and adults.  However, the emerging 
research suggests that the impact of CFS is unique and perhaps most profound in 
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younger patients, often resulting in significant disruptions in development and 
wellbeing throughout life. 
 
Course.  Although research in younger populations is scarce, preliminary 
findings suggest that the course of CFS is similar in adult and paediatric patients 
(Mears, Taylor, Jordan, & Binns, 2004).  Like in adults, illness course appears to be 
somewhat variable in young populations.  Some patients experience intermittent 
patterns of relapse and remittance, while others suffer from persistent, unchanging 
symptoms (Nisenbaum, Jones, Unger, Reyes, & Reeves, 2003; Smith et al., 1991).  
The period of illness onset is also variable.  For instance, 60% of adolescents in one 
study reported that onset occurred suddenly following an acute illness (Krilov et al., 
1998), while around 75% of adolescents in another study reported that onset was 
gradual (Patel, Smith, Chalder, & Wessely, 2003).  Young CFS patients also 
commonly report premorbid organic and psychological health problems (Rangel, 
Garralda, Levin, & Roberts, 2000), and high rates of comorbid psychological 
disturbances have been identified in both adolescent and adult populations (Hickie, 
Lloyd, & Wakefield, 1995; Patel et al., 2003; Rangel, Garralda, Hall, & Woodham, 
2003). 
Although the results are mixed, the prognostic outcome for CFS appears to be 
more positive for young patients compared to adults.  For instance, in a review of 
studies with varied follow-up durations, 54-94% of children and adolescents with 
chronic fatigue made substantial improvements or completely recovered, while only 
0-6% of adults with CFS returned to their premorbid health status (Joyce, Hotopf, & 
Wessely, 1997).  Importantly however, the children in these studies presented with 
chronic fatigue, while the adults met the criteria for CFS.  Given that the recovery 
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rates are much higher in those with chronic fatigue compared to CFS (Gill, Dosen, & 
Ziegler, 2004), the divergent prognostic outcome between adults and young people 
could be attributable to differences in illness type rather than age. 
Other research suggests that a significant portion of young CFS patients 
remain symptomatic for several years, and complete recovery from paediatric CFS is 
rare (Dale & Straus, 1992).  One group evaluated prognosis over a period of four 
years in a sample of 42 CFS patients aged between seven and 21 years.  At baseline, 
half the participants had been fatigued for one to six months and the other half had 
been fatigued for seven to 36 months.  After one year, 59% continued to report 
moderate to severe symptoms, although most patients gradually improved over the 
following three years.  At the final interview, 43% of parents considered their child 
to be completely recovered, 52% reported that their child had improved but not 
recovered, and 5% believed that their child had not improved at all (Krilov et al., 
1998).  Comparable results were found in a 13-year study involving 35 children and 
adolescents with CFS.  At follow-up, 13 participants (37.1%) considered themselves 
to be completely recovered, 15 (42.9%) reported that they were well but not 
recovered, four (11.4%) believed that they were chronically ill, and three (8.6%) 
considered themselves to be more ill than they had been previously (Bell, Jordan, & 
Robinson, 2001).   
However, many patients who report significant improvements continue to 
suffer debilitating symptoms.  For instance, in the 13-year follow-up study, half of 
those who stated that they were functioning well reported mild symptoms and 
activity limitations (Bell et al., 2001).  Similar results were found in a study of 28 
CFS patients aged between seven and 17 who were being treated in a specialist 
paediatric psychiatric service.  Although most young people regarded themselves to 
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be fully recovered at three-year follow-up, about one third reported ongoing 
disabling symptoms, and nearly 40% continued to experience fatigue (Sankey, Hill, 
Brown, Quinn, & Fletcher, 2006).  This suggests that even among those patients who 
identify as recovered or significantly improved, many experience ongoing symptoms 
and impairment. 
One group found that prognosis appears to be considerably worse for young 
CFS patients compared to fatigued patients who do not meet the criteria for CFS.  
Following an average of 4.57 years, 25% of 16 adolescents with CFS had made a 
complete recovery, while 44% continued to meet met the 1994 criteria for CFS.  In 
contrast, of the 10 participants who reported fatigue lasting more than six months, 
50% reported an almost complete recovery, 10% reported a partial recovery, and 
40% reported no improvement.  Most remarkably, all of the eight adolescents who 
had presented with disabling unexplained fatigue of less than six months duration 
had made a complete recovery (Gill et al., 2004). 
In adult patients, the best predictors of poor prognosis include older age, 
greater illness chronicity, higher incidence of psychological illnesses, and increased 
somatic attributions to illness cause (Joyce, et. al., 1997).  Conversely, Gill et al. 
(2004) found that demographic factors are not reliable predictors of prognosis.  
Interestingly, secondary school attendance when unwell is an exceptionally strong 
predictor of positive outcomes in school-aged patients (Bell et al., 2001). 
Taken together, these findings suggest that although the course of CFS is 
variable, many young patients suffer from ongoing symptoms and impairment, and 
few make a full recovery even after several years.  Moreover, it is important to note 
that young people with lifelong fatigue and patients who were unable to determine 
the period of illness onset were typically excluded from these studies.  As such, the 
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data may underestimate the long-term morbidity of CFS in young people.  The 
implications for ongoing illness are likely to be considerable when they occur at this 
vulnerable time of identity formation, academic accomplishment, and general 
developmental growth. 
 
Impact.  The unique impact of CFS in young people perhaps represents the 
greatest distinction between paediatric and adult CFS.  For adolescents, CFS can 
have a particularly substantial negative effect on education, psychological wellbeing, 
social relationships, and physiological functioning.  Due to the critical processes 
necessary for normal development in young people, CFS is likely to have a 
distinctive and profoundly damaging impact on this age group. 
 
Educational disturbance.  Frequent school absenteeism is a characteristic 
feature of CFS in young patients, and CFS constitutes the leading cause of long-term 
sickness resulting in absence from school (Colby, 2006).  In a longitudinal study of 
adolescents aged between 12 and 17, all 28 participants reported that CFS had 
interfered with their education to some degree.  At the initial interview, 21% were 
attending school part time or receiving home tuition, and 43% ceased regular 
schooling and participated in home education at some stage over a three-year follow-
up.  Following a period of absence, 64% took up to three months to return to school 
and 14% took even longer.  Further, 54% reported that this process was difficult or 
very difficult, and 68% felt that their illness had affected their education or career 
plans significantly (Sankey et al., 2006). 
Young CFS patients often miss a significant amount of school over extended 
periods.  This was demonstrated in a 13-year follow-up study involving 35 
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adolescents with CFS.  Over this time, eight participants had missed one to six 
months of school, three had missed six to 12 months, two had missed one to two 
years, and eight had missed two years or more (Bell et al., 2001).  Another group 
found that 41 school-aged CFS patients missed 33% of classes over a period of one 
month.  In addition, the 13 adolescents who were not of school age worked 38.7% of 
a full time job (van Geelen, Bakker, Kuis, & van de Putte, 2010).  Comparable 
results were observed in a larger study involving 211 young patients from a specialist 
paediatric CFS service.  Only 11% attended full-time school, 49% attended 20% or 
less, 62% attended 40% or less, and 28% did not attend school at all (Crawley & 
Sterne, 2009). 
A comprehensive investigation of school absenteeism was conducted in a 
cross sectional study of 36 adolescents with CFS.  The average rate of school 
attendance in the week preceding the survey was 29.9%.  During that period, 44% 
had not attended school at all, and only 37.5% attended more than half the full school 
week.  Over two-thirds of the sample expressed worry about returning to school, and 
38.9% felt that their school had not supported their educational requirements (Patel et 
al., 2003).  These factors could contribute to the tendency for CFS patients to avoid 
school and might explain why many do not return to school after their symptoms 
improve. 
It is possible that school absenteeism occurs as a consequence of the 
difficulties associated with managing school while suffering from a chronic illness.  
However, research suggests that absenteeism is a unique feature associated with CFS 
and not other debilitating chronic illnesses.  For instance, one group found 39% of 28 
CFS patients missed 15-50% of school compared to none of the patients with 
Juvenile Idiopathic Arthritis (JIA) and 15% of patients with an emotional disorder.  
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Further, 43% of those with CFS missed at least one school term compared to 3% of 
the JIA group and 15% of the emotional disorders group (Garralda & Rangel, 2004).  
Similar results were found in a study comparing young CFS patients with patients 
suffering from Juvenile Rheumatoid Arthritis (JRA) or Major Depressive Disorder 
(MDD).  In the CFS group, the average number of school days missed since being 
unwell was 72, and 86% required either half days or home-based education to 
accommodate for their condition.  In contrast, adolescents with MDD and JRA 
missed 11.4 and 7.5 days per year respectively (Gray, 2001).  These results suggest 
that the frequency of school absenteeism in CFS patients is unlikely to be caused by 
the general physical or emotional impact of chronic illness.  Intriguingly, this 
indicates that there is something unique to CFS that causes patients to avoid school. 
In the context of such severe school absenteeism, it is not surprising to find 
that CFS is associated with poor academic achievement.  Results from a cross-
sectional survey in 36 CFS patients revealed that students achieved three out of 10 
passes on average over an 18-month period.  Of these students, 44% received more 
than five passes, 25% received one to four passes, and 30.6% failed to receive a 
single pass grade or even sit their examinations (Patel et al., 2003).  In a more recent 
study, 70% of 21 adolescents with CFS had failed at least one year of study since 
illness onset.  Further, 70% were unable to follow the standard exam schedule, and 
only 33% of students felt that their grades were in accordance with their capacities 
(van Hoof, De Becker, Lapp, & De Meirleir, 2009). 
Research in this area is impeded by inconsistencies in time parameters, 
participant sampling, and methods of data collection.  This makes it difficult to 
compare findings across studies and generalise the results to the population of young 
CFS patients.  Nonetheless, these initial findings depict a clear pattern of significant 
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school absenteeism and educational impairment among young CFS patients.  Due to 
the fundamental importance of the many educational and social functions of 
schooling (Newman & Newman, 1987), prolonged periods of absence may result in 
enduring consequences within a range of essential developmental processes.  At this 
stage, it is unclear whether poor academic performance is a consequence of school 
absenteeism, cognitive impairment, or a combination of both.  Determining the 
unique contributions of these factors may lead to important new insights regarding 
how to address academic decline in young patients. 
  
Psychological disturbance.  Young people with CFS often report 
considerable psychological problems.  For instance, in a study of 54 adolescents with 
CFS, mean self-report scores on measures of mental health and self-esteem were 
approximately one standard deviation below those of the healthy population (van 
Geelen et al., 2010).  Young CFS patients also tend to report higher levels of 
psychological distress compared to young people with other chronic illnesses.  For 
example, Garralda and Rangel (2004) found that CFS participants responded to 
illness-related problems with increased levels of anxiety and depression than those 
with JRA or an emotional disorder.  However, both the CFS and the emotional 
disorders group reported higher levels of anger than those with JRA.  In a similar 
study, Gray et al. (2001) administered the Minnesota Multiphasic Personality 
Inventory – Adolescent (MMPI-A) to a small sample of young people with CFS or 
JRA.  Compared to participants with JRA, the CFS patients scored significantly 
higher on Conversion Hysteria and demonstrated clinical elevations on the 
Hypochondriasis, Hysteria, and Depression scales (Gray et al., 2001). 
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Several studies also suggest that diagnosable psychiatric disorders are 
common in young CFS patients.  One group identified psychiatric disorders in 
approximately half of 50 children and adolescents with a history of CFS.  Anxiety 
and depressive disorders were the most commonly diagnosed conditions (Garralda, 
Rangel, Levin, Roberts, & Ukoumunne, 1999).  The prevalence of comorbid 
psychiatric disorders also appears to be higher in young CFS patients compared to 
those with other chronic illnesses.  For instance, Rangel et al. (2003) identified 
psychiatric disorders in 72% of paediatric CFS patients compared to 34% of patients 
with JIA.  The CFS group also reported greater levels of impairment associated with 
a psychiatric illness.  The most common psychiatric complaints included depressive 
and anxiety disorders, as well as personality disturbances.  Another group found that 
even after controlling for somatic symptoms, adolescents with CFS scored 
significantly higher on a scale of depression compared to those diagnosed with JRA 
(Brace, Smith, McCauley, & Sherry (2000).  These findings suggest that the high 
rates of psychopathology in young CFS patients cannot be explained entirely by the 
presence of a chronic physical illness. 
Questions have been raised as to whether psychological disturbances 
contribute to the development of CFS or if mental health deteriorates following the 
onset of CFS.  One group investigated this subject using a prospective research 
approach in 301 adolescents diagnosed with glandular fever.  Six months following 
the infection, 39 participants met the criteria for CFS, and a further 39 recovered 
patients were selected to match the CFS participants.  While suffering from glandular 
fever, both groups reported similar levels of emotional function.  However, at a six- 
and 12-month evaluation, those who had developed CFS reported more difficulty 
with emotional function than the recovered controls, although these differences were 
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no longer significant at a 24-month follow-up (Taylor et al., 2010).  These results 
suggest that psychological distress emerges following the development of CFS.  
However, it is unclear whether CFS acts as a causative agent or whether extraneous 
factors lead to the development of both CFS and psychological symptoms. 
Together, the emerging research provides a clear indication that young people 
with CFS suffer from significant psychological distress and frequent comorbid 
psychiatric disorders.  The distress and functional impairment associated with 
psychological disturbances contributes to the already profound impact of CFS in 
young sufferers.  Moreover, patients suffering from these symptoms in adolescence 
may continue to experience psychological and interpersonal problems throughout 
life. 
 
Psychosocial impairment.  Preliminary research suggests that CFS interferes 
with psychosocial development and function in young people.  Rangel et al. (2000) 
noted that when illness was at its worst, family relationships became strained and the 
frequency of social contact declined.  In a recent study involving 27 CFS patients 
aged between 12 and 21, approximately half reported that they have had fewer 
friends since illness onset, and most limited their social outings with friends to once 
per month.  Around half the participants reported conflicts at school associated with 
CFS, and 56% reported that they had received negative comments from peers when 
they participated in leisure activities.  This was despite indications that 90% had quit 
their hobby due to their condition and that 93% did not participate in extracurricular 
activities (van Hoof et al., 2009).  
Findings from a prospective study also suggest that CFS patients engage in 
normal social activity prior to the development of CFS.  Specifically, no significant 
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differences were observed in social activity between patients with glandular fever 
who either went on to develop CFS or to make a full recovery.  However, at a six-, 
12-, and 24-month follow-up, those who had developed CFS reported greater 
limitations to social activity than the fully recovered matched controls (Taylor et al., 
2010). 
Preliminary research suggests that social impairment is not an inevitable 
outcome of chronic illness, but rather a unique feature associated with CFS.  For 
instance, Brace et al. (2000) found that compared to young people with JRA, CFS 
patients perceived themselves to be less socially competent.  Another group found 
that CFS patients participated less frequently in activities at home and with friends 
than patients with JIA or an emotional disorder.  Compared to the JIA group, the 
CFS participants also reported greater disturbances in social and familial 
relationships, as well as increased conflict with friends and family.  However, those 
with emotional disorders reported more severe disturbances on these measures and 
were more likely to withdraw socially than the CFS group (Garralda & Rangel, 
2004).  These results suggest that disturbances in social functioning are not simply a 
consequence of chronic illness or physical disability but that CFS is uniquely 
associated with social impairment.  Emotional disturbances, which frequently co-
occur with CFS, may also exacerbate the social impact of CFS. 
The results from other research investigating the social impact of CFS have 
been less consistent.  One group found that compared to population norms, a group 
of 36 female adolescents with CFS reported lower perceived competence in romance 
and less participation in recreational activities.  However, perceptions of social 
acceptance and friendships were within the normal range (van Middenthorp, Geenen, 
Kuis, Heijnen, & Gerben, 2001).  Another group found that young CFS patients 
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reported greater social limitations and less family activity than healthy controls, 
although there were no group differences with respect to family cohesion (Kennedy, 
Underwood, & Belch, 2010). 
CFS patients also appear to be particularly susceptible to victimisation.  Van 
Houdenhove et al. (2001) conducted a thorough investigation of victimisation in 95 
adults with either CFS or Fibromyalgia.  Comparison groups included a chronic 
illness group comprising of 26 Rheumatoid Arthritis patients and 26 Multiple 
Sclerosis (MS) patients, and a healthy control group matched for gender, age, civil 
state, and level of education.  Of those with CFS or Fibromyalgia, 64.1% reported 
victimisation compared to 42.3% of the chronic illness group.  The CFS patients also 
reported significantly greater levels of emotional neglect and abuse than the other 
control groups.  Physical abuse was more common in the CFS group compared to 
healthy controls but not the chronic illness group.  The rates of sexual harassment or 
abuse were similar between groups.  Compared to the other chronically ill patients, 
victimisation was more likely to be carried out by a family member, occur over a 
life-long period, and have a greater negative impact in the CFS group (Van 
Houdenhove et al., 2001). 
Taken together, these results suggest that CFS patients suffer profound 
psychosocial impairment and are subject to significant victimisation and abuse.  
Given that the formation of interpersonal relationships is considered to be a vital 
component of adolescent development (Greenberg, Siege, & Leitch, 1983), the 
psychosocial disturbances associated with CFS are likely to be particularly disruptive 
for young people.  These disturbances may limit lifelong opportunities and impede 
the negotiation of the social developmental tasks of adolescence. 
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Physical impairment.  Physical limitations are another source of considerable 
impairment for young sufferers of CFS.  In many cases, children are unable to 
perform basic mobility activities.  One group found that when illness was at its 
worst, 57% of 25 adolescents had been bedridden for prolonged periods and several 
others were confined to a wheelchair (Rangel et al., 2000).  In a more recent study, 
24 of 28 young CFS patients reported difficulty with mobility and could only walk 
with support for short distances or not at all (Sankey et al., 2006).  However, it is 
worth noting that the patients in these studies were drawn from tertiary healthcare 
settings, where the most severely affected patients are likely to present.  As a result, 
these findings may overestimate the prevalence and severity of physiological 
impairment in CFS patients.  Conversely, a substantial portion of patients who were 
approached for these studies chose not to participate.  It is probable that some 
declined due to the severity of their condition, lowering the prevalence estimates of 
severe physiological impairment. 
Physiological impairment may also cause further limitations to activity.  For 
instance, in a community sample of 25 CFS patients aged from nine to 18, significant 
role or social limitations were attributable to physical health problems (Kennedy et 
al., 2010).  Similarly, self-report data from a sample of 211 young CFS patients 
indicated that physical function, and not anxiety, depression, or pain, was positively 
related to school attendance.  Of this sample, 98% reported limitations to mobility or 
activities of daily living (Crawley & Sterne, 2009).  These findings indicate that 
physical impairment may lead to withdrawal from social and educational activities. 
Based on the small number of studies conducted thus far, physiological 
function appears to be severely limited in a significant portion of young CFS 
patients, resulting in reduced participation in educational, social, and recreational 
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activities.  Therefore, physiological deterioration could potentially amplify the 
already profound impairments experienced by young CFS patients. 
 
Conclusion.  Epidemiological research for CFS in young populations is still 
in the preliminary stages.  To date, findings suggest that the prevalence rates in 
adolescents approach those observed in adults.  Recovery is prolonged for many, and 
although most young patients improve over time, symptoms often persist for years 
and many patients fail to recover completely.  In addition, CFS causes considerable 
impairment that uniquely affects young patients, interfering with several vital 
developmental behaviours and activities at an especially vulnerable age.  Given that 
CFS has such a profound impact on a significant number of young patients over 
prolonged periods, it is important to build a sound understanding of how young 
patients are affected.  However, even though cognitive impairment is a common 
symptom that can cause considerable disruption to development and education, little 
is known about the nature and extent of cognitive dysfunction in young patients.  
Further research aimed at developing a more complete understanding of how CFS 
affects young patients will assist in the process of establishing appropriate and 
effective treatments for this population. 
 
Aetiology of CFS 
Despite more than two decades of rigorous research, the aetiology of CFS 
remains largely unknown.  Findings from the existing literature are typically 
ambiguous and contradictory.  With the exception of psychiatric theories, paediatric 
populations have largely been excluded from aetiological research, and current 
conceptualisations rely on the assumption that children and adults share similar 
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pathophysiological processes.  The following includes a brief examination of the 
major aetiological theories for CFS. 
 
Infectious process theories.  Observations of viral infections preceding the 
development of CFS, along with evidence of shared symptomatology between CFS 
and infectious illnesses led researchers to theorise that infection was an important 
causative factor in CFS (Levy, 1994).  Initially, researchers gave considerable 
attention to the role of EBV (Buchwald et al., 1987).  Early research suggested that 
compared to healthy people, patients with a prolonged illness have elevated levels of 
EBV antibodies (Tobi et al., 1982).  Yet further studies revealed that group 
differences are often mild or not statistically significant, and the majority of people 
who are infected with EBV do not go on to develop a chronic illness (Buchwald et 
al., 1987). 
However, subsequent research reaffirmed the relationship between CFS and 
infectious illnesses.  In a prospective Australian study, researchers investigated 253 
patients infected with EBV, Coxiella Burnetii (Q fever), or Ross River virus.  Six 
months following the initial infection, 11% of patients met the criteria for CFS and a 
further 1% developed a fatigue syndrome.  However, the strongest predictor of 
enduring fatigue was the severity of the original illness rather than infection type, 
demographic variables, or psychological factors (Hickie et al., 2006).  Using a 
similar approach, another group found that patients with glandular fever and EBV 
were no more likely to develop CFS than those who had glandular fever alone 
(White et al., 1998; White et al., 2001).  Recent evidence also suggests that CFS 
patients have high rates of enteroviral RNA (Chia, 2005; Chia & Chia, 2008; Colby, 
2007; Jason et al., 2005). 
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The infectious illness hypothesis has also been investigated in samples of 
young patients.  One group identified serological evidence of a recent EBV-
associated infectious mononucleosis in five of 36 paediatric patients with chronic 
fatigue (Carter et al., 1995).  Laboratory investigations in another sample of 15 
adolescents with CFS revealed little evidence of an active infection and no evidence 
of HHV-6, CMV, Coxsackie virus, EBV, or Toxoplasma (Smith et al., 1991).  In a 
more recent investigation of 58 young people with chronic fatigue, 60% indicated 
that their fatigue first began during an acute infection.  Indicators of previous EBV 
were detected in 55% of the sample, although only three of these participants 
demonstrated evidence of an acute infection in the six months preceding assessment 
for CFS (Krilov et al., 1998). 
It is important to note that the infectious process hypothesis is frequently 
undermined by other research suggesting that CFS often develops following a 
noninfectious illness or without any apparent preceding condition (Salit, 1997).  
Even in those studies where infections have been detected, the vast majority of 
patients exhibit normal laboratory results.  As such, it appears likely that the link 
between CFS and infection is only small or indirect. 
 
Immunological disturbance theories.  Evidence of a relationship between 
CFS and infectious diseases generated interest in the role of immunological 
disturbances in the onset CFS.  Immune system dysfunction may be directly 
responsible for generating some of the common symptoms of CFS.  For instance, 
disturbances in the levels of certain cytokines are associated with fatigue, sleep 
disturbance, myalgia, and fever (Moldofsky, 1993).  Alternatively, immune system 
abnormalities could have a more indirect association with CFS through the activation 
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of latent infections or by generating an abnormal response to infection.  A range of 
immune system abnormalities have been identified in CFS patients. 
Abnormalities in the quantity and activity of natural killer (NK) cells are 
common in CFS patients, although there is little consistency between studies in the 
nature of these abnormalities (Bates et al., 1995; Gold et al., 1990; Klimas, Salvato, 
Morgan, & Fletcher, 1990).  Using serological evaluations, one group found that 
CFS patients had elevated numbers and reduced cell cytotoxicity of NK cells 
(Klimas et al., 1990), and another group found that CFS patients with low NK cell 
activity had greater fatigue, sleep disturbance, functional impairment, and cognitive 
deficits compared to those with normal NK cell activity (Siegal et al., 2006).  See 
and Tilles (1996) also found that NK cell activity increased in CFS patients 
following treatment with interferon, and this change was associated with 
improvements in quality of life.  In contrast, several studies suggest that CFS patients 
have increased NK cell activity (Gold et al., 1990; Peakman, Deale, Field, 
Mahalingam, & Wessely, 1997).  Given that stress and depressive symptoms often 
correlate strongly with low NK cell activity (Bonneau, Sheridan, Feng, & Glaser, 
1991), these contradictory findings could be at least partially explained by patient 
differences in psychological distress. 
T-cell function has also been investigated in CFS aetiology.  T-cells have a 
central role in cell-mediated immunity and belong to the same group of white blood 
cells as NK cells.  Researchers have identified lower numbers and reduced function 
of T-cells in CFS patients compared to healthy controls (Lloyd, Wakefield, 
Boughton, & Dwyer, 1989) and depressed patients (Lloyd, Hickie, Hickie, Dwyer, & 
Wakefield, 1992).  However, examination of T-cell subtypes reveals that the patterns 
of abnormality are largely inconsistent (Gold et al., 1990; Klimas et al., 1990; 
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Landay, Jessop, Lennette, & Levy, 1991; Wilson Hickie, Lloyd, Hadzi-Pavlovic, & 
Wakefield, 1995). 
Young CFS patients have been included in a small number of studies 
investigating immunological disturbances.  Ter Wolbeek et al. (2007) recently 
conducted a longitudinal study involving 61 nonfatigued and 67 severely fatigued 
adolescent girls, 11 of whom met the criteria for CFS.  No diơerences between 
groups were observed in mitogen-induced cytokine production or T-cell 
proliferation.  However, despite similar levels of symptom severity between the CFS 
group and the severely fatigued patients, only those with CFS exhibited increased 
levels of anti-inflammatory cytokines and reduced levels of proinflammatory 
cytokines.  Rowe (1997) also found that infusions of gammaglobulin, an 
immunological restoration treatment, were similar to a placebo in generating 
functional improvements in adolescent CFS patients.  Finally, using a prospective 
study in 14 children who initially presented with nonspecific symptoms, one group 
found that antinuclear antibodies and the antibody to the 62 kDa protein were 
significant risk factors for the development of CFS, indicating that autoimmunity 
may be related to the pathogenesis of childhood CFS (Itoh et al., 1997, 1998). 
Researchers have also investigated the role of intracellular immune function 
in CFS.  Several studies suggest that the 2-5A synthetase/RNase L pathway is 
strongly dysregulated in CFS patients (De Meirleir & Bisbal, 2000; Nijs & De 
Meirleir, 2005; Suhadolnik et al., 1999; Suhadolnik, Reichenbach, Hitzges, Sobol et 
al., 1994).  Further, studies covering diverse international populations suggest that 
CFS patients have lower activity levels of 2-5A synthetase, increased concentrations 
of activated 2-5A synthetase, and elevated RNase L activity compared to healthy 
controls (Suhadolnik et al., 1999; Suhadolnik, Reichenbach, Hitzges, Adelson et al., 
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1994; Suhadolnik, Reichenbach, Hitzges, Sobol et al., 1994).  More recently, 
researchers have identified an association between indicators of intracellular immune 
dysfunction and CFS severity (Meeus et al., 2008; Snell, Vanness, Strayer, & 
Stevens, 2002, 2005). 
Despite being investigated at length, consistent patterns of immunological 
disturbances have not been identified.  Indeed, one group noted that the collection of 
research findings is so diverse that almost any conclusion could be drawn about 
immunological disturbances in CFS (Lyall, Peakman, & Wessely, 2003).  Even when 
disturbances have been identified, they do not provide an adequate or complete 
explanation for the severity of symptoms and level of impairment observed in CFS 
patients.  The inconsistent and contradictory findings could be partially explained by 
a range of methodological issues, such as inconsistencies in the application of 
immunological parameters and laboratory techniques.  Moreover, due to the often 
small and heterogenic samples used, many studies may have failed to account for 
potentially important differentiating factors such as illness length, inactivity, 
medication and comorbid psychiatric conditions (Lyall et al., 2003).  In consideration 
of these factors, it seems likely that as a group, CFS patients are affected by a range 
of subtle immunological abnormalities.  However, the diversity of the results 
suggests that the immune system plays a complex and multifaceted role in CFS 
aetiology that is far from being well understood. 
 
Psychological theories.  In the absence of a consistent physiological marker 
for CFS, many researchers proposed that an underlying psychiatric process could be 
central to illness aetiology.  Evidence for this was initially drawn from consistent 
findings that CFS patients have high rates of comorbid psychological disturbances 
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(Hickie et al., 1995; Patel et al., 2003).  The prevalence of psychiatric disorders in 
CFS patients ranges between approximately 50-75% for both adults (Matsuda et al., 
2009; Nater et al., 2009; Wessely & Powell, 1989) and young people (Garralda et al., 
1999; Lines, 2004).  Mood and anxiety disorders are consistently identified as the 
most common conditions.  Researchers have suggested that the frequency of 
psychiatric disorders in CFS patients is caused by the ongoing stress and demands of 
suffering from a chronic illness.  However, this is inconsistent with evidence 
suggesting that psychiatric illnesses are more common in young CFS patients 
compared to patients with other chronic illnesses such as JRA (Brace et al., 2000), 
JIA (Rangel et al., 2003), and MS (Johnson, DeLuca, & Natelson, 1996). 
Determining whether psychiatric morbidity exists prior to, or develops 
following the onset of CFS may afford a valuable insight into the aetiological role of 
psychiatric disturbances in CFS.  In a prospective study, one group found that 
patients with glandular fever who later developed CFS had similar levels of 
emotional wellbeing to those who went on to recover.  However, the CFS group 
reported more difficulty with emotional adjustment than the recovered controls at a 
six- and 12-month evaluation (Taylor et al., 2010).  Other prospective research 
suggests that prolonged fatigue does not predict the development of psychiatric 
disorders or psychological distress, and psychological factors do not increase the risk 
of developing fatigue (Hickie, Koschera, & Hadzi-Pavlovi, 1999; van der Linden et 
al., 1999).  These results suggest that although psychiatric disturbances and 
prolonged fatigue often co-occur, it is unlikely that CFS develops in response to 
psychiatric morbidity or that CFS causes psychological problems.  Nonetheless, 
psychological wellbeing may decline in some patients following the development of 
CFS and contribute to the perpetuation of CFS symptoms. 
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The hypothesis that psychological factors contribute to the maintenance of 
CFS is supported by a wealth of evidence suggesting that psychological interventions 
are effective in treating CFS (de Lange et al., 2008; Friedberg & Sohl, 2009; Knoop, 
Stulemeijer, de Jong, Fiselier, & Bleijenberg 2008; Malouff, Thorsteinsson, Rooke, 
Bhullar, & Schutte, 2008; Roberts et al., 2009).  Moreover, meta-analytic research 
suggests that Cognitive Behavioural Therapy is similarly effective for people with 
CFS and those with psychological conditions (Lipsey & Wilson, 1993).  However, 
the effect of psychotherapy is generally moderate, and a significant portion of 
patients in these studies achieved only minimal improvements or did not respond at 
all.  Nonetheless, these findings suggest that cognitions and behaviours may serve to 
perpetuate CFS. 
Researchers have also given particular attention to the role of personality 
disturbances in CFS.  As with other psychiatric illnesses, personality disorders 
appear to be remarkably common in CFS patients (Blakely et al., 1991; Buckley et 
al., 1999; Fiedler et al., 2000; Henderson & Tannock, 2004; Johnson et al., 1996; 
Schmaling & Jones, 1996).  However, given that personality disturbances are 
sensitive to somatic symptoms and are particularly common in medically ill patients, 
it is important to contrast CFS patients with other chronically ill patients.  Using this 
approach, researchers have found that personality disturbances are more common in 
CFS patients compared to those with chronic pain (Blakely et al., 1991), but not 
those with MS or Rheumatoid Arthritis (Johnson et al., 1996; Wood & Wesseley, 
1999).  In young patients, personality disturbances have been identified more 
frequently in CFS patients compared to those with JRA or mood disorders (Gray et 
al., 2001; Rangel et al., 2003).  However, personality disturbances are common in 
people with psychiatric disorders, and personality problems primarily affect CFS 
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patients who present with comorbid psychiatric disorders (Fiedler et al., 2000; 
Johnson et al., 1996; Wood & Wesseley, 1999).  As such, the frequency of 
psychiatric disturbances in CFS patients may account for their high rates of 
personality disturbances. 
A possible explanation for the high rates of psychiatric morbidity in CFS 
patients could be that these conditions originate from a shared pathology.  Factors 
that increase vulnerability to CFS might also increase the probability of developing a 
psychiatric condition.  Alternatively, the exceptionally high rates of depression in 
CFS patients could be explained by the diagnostic and conceptual overlap between 
these conditions.  However, evidence of phenomenological differences between these 
conditions suggests that CFS is unlikely to be a subtype of depression (Carter et al., 
1995, 1996; Hickie et al., 1995; Jason et al., 2005; Powell, Dolan, & Wessely, 1990; 
van Middenthorp et al., 2001). 
Research investigating the relationship between CFS and psychological 
disturbances has produced vastly mixed results.  Although psychological factors are 
likely to influence the development and course of CFS, it is immensely difficult to 
determine the exact nature of the relationship between these factors.  At this stage, 
the importance of psychological factors in the pathogenesis of CFS is not yet 
established. 
  
Neuroendocrine theories.  The diversity of physiological and psychological 
problems associated with CFS is indicative of a centralised physiological 
disturbance.  As such, many researchers have been interested in the role of 
neuroendocrine function, and in particular, the hypothalamic-pituitary-adrenal (HPA) 
axis.  The HPA axis is the primary endocrine stress axis.  Corticotrophin releasing 
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hormone (CRH) is released by the hypothalamus in response to stress and 
synergistically causes it to release adrenocorticotrophic hormone (ACTH), which in 
turn, stimulates the release of cortisteroids (Parker, Wessely, & Cleare, 2001).  
Control of the HPA axis is also partly achieved through reciprocal interactions with 
the 5HT (serotonin) system (Chaouloơ, 1993). 
Findings from a range of studies support the significance of the HPA axis in 
CFS aetiology.  HPA axis dysfunction could potentially account for much of the 
symptomology and physiological abnormalities observed in CFS patients (Demitrack 
et al., 1991).  After finding evidence of hypocortisolism in CFS patients, Demitrack 
et al. (1991) suggested that various neuroendocrinological abnormalities are caused 
by a deficiency in the release of CRH and possibly other secretagogues.  The 
researchers proposed that HPA axis dysfunction might be the common pathway 
through which several aetiological factors converge to generate the symptom patterns 
of CFS (Demitrack et al., 1991).   
More recently, researchers have found that CFS patients have lower early 
morning cortisol and ACTH levels than healthy controls (Crofferd et al., 2004; Di 
Giorgio, Hudon, Jerjes, & Cleare, 2005).  Evidence of hypocortisolism in CFS has 
also been identified by examining the HPA axis response to hormonal infusions.  
Minimal changes in cortisol and ACTH levels have been observed in CFS patients 
following the administration of CRH infusions (Cleare et al., 2001; Scott, Medbak, & 
Dinan, 1999; Van den Eede et al., 2008).  Others have found that CFS patients 
exhibit significantly lower cortisol levels than healthy controls after receiving the 
corticosteroid, dexamethasone (Gaab et al., 2002; Van den Eede et al., 2008). 
Given the high rates of comorbid mood disorders in CFS patients, it is 
important to acknowledge the relationship between HPA axis dysfunction and 
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depression.  Depressed patients demonstrate elevated levels of cortisol excretion 
(Gold et al., 1986; Thase et al., 1996), downregulation of the HPA axis (Gold and 
Chrousos, 2002), and, following infusions of glucocorticoids, blunted ACTH 
response (Gold et al., 1986).  Therefore, the key difference between depressed 
patients and those with CFS appears to baseline cortisol levels, which are elevated in 
the former group and reduced in the latter.  This hypothesis is supported by studies 
that include a direct comparison of cortisol excretion levels between CFS and 
depressed patients (Scott & Dinan, 1998; Strickland, Morriss, Wearden, & Deakin, 
1998). 
The HPA axis is also implicated in the aetiology of CFS through its role in 
central nervous system oscillators.  The HPA axis forms part of the system that 
controls circadian rhythm and is involved in adjusting the light-dark and sleep-wake 
cycles (Crofferd et al., 2004; Demitrack & Crofferd, 1998).  As such, it is possible 
that impaired HPA axis function disrupts circadian rhythmicity in CFS patients 
(Williams, Waterhouse, Mugarza, Minors, & Hayden, 2002).  In support of this 
hypothesis, several studies suggest that CFS patients have depressed early morning 
cortisol levels and a weakened cortisol response to waking (Jerjes, Cleare, Wessely, 
Wood, & Taylor, 2005; Jerjes, Taylor, Wood, & Cleare, 2007; Nater et al., 2008; 
Roberts, Wessely, & Chalder, 2004).  However, other researchers have found that 
CFS patients exhibit normal cortisol responses to waking and share similar daytime 
circadian patterns with nonfatigued peers (Gaab et al., 2002; Jerjes, Taylor, Peters, 
Wessely, & Cleare, 2006). 
Taken together, research suggests that HPA axis dysfunction is common in 
CFS patients and may be an important factor in illness aetiology.  As Demitrack et al. 
(1991) suggested, HPA axis dysfunction could be the general biological pathway 
49 
 
through which multiple factors collectively generate the symptoms of CFS.  The 
current findings provide evidence of hypocortisolism in many, but by no means all 
CFS patients.  However, variations in the methodological approach and external 
factors, such as environment, stress, food intake, weight, and natural hormonal cycles 
can have a particularly profound effect on the results in this area of study.  Further, 
several researchers have found that HPA axis underactivity can occur as a 
consequence of the factors associated with chronic illness, particularly sleep 
disturbance, inactivity, and prolonged stress (Demitrack & Crofferd, 1998; Di 
Giorgio et al., 2005; Gaab et al., 2002; Scott & Dinan, 1999).  To date, it remains 
unclear whether HPA axis dysfunction forms a primary aetiological factor, or 
develops as a secondary response to the symptoms and behaviours associated with 
CFS. 
 
Conclusion.  Extensive research over several decades reveals that CFS is a 
condition of complex, multifaceted aetiology.  Findings across and even within 
studies are often unclear and contradictory.  The infectious process hypothesis 
attracted moderate support, however it was undermined by contradictory findings 
and evidence that many patients have not suffered from a recent infection.  Although 
immunological abnormalities are common in CFS patients, many are subtle and not 
clinically significant.  Psychological factors appear to have a significant impact on 
the development and course of CFS, however the relevance of these factors in the 
pathogenesis of the condition has not been established.  Finally, although the HPA 
axis theory has considerable explanatory power, it remains unclear whether HPA 
axis dysfunction develops in response to CFS or forms a primary aetiological factor.  
The role of each possible factor is complex, and further research is required before 
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conclusions can be drawn.  At this stage, a multidimensional conceptualisation 
involving both physical and psychological factors provides the most appropriate and 
functional aetiological. 
The ambiguity surrounding the aetiology and epidemiology of CFS has 
significant implications for determining an effective treatment approach.  It is 
difficult to identify appropriate treatments for all patients given the diversity of 
symptoms and severity levels between patients, as well as the high rates of comorbid 
illnesses.  Further, unknown aetiology places a great restriction on the process of 
developing treatments that address the underlying cause of CFS.  As such, treatments 
may be more viable and effective if they are aimed at reducing the impact of CFS by 
addressing the most debilitating symptoms. 
 
Chapter Summary 
The research discussed in this chapter suggests that CFS is most accurately 
conceptualised as a multidimensional heterogenic illness.  In young populations, CFS 
is a common illness that causes considerable impairment.  Symptoms often persist 
over many years and the impact of CFS interferes with several vital developmental 
domains.  Decades of extensive research suggests that CFS is a condition of 
complex, multifaceted aetiology.  However, it is not yet known whether the 
biological and psychological disturbances identified in CFS patients play a primary 
aetiological role or arise as consequence of the illness and associated behaviours.  
Establishing an effective treatment approach is limited by the exceptionally 
heterogeneous nature of the condition and poor understanding of the aetiological 
factors and processes underlying CFS.  This highlights the need to withdraw focus 
from treatments that attempt to cure CFS, and instead centre research on ameliorating 
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symptoms to enhance quality of life.  In taking a symptomatological approach, it is 
essential to determine which symptoms produce the greatest impairment.  Specific 
investigation in younger populations is required due to the unique impact of CFS in 
paediatric patients.  The discussion in the following chapter focuses on cognitive 
function, one of the most common and debilitating symptoms in young patients. 
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Chapter 3: Cognitive Function in CFS  
Although research is only just emerging, the significant and unique impact of 
CFS in young patients is already clear.  However, despite rigorous research efforts 
over several decades, the aetiology of CFS remains unknown and treatments that 
address illness cause are greatly limited.  As such, interventions may be most 
effective if designed to address the debilitating symptoms and reduce the functional 
impact of CFS.  Impaired cognitive function is one of the most frequently reported 
and debilitating symptoms in patients with CFS.  Research from community 
populations indicates that cognitive impairment is an essential feature of empirically 
defined CFS (Nisenbaum et al., 2004), and cognitive dysfunction forms a symptom 
category in the paediatric case definition (Jason et al., 2006).  In young patients, 
cognitive impairment is likely to generate major difficulties in education and 
learning, restricting future educational and career opportunities.  Increased school 
absenteeism and delays in education associated with impaired cognitive function 
may also interfere with social and emotional and development (Newman & Newman, 
1987).  Despite the potentially severe consequences, there is almost a complete 
absence of objective research investigating cognitive dysfunction in paediatric CFS 
patients. 
This chapter commences with an exploration of CFS patients’ perceptions of 
cognitive disturbances through a review of self-report studies and an examination of 
the discrepancy between these results and those drawn from objective 
neuropsychological measures.  This is followed by an overview of the research 
investigating neuropsychological performance in CFS patients, including 
intelligence, academic function, and cognitive processes.  A brief discussion of 
neuroimaging is also presented.  This section concludes with a concise overview of 
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the methodological issues pertaining to the investigation of cognitive function in 
patients with CFS. 
  
Subjective Reports of Cognitive Function in CFS 
Cognitive impairment is reported by approximately 85-95% of adults with 
CFS (Jason, Torres-Harding, Carrico, & Taylor, 2002; Becker, McGregor, & De 
Meirleir, 2001).  Complaints commonly include difficulties with sustained attention, 
concentration, thinking speed, reaction time, and memory (DeLuca, Johnson, 
Beldowicz, & Natelson, 1995; Michiels et al., 1996; Michiels, de Gucht, Cludyts, & 
Fischler, 1999; Ray, Phillips, & Weir, 1993; Smith, Pollock, Thomas, Llewely, & 
Borysiewicz 1996; Vercoulen et al., 1998). 
The level of cognitive impairment reported by adult CFS patients appears to 
exceed that reported by patients with other chronic illnesses.  DeLuca et al. (1995) 
investigated cognitive impairment in 26 CFS patients, 14 depressed patients, 12 
patients with MS, and 20 healthy controls.  The CFS group reported greater 
disturbances in attention, concentration, and anterograde memory compared to the 
MS and healthy control groups but not the depressed group.  The CFS patients also 
reported significantly greater levels of impairment in attention, prospective memory, 
and reasoning ability than the other three groups.  In addition, only the CFS group 
reported greater disturbances in retrograde memory than controls.  This study 
suggests that CFS patients perceive themselves to have higher levels of cognitive 
impairment than those with other chronic illnesses, although further research is 
required to verify this conclusion. 
The emerging research also suggests that young people with CFS frequently 
report cognitive impairment, although the findings are variable.  For instance, one 
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group found that 33% of 58 young CFS patients reported cognitive difficulties 
(Krilov et al., 1998), while another found that 60% of 20 young CFS patients 
reported poor concentration and 20% reported memory difficulties (Lines, 2004).  
Conversely, no disturbances in attention, thinking, or academic performance were 
reported by another group of 35 female adolescents with CFS (van Middenthorp et 
al., 2001).  Young CFS patients appear to report similar levels of impairment in 
attention and information processing compared to patients with other chronic 
illnesses such as depression and JRA (Carter et al., 1995; Rangel et al., 2003). 
  It is important to acknowledge that many of these findings were derived 
from a single question as part of a larger symptom checklist, providing a very limited 
account of self-perceived cognitive performance.  One group recently sought to 
develop a more detailed understanding of perceived cognitive function in young CFS 
patients by conducting a qualitative analysis.  Parents, teachers, and young people 
with CFS were asked to describe any memory or concentration difficulties 
experienced as a consequence of CFS.  Using thematic analysis, three cognitive 
themes were identified: sustained attention, focused attention, and recall.  The 
participants frequently reported that these difficulties were associated with stress.  
Commonly described problems included attending to external cues, becoming 
distracted, maintaining mental stamina and interest, concentration span, remembering 
specific information, recalling learned information, losing things, and retrieving 
information and relaying it to others (Haig-Ferguson, Tucker, Eaton, Hunt, & 
Crawley, 2009).  However, it is important to note that these participants were 
recruited from a regional specialised service, and only those patients who reported 
memory or concentration problems were selected to participate.  These factors may 
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have biased the sample to represent patients with more severe cognitive disturbances 
than the general population of young CFS patients. 
Collectively, these studies suggest that adults and young people with CFS 
perceive themselves to have significant cognitive impairment.  Interestingly 
however, patients typically report higher levels of impairment than that shown using 
objective neuropsychological tests.  For instance, in a study of 51 CFS patients, no 
correlation was identified between neuropsychological assessment results and self-
reported concentration or memory problems.  Moreover, deficits were not detected 
using neuropsychological assessments in 70% of those who reported concentration 
problems and 77% of those who reported memory problems (Vercoulen et al., 1998).  
Another group found that even though a sample of CFS patients reported 
significantly greater levels of cognitive impairment than healthy controls, 
neuropsychological assessment results were comparable between groups (Cope, 
Pernet, Kendall, & David, 1995).  In addition, findings from treatment trials in CFS 
patients suggest that even though perceived cognitive impairment decreases 
significantly following Cognitive Behavioural Therapy (CBT), neuropsychological 
test performance remains the same (Prins et al., 2001; Stulemeijer, Jong, Fiselier, 
Hoogveld, & Bleijenberg, 2005). 
The inconsistencies observed between subjective reports and objective 
assessments of cognitive function could be explained by the differences between 
controlled laboratory settings and naturalistic environments.  Neuropsychological 
assessments may fail to capture the deficits experienced within everyday settings.  
Supporting this conjecture, evidence suggests that the correlation between self-
reported cognitive function and neuropsychological test performance becomes larger 
when laboratory tests more closely represent everyday cognitive demands (Bennet-
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Levy & Powell, 1980; Sunderland, Watts, Baddeley, & Harris, 1986).  Further, 
neuropsychological assessments conducted in controlled studies often require 
participants to maintain focus for a limited time with the added social pressure to 
apply effort and comply with the task demands (Broadbent, 1979; Wearden & 
Appelby, 1996).  In contrast, cognitive function in naturalistic settings requires 
ongoing mental effort and could also be particularly susceptible to limitations caused 
by distraction, divided attention, fatigue, sleepiness, or negative beliefs about 
cognitive capacity (Devolder & Pressley, 1991).  Further, although laboratory 
assessments typically assess isolated cognitive functions under controlled settings, 
CFS patients generally report problems with complex, everyday tasks that rely on 
multiple cognitive faculties (Wearden & Appelby, 1996).  It is possible that the 
functions assessed within a laboratory differ from those generally used in naturalistic 
environments.  As such, data drawn from both self-report measures and 
neuropsychological assessments may provide distinct but similarly important 
information regarding cognitive impairment in CFS. 
 
Objective Assessments of Cognitive Function in CFS 
Neuropsychological testing has been employed to provide an objective 
assessment of various cognitive domains in adult CFS patients.  The following 
presents an overview of the key findings in regards to intellectual functioning, 
academic ability, executive functioning, working memory, information processing 
speed, and attention. 
 
Intellectual functioning.  It is reasonably well established that general 
intellectual function and higher order cognitive skills remain intact in adult CFS 
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patients (Tiersky, Johnson, Lange, Natelson, & De Luca, 1997).  A large body of 
evidence suggests that CFS patients match healthy controls on measures that are 
resistant to brain damage, such as acquired knowledge (DiClementi Schmaling, & 
Jones, 2001; Johnson, DeLuca, Diamond, & Natelson, 1998; Krupp, Sliwinski, 
Masur, Friedberg, & Coyle, 1994; Short et al., 2002).  Intellectual functions 
considered more vulnerable to brain-related changes also appear to remain 
unaffected by CFS.  For instance, one group found comparable scores on the 
Wechsler Adult Intelligence Scale-Revised (WAIS-R) between a group of 20 CFS 
patients and 17 matched healthy controls (Grafman et al., 1993).  Similarly, Cope et 
al. (1995) found no differences between chronically fatigued patients (most of whom 
were diagnosed with CFS), matched healthy controls, and depressed patients in 
performance on the WAIS-R.  In a rare twin study, researchers investigated 
intellectual function in 22 pairs of monozygotic twins.  One participant within each 
pair had been diagnosed with CFS; the other presented without any significant 
fatigue.  Both groups achieved average scores on a seven-subtest version of the 
WAIS-R, and there were no significant differences between the pairs on any measure 
(Claypoole et al., 2007).  The consistency of these findings provides a reliable 
indication that global intellectual functioning is not affected by CFS. 
 
Academic performance.  Relatively few studies have been designed to 
investigate academic performance in CFS patients despite the potentially severe 
consequences for young people if disturbances are present.  To date, preliminary 
findings suggest that school performance is significantly diminished among CFS 
patients.  This is reflected in young peoples’ perceptions of how CFS affects their 
education.  For instance, Sankey et al. (2006) found that 68% of 28 school-aged 
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children felt that their illness had affected their education or career plans 
significantly, and all participants reported that their education had been affected by 
CFS to some degree.  In contrast, Richards, Chaplin, Starkey, and Turk (2006) found 
that only two of 21 adolescents believed that their academic performance was 
impaired as a consequence of CFS. 
Academic decline in CFS patients is also evident in grades achieved at 
school.  For instance, data from a cross-sectional study in 36 adolescents with CFS 
revealed that participants achieved an average of three out of 10 passes over an 18-
month period.  Only 44% achieved more than four passes, and 30.6% failed to 
achieve a single pass grade (Patel et al., 2003).  However, it is possible that people 
with poor academic grades are particularly likely to develop CFS or are susceptible 
to academic decline following illness onset.  This question was investigated in a 
longitudinal follow-up study over a period of four years.  Preceding illness onset, 
43% of 58 CFS patients averaged A grades, 36% averaged B grades, 18% averaged 
C grades, and 4% averaged D grades.  Following illness onset however, 28% 
averaged A grades, 38% averaged B grades, 25% averaged C grades, and 9% 
averaged D grades.  Further, 30% reported average or poor academic scores prior to 
illness onset, compared to 50% at follow-up (Krilov et al., 1998).  This suggests that 
academic performance declines following the development of CFS.  However, 
without a comparison group, is unclear whether these performance changes are 
attributable to illness-related factors or to extraneous variables such as task difficulty 
or teacher effects.  Although the relationship between CFS and school performance is 
yet to be thoroughly investigated, the existing findings suggest that CFS is associated 
with a decline in academic performance. 
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Executive function.  Executive function is a higher order cognitive process 
that is used in initiating, planning, sequencing, and monitoring goal-directed 
behaviours (Goldberg & Bougakov, 2005).  Although the following section includes 
an independent examination of executive function in CFS patients, it is worth noting 
that executive processes are related to, and often depend on other cognitive functions 
(Rabbitt, 1997). 
Set shifting tasks are commonly employed as a measure of cognitive 
flexibility, a key component of executive function.  One such task, The Trail Making 
Test Part B (Reitan & Davidson, 1974), measures visual task switching ability by 
requiring participants to quickly connect the dots of consecutive targets, alternating 
between numbers and letters.  According to these tests, cognitive flexibility largely 
appears to be unaffected by CFS.  For instance, although one group identified slower 
performance among 35 CFS patients compared to 33 matched healthy controls 
(Michiels et al., 1996), several others found no differences between CFS patients and 
healthy controls in accuracy or speed (Busichio, Tiersky, DeLuca, & Natelson, 2004; 
Dobbs, Dobbs, & Kiss, 2001).  Moreover, task performance has not been linked to 
illness length (Santamarina-Perez et al., 2011).  Another group found that 
performance speed and accuracy on a similar task-switching test was comparable 
between CFS patients and healthy controls before, during, and after receiving a 
substance that induces flu-like symptoms (Arnold et al., 2002).  However, one group 
found that CFS patients performed similarly to those who had sustained a mild 
traumatic brain injury (Tiersky, Cicerone, Natelson, & Deluca, 1998). Nonetheless 
these results largely suggest that cognitive flexibility, as measured by set shifting 
tasks, remains intact in CFS patients.  However, it is worth noting that the Trail 
Making Test requires input from a range of cognitive faculties, and as such, 
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performance could be affected by information processing speed, visual tracking, fine 
motor skill, or attention (Crowe, 1998; Vercoulen et al., 1998).   
 
The Intra-Extra Dimensional Set Shift (IED) task is a sensitive measure of 
cognitive flexibility that forms part of the test battery on the computerised 
Cambridge Neuropsychological Test Automated Battery (CANTAB).  The IED is 
a test of rule acquisition and reversal, and it is the computerised analogue of the 
Wisconsin Card Sorting test.  Research using the IED task in CFS patients has drawn 
mixed results.  Joyce et al. (1996) assessed a group of 20 CFS patients and matched 
controls using the IED task as part of a larger neuropsychological assessment.  Up to 
and including the compound reversal stage, three CFS patients and no controls failed, 
and three CFS patients and one control failed at the intra-dimensional reversal stage.  
However, the number of trials needed and errors made on the extra-dimensional shift 
stage were comparable between groups.  In contrast, other researchers found no 
differences between CFS patients and healthy controls on any part of the IED task 
(Capuron et al., 2006; Majer et al., 2008; Morriss, Robson, & Deakin, 2002).  
Although the findings are mixed, the bulk of the research indicates that CFS patients 
and nonfatigued peers perform with a similar level of accuracy on tasks that require 
shifting and flexibility of attention.  However, the between-group differences evident 
in some studies may suggest that attentional flexibility is impaired in a subset of 
patients. 
The Rey-Osterrich Figure (Rey-O) recall condition is a common test of 
executive function that provides a measure of abstract planning.  In this task, 
examinees are required to reproduce a complex, abstract picture from memory (Rey 
& Osterrieth, 1993).  Again, research assessing CFS patients on this task has drawn 
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mixed results.  One group found that CFS patients were more likely to score at least 
one standard deviation below the healthy mean than controls, however test failure 
rates were similar between groups (Busichio et al., 2004).  In contrast, Tiersky et al. 
(1998) found no differences between a group of 30 CFS patients and matched 
healthy controls, and performance on the Rey-O has not been linked to illness length 
(Santamarina-Perez et al., 2011).  Although these results do not provide enough 
evidence to form conclusions regarding the nature of abstract planning in CFS 
patients, the data suggest that a subset of CFS patients may experience mild 
impairment.  Further research with a diverse range of measures is needed to provide 
a greater understanding of how abstract planning is affected by CFS. 
The Category Test is measure of problem solving ability that is comprised of 
several stimulus sets that must be organised according to certain rules.  The 
examinee is required to discover suitable rules and consistently employ those rules 
on successive trials (DeFilippis & McCampbell, 1979).  Researchers have found that 
CFS patients achieve similar scores on this task compared to healthy controls 
(Busichio et al., 2004; Tiersky et al., 1998) but also to patients who had sustained a 
brain injury (Tiersky et al., 1998).  Another common measure of planning and 
problem solving ability is the CANTAB Stockings of Cambridge (SOC) subtest, the 
computerised version of the Tower of London task.  Again however, several studies 
suggest that CFS patients are able to plan and problem solve on the SOC with a 
similar level of proficiency as healthy controls (Capuron et al., 2006; Joyce et al., 
1996; Majer et al., 2008; Morriss et al., 2002; Santamarina-Perez et al., 2011). 
Executive function in CFS patients is still in the preliminary stages of 
research, and it is not yet clear how or to what degree patients are affected in this 
area.  The limited evidence suggests that at least some CFS patients have deficits in 
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cognitive flexibility and abstract planning.  However, general planning and problem 
solving ability appears to be unaffected by CFS.  Further investigation is required to 
verify these findings and clarify the inconsistent results.  The subtle and often 
ambiguous nature of the disturbances observed on measures of executive function 
may be indicative of deficits in related cognitive domains. 
 
Attention.  Attention is a complex and multifaceted construct that constitutes 
a fundamental component of cognitive function.  Researchers have investigated the 
impact of CFS on divided attention, sustained attention, attentional control, and 
selective attention (Wickens & McCarley, 2008).   
The Paced Auditory Serial Addition Task (PASAT) is a popular tool that 
measures divided attention by requiring examinees to attend simultaneously to 
several subtasks (Gronwall & Sampson, 1974).  In this test, a series of auditory 
numbers from one to nine is presented, and participants are instructed to sum each 
new number to the last over several trials of increasing speed (Gronwall, 1977).  
Much of the research suggests that CFS patients perform poorly the PASAT.  For 
instance, Busichio et al. (2004) found that 36.7% of 141 CFS patients performed one 
standard deviation below the healthy group mean on the PASAT compared to 15.7% 
of 76 healthy participants.  Tiesky et al. (1998) also found that CFS patients achieved 
lower scores than healthy controls and performed similarly to those who had suffered 
from a traumatic brain injury.  Another group found that only CFS patients without a 
comorbid psychiatric condition scored less well than nonfatigued peers (DeLuca, 
Johnson, Ellis, & Natelson, 1997).  In contrast, no significant differences were 
identified between a group of 25 CFS patients and either matched healthy controls or 
depressed patients (Constant et al., 2011), and task performance appears to be 
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uncorrelated with illness length (Santamarina-Perez et al., 2011).  Although these 
studies largely suggest that divided attention is impaired in CFS patients, it is 
important to note that performance on the PASAT is sensitive to mathematical ability 
(Chronicle & MacGregor, 1998) and intelligence (Egan, 1988).  These factors may 
act as confounding variables if they are not adequately controlled. 
The Stroop Colour Word task (Stroop, 1935) is another popular tool for 
measuring divided attention.  Colour-words are printed in a colour that differs from 
the word, and examinees are instructed to verbalise the colour while ignoring the 
word.  Research investigating CFS patients using the Stroop has produced mixed 
results.  One group identified significantly lower scores among twins with CFS 
compared to healthy twins (Claypoole et al., 2007), and DiClementi et al. (2001) 
found that according to published norms, mean Stroop scores for a group of 21 CFS 
patients were in the impaired range.  Further, CFS patients regularly perform on the 
Stroop at a slower pace than nonfatigued peers (Mahurin et al., 2004; Michiels, 
Cluydts, & Fischler, 1998; Ray et al., 1993; Smith, Behan, Bell, Millar, & Bakheit, 
1993), suggesting that impaired information processing speed could account for 
some of the performance deficits on this task.  Conversely, other studies indicate that 
CFS patients and healthy controls complete the Stroop test with similar levels of 
accuracy and speed (Daly, Komaroff, Bloomingdale, Wilson, & Albert, 2001; 
Marcel, Komaroff, Fagioli, Komish, & Albert, 1996; Short et al., 2002).  Although 
the results are somewhat varied, research using the PASAT and Stroop largely 
suggests that many CFS patients have difficulty on tasks that require divided 
attention. 
Researchers have also been interested in how sustained attention is affected 
by CFS.  The Rapid Visual Information Processing (RVIP) task on the CANTAB is a 
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challenging measure of sustained attention that is capable of detecting subtle 
performance deficits.  In this task, a series of single digits are presented in 
pseudorandom order at the rate of 100 digits per minute over four minutes, and 
participants are required to detect three target sequences.  In addition to sustained 
attention, the task places demands on working memory, processing speed, and 
executive function.  Capuron et al. (2006) found that CFS patients with high self-
reported mental fatigue achieved lower accuracy scores on RVIP compared to CFS 
patients without significant mental fatigue and healthy controls.  Interestingly, 
although there were no between-group differences in response latency overall, the 
mentally fatigued patients became slower in the later stages of the task, suggesting 
that mental fatigue impairs processing speed for sustained attentional tasks in CFS 
patients.  In contrast, Majer et al. (2008) found no differences between CFS patients 
and healthy controls in accuracy or response latency on the RVIP task. 
Attention can also be measured though movement based reaction tasks that 
require participants to respond quickly by attending to particular stimuli.  Several 
studies suggest that CFS participants respond more slowly than controls when 
performing choice, but not simple reaction tasks (Crowe & Casey, 1999; DeLuca et 
al., 2004); however others have found no differences between CFS patients and 
healthy participants on similar tasks (Capuron et al., 2006; Mahurin et al., 2004; 
Majer et al., 2008). 
Finally, researchers have investigated selective attention in CFS patients by 
measuring how well participants can focus on a particular target while ignoring 
interfering stimuli.  Using the Flanker Test of Selective Attention, Arnold et al. 
(2002) found that participants with CFS could selectively attend to information as 
effectively as healthy controls.  Similarly, no differences have been found between 
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CFS patients and healthy controls on the Match to Sample Visual Search task on the 
CANTAB (Joyce et al., 1996; Morriss et al., 2002).  Although the preliminary 
evidence suggests that selective attention is unaffected by CFS, further research with 
a wider range of assessment tools is required before conclusions can be drawn. 
Taken together, the research suggests that several components of attention 
may be impaired in CFS patients.  However, many findings are contradictory and it 
is unclear whether the inconsistencies result from variations in sample 
characteristics, methodological approaches, or other unknown factors.  CFS patients 
often perform poorly on tasks that require divided attention and choice reaction, 
although a small number of studies suggest that these functions remain intact.  
Findings from investigations of sustained attention in CFS patients have been less 
clear; approximately half of all studies suggest that CFS patients are able to maintain 
attention over time, while the other half suggest that sustained attention is impaired.  
The limited evidence suggests that selective attention is not affected by CFS, 
however further research with alternative measurement tools is required to verify 
these findings.  At this stage, the preliminary research suggests that at least a subset 
of CFS patients suffer from disturbances in several components of attentional 
function. 
 
Processing speed.  Processing speed refers to the rate that cognitive tasks can 
be performed fluently, and includes speed of perceiving, encoding, response 
selection, and memory retrieval (Wright et al., 2001).  Efficient processing speed is 
required to perform several high level cognitive functions, such as comprehension, 
working memory, reasoning, planning, and learning (Baddeley, 1986).  For this 
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reason, it is often difficult to distinguish between deficits in processing speed from 
those of other cognitive functions. 
One of the most commonly used tests for assessing processing speed is the 
Digit Symbol Coding subtest on the WAIS.  Several studies suggest that CFS 
patients perform slowly on this task.  For instance, Michiels et al. (1996) found that 
compared to healthy controls, a group of 35 CFS patients were significantly slower, 
but not less accurate in correctly matching digits and symbols.  Busichio et al. (2004) 
also found that compared to nonfatigued participants, significantly more CFS 
patients scored at least one standard deviation below the healthy control mean.  
Another group identified lower composite scores based on the Digit Span and Digit 
Symbol Coding tests among a group CFS patients compared to healthy controls and 
patients with an autoimmune thyroid disease (Dickson, Toft, & OʼCarroll, 2009).  
Neu et al. (2011) also found that CFS patients obtained lower scores on Digit Symbol 
Coding than healthy participants, but scored higher than patients with sleep apnoea.  
This suggests that sleep disturbance may contribute to impairments in processing 
speed. 
The Sternberg Memory Scanning Test (Sternberg, 1966) is another common 
measure of processing speed that assesses speed of searching through memory.  
Participants are required to encode one to six to digits that are initially presented for 
500ms.  A target digit then appears for 500ms and participants must determine if the 
target digit was included in the initial set.  One group found that CFS participants 
detected shorter targets more slowly but not less accurately than healthy controls 
(Arnold et al., 2002).  However, Mahuran et al. (2004) found no performance 
differences between CFS patients and healthy controls on a similar test. 
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Processing speed can also be assessed by investigating the extent to which 
thinking time contributes to performance on other cognitive tasks.  Using this 
procedure, Majer et al. (2008) found that differences between CFS patients and 
controls on one of two visual memory tests became nonsignificant after controlling 
for processing speed.  Similarly, another group found that CFS patients continued to 
perform more slowly than healthy participants on a choice reaction task after 
controlling for movement time, indicating that processing speed rather than 
movement time accounted for the performance deficits (Vercoulen et al., 1998).  
Taken collectively, the research provides relatively consistent evidence suggesting 
that CFS patients have impaired processing speed, and that these deficits may inhibit 
accuracy and efficiency in other cognitive domains.  
 
Memory.  Researchers have given a lot of attention to the function of 
memory and working memory in CFS patients.  Although are several 
conceptualisation models, it is generally agreed that working memory is a system for 
temporarily storing and managing the information required to perform complex 
cognitive tasks (Miyake & Shah, 1999).  Baddeley and Hitch (1974) argue that the 
working memory system is comprised a number of interrelated components, 
including the phonological loop and the visuospatial sketchpad. the phonological 
loop, which processes sound or phonological information, and the visuospatial 
sketchpad, which is involved in the manipulation and storage of spatial and visual 
information. 
Particular attention has been given to verbal memory function in CFS 
patients.  Verbal memory tasks typically involve free recall or recognition of material 
that is presented immediately or with a delay of approximately 20 minutes.  A large 
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body of evidence suggests that patients with CFS achieve lower scores than healthy 
controls on measures of verbal free recall (Constant et al., 2011; Daly et al., 2001; 
Dickson et al., 2009; DeLuca et al., 1997; Marcel et al., 1996; Michiels et al., 1996; 
Neu et al., 2011; Tiersky et al., 1998; Vercoulen et al., 1998).  CFS patients also 
generally perform these tasks with a similar level of proficiency as other patient 
groups, such as patients with sleep apnoea (Neu et al., 2011), brain injuries (Tiersky 
et al., 1998), MS (Daly et al., 2001), and depression (Constant et al., 2011; Daly et 
al., 2001).  One group found that CFS patients without a psychiatric condition 
achieved lower scores on a short delay verbal recall task compared to CFS patients 
with a comorbid psychiatric illness (DeLuca et al., 1997).  This suggests that verbal 
memory impairment is not attributable to comorbid psychiatric issues. 
Assessment results from tasks that require recognition of verbal material have 
been more variable.  Several studies suggest that CFS patients recognise significantly 
fewer words than healthy peers (Constant et al., 2011; Lawrie, MacHale, Cavanagh, 
O'Carroll, & Goodwin, 2000; Smith et al., 1993), while others indicate that CFS 
patients and healthy controls achieve comparable scores on verbal recognition tests 
(DeLuca et al., 2004; Mahurin et al., 2004; Michiels et al., 1996; Neu et al., 2011; 
Vercoulen et al., 1998). 
Another method of testing verbal memory is to measure how well examinees 
can recall meaningful components of a narrative.  Preliminary evidence suggests that 
CFS patients recall fewer narrative details compared to healthy controls (Daly et al., 
2001; Dickson et al., 2009) but not to patients with autoimmune thyroid disease 
(Dickson et al., 2009), MS, or depression (Daly et al., 2001).  However, another 
group found similar scores among CFS patients and healthy controls on a narrative 
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recall task, and the CFS group recalled more information than participants with a 
brain injury (Tiersky et al., 1998). 
The phonological loop component of working memory is also commonly 
assessed by measuring immediate recall of numerical data.  The Dobbs and Rule 
Working Memory Task (Dobbs & Rule, 1989) is an established test of immediate 
auditory memory that requires examinees to recall single digits from randomly 
ordered digit sets according to a sequence order.  One group identified poorer 
performance on this task among 20 CFS patients compared to matched healthy 
controls (Dobbs et al., 2001).  On a similar task, another group found that CFS 
patients took longer to respond and made fewer correct responses than healthy 
controls, but achieved similar scores to participants with depression.  A negative 
correlation was also identified between illness length and median response time and 
accuracy (Constant et al., 2011). 
The Digit Span subtest of the WAIS is common measure of memory that has 
been used extensively in CFS research.  The results largely suggest that CFS patients 
are able to recall numerical information in forward and reverse order to the same 
level as healthy controls (Busichio et al., 2004; Daly et al., 2001; Dobbs et al., 2001; 
Marcel et al., 1996; Tiesky et al., 1998; Vercoulen et al., 1998).  However, a small 
number of studies suggest that CFS patients perform poorly on the Digit Span task.  
For instance, one group identified poorer performance on Digit Span Forward and 
Backward in a sample of 35 CFS patients compared to 33 healthy controls (Michiels 
et al., 1996).  DeLuca et al. (1997) also found lower scores among CFS patients on 
Digit Span Backward but not forward compared to a group of healthy controls and 
CFS patients with a comorbid psychiatric condition.  Other studies suggest that CFS 
participants are able to perform at least as proficiently as patients with MS, 
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depression (Daly et al., 2001), brain injury (Tiesky et al., 1998), and sleep apnoea 
(Neu et al., 2011).  Finally, lower scores on Digit Span were identified among CFS 
patients compared to patients with an autoimmune thyroid disease, and these 
differences could not be accounted for by self-reported differences in mood (Dickson 
et al., 2009).  The conflicting results could be at least partially attributable to 
differences in attention, which is an essential function required to complete the Digit 
Span task. 
Researchers have devoted less attention to the visuospatial component of 
working memory in CFS patients, however current findings reveal similar patterns to 
those observed for phonological working memory.  For instance, several studies 
suggest that CFS patients achieve lower scores than healthy controls on tasks that 
require free recall (Attree et al., 2009; Busichio et al., 2004; Capuron et al., 2006; 
Joyce et al., 1996; Marcel et al., 1996; Michiels et al., 1996), although a minority 
show no differences between groups (Morriss et al., 2002; Vercoulen et al., 1998).  
Comparable scores on visuospatial recall tasks have also been identified between 
CFS patients and those with MS (Daly et al., 2001) and depression (Constant et al., 
2011; Daly et al., 2001).  Akin to the findings for phonological working memory, 
tasks that require participants to recognise visual information have drawn mixed 
results.  Some studies suggest that CFS patients perform less well than healthy 
controls (Capuron et al., 2006; Joyce et al., 1996; Mahuran et al., 2004; Morriss et 
al., 2002), while others suggest that there are no differences between groups 
(Constant et al., 2011; Daly et al., 2001; Majer et al., 2008). 
Researchers have also employed the recall test phase of the Rey-O to assess 
visuospatial memory in CFS patients.  One group found that scores of one standard 
deviation below the healthy mean were significantly more common in CFS patients 
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compared to healthy controls on the Rey-O immediate, but not the delayed condition 
(Busichio et al., 2004).  Tiersky et al. (1998) also found that CFS patients performed 
more poorly than healthy controls in the immediate recall condition but matched 
controls on the copy stage, indicating that poor recall was not attributable to impaired 
planning or motor skill (Tiesky et al., 1998).  In contrast, Vercoulen et al. (1998) 
found that even though patients with CFS were less accurate on the figure copy 
phase than healthy controls, scores on the recall condition were comparable between 
groups.  DeLuca et al. (1995) also found no significant differences between CFS 
patients and healthy controls on either the immediate or the delayed condition. 
The CANTAB has become an increasingly popular tool for assessing visual 
memory.  An estimate of visuospatial working memory using free recall can be 
derived from the Spatial Working Memory (SWM) and Spatial Span (SSP) subtests.  
SWM begins with several coloured boxes positioned in various places on the screen.  
By touching the boxes and using a process of elimination, the participant must find 
one blue token in each box over repeated trials of increasing difficulty.  For SSP, the 
participant is presented with several white squares scattered on the screen that briefly 
change colour in a sequence.  The participant is asked to recall the sequence by 
touching the squares in order (Cambridge Cognition, 2006).  Estimates of visual 
working memory from these subtests in CFS patients have been inconsistent.  One 
group found that, compared to healthy controls, patients with CFS achieved lower 
scores on SSP and made more errors between, but not within trails on SWM (Joyce 
et al., 1996).  Similarly, another group reported that CFS patients with significant 
mental fatigue made more between-, but not within-search errors on SWM than 
healthy controls (Capuron et al., 2006).  In contrast, others have found no differences 
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between CFS patients and healthy controls on SWM or SSP (Majer et al., 2008; 
Morriss et al., 2002). 
The CANTAB also consists of several tests that are designed to assess visual 
memory through recognition, such as Pattern Recognition Memory (PRM), Spatial 
Recognition Memory (SRM), and Delayed Matching to Sample (DMS).  For PRM, 
the examinee is presented with a series of 12 abstract patterns followed by 12 sets of 
two patterns.  The examinee must select the pattern within each set that is identical to 
one of those presented in the first phase.  SRM reveals a series of single white 
squares in different locations on the screen, followed by a series of five pairs of 
squares.  Participants must select the square within each pair that matches the 
location of those in the presentation phase.  The DMS task presents a complex visual 
pattern followed by four similar patterns after a brief delay.  The participant must 
identify the pattern that matches the original sample (Cambridge Cognition, 2006).  
Based on these tests, several studies suggest that CFS patients are able to recognise 
visual information within memory with a similar level of proficiency as healthy 
controls, albeit often at a slower pace (Capuron et al., 2006; Joyce et al., 1996; 
Morriss et al., 2002).  In contrast, Majer et al. (2008) found that a group of 54 CFS 
patients made fewer correct responses on SRM, and had longer response latencies on 
PRM compared to 104 healthy controls. 
Despite a growing body of research, working memory function in CFS 
patients remains poorly understood due to the inconsistent findings between studies.  
The contradictory results could reflect the complexity of how working memory is 
affected by CFS.  Assessment of working memory is also complicated by 
confounding factors associated with the function of other cognitive domains (Joyce 
et al., 1996; Michiels et al., 1998).  For example, poor performance on the Digit Span 
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subset of the WAIS may be caused by an inability to attend to and encode the 
information rather than a disturbance in working memory.  To date, the research 
suggests that CFS patients often have difficulty completing a range of tasks that 
require working memory.  However, further research designed to clarify the 
relationships between various cognitive functions will provide a more reliable 
understanding of working memory capacity in CFS. 
 
Neuroimaging.  Neuroimaging research may serve to clarify and build on the 
findings drawn from neuropsychological assessments.  This approach provides some 
insight into how neurological function might account for the cognitive deficits 
observed in CFS patients.  A range of neurological abnormalities have been 
identified in CFS patients.  In an early study, higher quantities of white matter 
hyperintensities were observed in 78% of 144 CFS patients and only 21% of healthy 
controls (Buchwald et al., 1992).  Natelson, Cohen, Brassloff, and Lee (1993) also 
found abnormal brain scans in 14 of 52 CFS patients compared to just one in 
matched controls with a history of headaches or a brain injury.  Abnormalities 
observed in the CFS group included an increased T2 signal in the subcortical region 
of white matter, or enlarged ventricular or sulcal regions.  However, a large portion 
of the CFS patients in these studies reported depressive symptoms, which may at 
least partially account for the abnormalities.  It is also important to consider that even 
though abnormal brain scans were significantly more common in the CFS group, 
most patients presented without any abnormalities despite reports of being 
considerably unwell. 
Adding to the complexity, two similar studies indicated that CFS patients and 
healthy controls possessed similar numbers of white matter hyperintensities (Cope et 
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al., 1995; Schwartz et al., 1994).  The inconsistent findings could be accounted for by 
differences in the rates of comorbid psychiatric disorders in CFS patients.  
Supporting this, Lange et al. (1999) found small subcortical white matter 
hyperintensities in 66.7% of CFS patients without a comorbid psychiatric condition 
compared to 22.2% of CFS participants with a comorbid condition.  Brain 
abnormalities were significantly more common in the nonpsychiatric CFS group 
compared to healthy controls, however, when the two CFS groups were combined, 
the differences between CFS patients and controls were no longer apparent. 
More recently, researchers have explored the relationship between 
neurological factors and the severity of symptoms associated with CFS.  One group 
found that CFS patients with neurological abnormalities reported significantly 
greater levels of physical impairment than CFS patients without an identified brain 
abnormality (Cook, Lange, Deluca, & Natelson, 2001).  Another group identified a 
correlation between gray matter volume in the right prefrontal cortex and self-
reported fatigue severity in a group of 16 CFS patients (Okada, Tanaka, Kuratsune, 
Watanabe, & Sadato, 2004).  In contrast, although researchers have found that CFS 
patients have higher rates of cerebral perfusion than controls (MacHale et al., 2000; 
Schwartz et al., 1994), others have found no evidence of a relationship between 
perfusion and fatigue severity in CFS patients (Fischler et al., 1996).  Similarly, even 
though ventricular volumes were found to be larger in a group of CFS patients 
compared to healthy controls, this irregularity was not associated with illness 
duration, functional impairment, or psychiatric diagnosis (Lange et al., 2001).  
Although the findings are variable, this research provides preliminary evidence of an 
association between cerebral abnormalities and clinically important features 
associated with CFS. 
75 
 
By monitoring brain activity during performance on neuropsychological 
assessments, it is possible to determine whether neurological abnormalities are 
directly related to cognitive function.  Using this approach, researchers have found 
that CFS patients often exhibit unusual cerebral activity while completing 
neuropsychological tasks.  One group recently investigated brain function during 
verbal and spatial cognitive activity in 61 female CFS patients and 80 healthy 
controls.  The spatial pattern results correctly predicted group classification in 72% 
of cases, and activity during the verbal task predicted group classification in 83% of 
cases.  The CFS group also exhibited greater brain activity than controls in the left 
frontal–temporal–parietal regions during all cognitive activity (Flor-Henry, Lind, & 
Koles, 2010).  Similarly, Lange et al. (2000) found that during the completion of a 
working memory task, CFS patients exhibited bilateral frontal and parietal activity, 
while healthy controls showed only left-sided activity in the same regions.  Cook, 
O’Connor, Lange, and Steffenerf (2007) argued that abnormal brain function only 
becomes apparent during tasks that require significant cognitive effort.  This group 
identified a significant relationship between mental fatigue and neuroimaging results 
during a fatiguing cognitive task but not finger tapping or simple auditory monitoring 
tasks.  Affected brain regions included the cerebella, cingulate cortex, and the 
temporal,, frontal, and left parietal regions. 
Preliminary findings also suggest that even when CFS patients and controls 
receive similar scores on challenging cognitive tasks, participants often exhibit 
significant differences in cerebral activity.  For instance, Lange et al. (2005) found 
that even though CFS patients and healthy controls processed challenging auditory 
stimuli with similar levels of proficiency, the CFS group completed the task while 
using more extensive regions of their verbal working memory system than controls.  
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This suggests that CFS patients require greater effort than nonfatigued peers to 
complete the same cognitive activity.  Similarly, during the PASAT, patterns of 
diffuse regional cerebral blood flow were observed in a group of CFS patients 
compared to patterns of a focal regional cerebral blood flow in healthy controls.  
However, task performance was not distinguishable between groups, suggesting that 
CFS patients and nonfatigued peers require different neurological activity to perform 
similarly on the same task (Schmaling, Lewis, Fiedelak, Mahurin, & Buchwald, 
2003).  Another group also found that even though CFS patients and healthy controls 
performed comparably throughout a working memory task, the CFS group 
demonstrated greater activation in the medial prefrontal regions during the easier task 
phase.  Conversely, throughout the more challenging phase, the CFS patients 
exhibited reduced activation in the dorsolateral prefrontal and parietal cortices and 
significant activation of a cluster in the right inferior/medial temporal cortex.  Based 
on these results, the researchers suggested that CFS patients have impairments in the 
neurological working memory system and that other cerebral systems are employed 
to compensate for these deficits (Caseras et al., 2006). 
This unusual cerebral activity in the absence of cognitive performance 
deficits in CFS patients could explain why cognitive function appears to be intact 
even when patients report significant impairments.  Cognitive functions are generally 
assessed in isolation from other activity, enabling patients to compensate for deficits 
in one area by employing other cognitive faculties.  However, mental activity in 
everyday environments rarely relies on a single cognitive domain, preventing 
patients from using other cognitive functions to compensate for impairments. 
Although neuroimaging research is still in its infancy, the current findings 
suggest that structural and functional abnormalities are common in CFS patients.  In 
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particular, CFS patients often present with enlarged brain regions and exhibit greater 
neurological activity while completing cognitive tasks.  However, many patients 
present with no neurological irregularities, and psychological disturbances may 
account for the atypical findings in some patients.  As such, neurological factors are 
unlikely to provide a complete explanation of the mechanisms underlying cognitive 
impairment in CFS patients.  
 
Objective Assessments of Cognitive Function in Young People With CFS 
In the last few years, research investigating cognitive impairment in young 
CFS patients has begun to emerge.  To date, findings suggest that adults and young 
patients present with similar cognitive profiles.  However, due to the potentially 
devastating educational and developmental impact of cognitive dysfunction in young 
people, further research designed to investigate how CFS uniquely affects this 
population is especially critical. 
In the first of major study to investigate neuropsychological function in 
young CFS patients, 20 participants aged between eight and 16 were recruited from a 
regional CFS/ME clinical service in England.  As part of the inclusion criteria, all 
participants were required to report current memory or concentration problems.  
Cognitive assessments included the Behavioural Assessment of the Dysexecutive 
Syndrome, the Children’s Memory Scale, the Test of Everyday Attention for 
Children, and the Symbol Search, Digit Span, and Letter-Number Sequencing 
subsets of the WISC-IV.  Participants scored below the normative mean on measures 
of sustained attention, switching attention, divided attention, auditory learning, and 
immediate verbal recall.  Scores averaging more than one standard deviation below 
the normative mean were only evident in divided attention.  Conversely, scores were 
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not significantly different from normative data on measures of processing speed, 
focused attention, spatial learning, immediate and delayed recall, delayed 
recognition, working memory, and executive function (Haig-Ferguson et al., 2009). 
This pioneering study demonstrates that it is feasible to conduct 
neuropsychological testing in children with CFS, and the results suggest that young 
CFS patients suffer from cognitive deficits in several domains.  However, there are a 
few important issues to consider.  First, all participants were recruited from specialist 
service, and only those who reported memory or concentration problems were 
selected to participate.  As such, the sample may have represented patients with more 
severe symptoms and greater cognitive impairment than the general population of 
young CFS patients.  In addition, the participants were required to complete a small 
number of neuropsychological tests over a period of approximately 30 minutes in 
order to prevent participants from becoming fatigued (Haig-Ferguson et al., 2009).  
However, given that many real life circumstances require ongoing cognitive activity, 
these results may not reveal the severity of typical cognitive function in CFS 
patients.  Finally, the study did not include a comparison group, instead relying on 
normative data collected by different researchers, under different conditions, and at a 
different time period.  Therefore, the results may be attributable factors associated 
with the nature of this particular study.  In consideration of these factors, the findings 
in this study need to be substantiated by further research with a larger and more 
variable sampling pool before conclusions can be drawn. 
Cognitive function in young CFS patients was also assessed in a recent 
unpublished study by some of the members of the current research team (Younis, 
2009).  A group of 27 adolescents with CFS and 27 age and sex matched healthy 
controls completed a comprehensive neuropsychological test battery from the 
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CANTAB.  Subsets included IED, SOC, RVIP, RTI, SWM, SSP, and Verbal 
Recognition Memory (VRM).  Participants also completed the Wide Range 
Achievement Test, third edition, (WRAT-III) and the Vocabulary and Matrix 
Reasoning subsets of the Wechsler Abbreviated Scale of Intelligence (WASI).  
Consistent with the research in adults, both groups achieved similar scores on the 
intelligence assessment.  However, there were no differences between groups on any 
neuropsychological or academic task.  This was particularly surprising given that the 
CFS group reported significantly greater cognitive impairment, school absenteeism, 
sleep disturbance, fatigue, and psychological distress than the controls.  Based on 
observations of the participants during the assessments, the researchers proposed that 
the CFS patients may have had higher levels of motivation or perfectionism than 
controls, and that these differences may have accounted for the nonsignificant 
results.  It is also worth noting that some of the cognitive tasks were given in the 
early stages of the assessment and the participants were provided with rest breaks if 
they became fatigued.  Therefore, the CFS patients may not have been given 
sufficient opportunity to reach a level of fatigue that would normally affect cognitive 
performance in everyday settings.  This study is discussed in more detail in Chapter 
5. 
Evidence of cognitive impairment in young CFS patients was identified in a 
recently published treatment trial.  Participants included 19 adolescents aged between 
13 and 15, diagnosed according to the paediatric criteria for CFS (Jason et al., 2006).  
An age and sex matched healthy control group of 25 adolescents was also included.  
Before and after receiving CBT and antidepressant medication, the CFS patients 
completed the Modified Advanced Trail Making Test and the Japanese Kana Pick-
Out Test.  Prior to treatment, differences in reaction time from the three outcome 
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measures for the Trail Making Test, including motor skill, selective and alternative 
attention, and spatial working memory, could differentiate CFS patients from 25 age 
and sex matched healthy controls with 70.5% accuracy.  However, reaction time on 
Task E (alternative attention) was the only component to contribute significantly to 
the analysis.  The overall and comprehension scores on the Kana Pick-Out Test were 
not distinguishable between groups, indicating that short-term memory, allocation, 
and information processing were not affected by CFS.  Alternative attention on Task 
E scores were not related to IQ, depressive symptoms, feeling too unwell to attend 
school, or short-term memory and information processing on the Kana Pick-Out 
Test.  Reaction time and difference in reaction time on task on alternative attention 
(Task E) improved significantly from baseline to follow-up.  Performance on the 
other components of the Trail Making Test, including selective attention and spatial 
working memory did not change from baseline to follow-up.  A negative correlation 
was observed between mental fatigue and difference in reaction time on task on Task 
E (alternative attention) from baseline to follow-up.  No other cognitive indicators 
were related to changes in physical or mental fatigue following the intervention 
(Kawatani et al., 2011).   
In an earlier study by the same group, cognitive function in 414 young CFS 
patients was evaluated using event-related potentials and the Kana Pick-Out Test.  
Compared to 190 healthy controls, the CFS achieved lower scores on measures of 
information processing, sustained attention, and divided attention (Tomoda, et al., 
2007). 
Further evidence of cognitive impairment in young CFS patients has been 
found using neuroimaging technology.  For instance, in a sample of 13 children with 
CFS, hypoperfusion was observed in the left and right temporal and parietal lobes.  
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There was also evidence of bilateral orbitofrontal and anterior temporal 
hypoperfusion, as well as hypoperfusion in the right frontal lobe and dorsal aspects 
of both frontal lobes and both parietooccipital lobes (Goldberg, Mena, & Darcourt, 
1997).  However, this study lacked a comparison group and the sample size was very 
limited.  In a more recent case report study, regional cerebral blood flow and brain 
metabolic levels were assessed in three CFS patients aged 11, 12 and, 13.  The 
results were compared to healthy data drawn from another study.  Blood flow in the 
left temporal and occipital lobes was markedly lower than healthy controls in cases 
two and three.  In case one however, blood flow in the left basal ganglia and 
thalamus was significantly higher than controls.  A considerable elevation of the 
choline/creatine ratio was also observed in all CFS patients.  There was no evidence 
of any focal structural abnormalities (Tomoda et al. 2000). 
Although significant advances in the quality and quantity of research are 
required, preliminary findings suggest that young CFS patients experience significant 
cognitive impairment, particularly in terms of attention and working memory. 
   
Methodological Considerations 
There are a number of methodological issues to be considered when 
interpreting research investigating cognitive function in CFS patients.  Firstly, many 
of the neuropsychological tests used in this research are designed to detect 
impairment in patient groups with substantial impairment (Gronwall, 1977; Rey & 
Osterrieth, 1993), and these tests may lack adequate sensitivity for identifying 
abnormalities in CFS patients who experience mild cognitive deficits in everyday 
function (Wearden & Appelby, 1996).  Moreover, neuropsychological testing 
performed within a laboratory setting may be inappropriate for detecting deficits that 
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occur in naturalistic settings (Tiersky et al., 1997; Wearden & Appelby, 1996).  In a 
laboratory, patients are less affected by noise interference, distraction, fatigue, 
drowsiness, or a willingness to give up.  Further, there is often a social obligation to 
please the researcher and to perform at a high standard.  These factors may serve to 
conceal or compensate for the cognitive deficits that are normally present in CFS 
patients. 
Cognitive assessments and findings are routinely categorised into various 
domains, such as executive function, attention, and processing speed.  However, 
these faculties are theoretically derived operational constructs that fail to represent 
the true complexities of cognitive processes.  A test designed to assess a single 
cognitive domain almost always requires the use of one or more other functions.  
Determining the precise cognitive function that accounts for poor performance can 
be exceedingly difficult.  Conversely, cognitive deficits may be concealed by the 
superior performance of other cognitive domains. 
In light of these issues, caution is recommended when interpreting findings 
from studies in cognitive function.  In future research, some of these issues could be 
addressed by including measures of both perceived cognitive function and 
neuropsychological test performance in several cognitive domains.  This would 
contribute to a greater understanding of how CFS affects various cognitive functions 
in a range of settings. 
 
Chapter Summary 
In summary, current research suggests that adults and young people with CFS 
perceive themselves to have a range of cognitive impairments, and many patients 
perform poorly on academic and neuropsychological tests.  Some adults with CFS 
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experience deficits in executive function, particularly on tasks that involve cognitive 
flexibility and abstract planning.  However, general planning and problem solving 
ability appears to remain intact.  CFS patients also tend to perform poorly on tasks 
that require divided attention, choice reaction, and sustained attention, but not 
selective attention.  There is considerable evidence suggesting that processing speed 
is impaired in many CFS patients, and that these deficits decrease the precision and 
efficiency of other cognitive functions.  Finally, performance deficits are often 
observed on challenging working memory tasks that require free recall of 
phonological or visuospatial information.  CFS patients often have structural and 
functional neurological abnormalities, and many patients employ different cognitive 
strategies or require greater neurological effort to complete the same cognitive tasks 
as nonfatigued peers.  However, many patients present with no neurological 
irregularities at all.  In the few studies in young patients, there is evidence of deficits 
in attention, working memory, and learning. 
Nonetheless, the nature of cognitive dysfunction in CFS patients is still far 
from being well understood, and findings in this area are perhaps best described as 
inconsistent.  This could be caused by methodological variability or inconsistencies 
in external factors such as environment and time, or internal factors such as symptom 
severity.  It is also possible that these results reflect the true complexities of cognitive 
function or the heterogeneity of symptom profiles in CFS patients.  Until further 
research becomes available, the nature of cognitive function in CFS patients is 
largely speculative. 
Even less is known about cognitive function in young patients due to the near 
absence of research in paediatric populations.  It cannot be assumed that adults and 
young people present with similar cognitive symptoms, particularly given that 
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neurological development continues into young adulthood (De Luca et al., 2003).  
This research gap is particularly remarkable given the significant implications for 
young people if cognitive impairments are present.  If CFS affects cognitive function 
at such critical stages of development, cognitive dysfunction could become lifelong, 
and performance at school may be severely impaired.  These factors could cause 
limitations to educational and occupational opportunities throughout life (Fröjd et al., 
2008; Kovacs & Goldston, 1991), and may generate secondary problems in identity 
formation (Flum, & Kaplan, 2012; Vågan, 2011), social development (Honn & 
Bornstein, 2002; Kovacs & Goldston, 1991), and psychological adjustment (Austin 
et al., 2010).  In the absence on curative treatments, it is essential to develop targeted 
interventions that address the most disturbing symptoms of CFS.  For young patients, 
one of these symptoms is likely to be cognitive dysfunction. 
Further research is critical to forming an accurate conceptualisation of how 
CFS affects cognitive function in young people, with the expectation that this will 
promote additional investigation into treatment or compensatory approaches for 
cognitive disturbances.  Due to the potentially devastating consequences of cognitive 
impairment in this population, research designed to understand and treat cognition 
may lead to considerable improvements in the quality of life of young CFS patients. 
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Chapter 4: Factors That Affect Cognitive Function in CFS 
The research discussed in the previous chapter demonstrates that people with 
CFS commonly experience impairment in several cognitive faculties.  However, 
these deficits might be amplified by the severity of several symptoms common in 
CFS, including fatigue, sleep disturbance, and psychological distress.  The following 
chapter includes a brief overview of the literature regarding how these factors 
influence cognitive function in CFS patients. 
 
Fatigue 
Fatigue is an enormously complex phenomenon that is greatly influenced by 
several interrelated psychosocial and behavioural processes (Zwarts, Bleijenberg, & 
van Engelen, 2008).  Even outside clinical populations, fatigue is strongly associated 
with significant morbidity (Shen, Barbera, & Shapiro, 2006).  Constituting the key 
symptom of CFS, chronic fatigue is responsible for considerable disability and 
functional impairment in these patients.  Considerable efforts have been made to 
understand the relationship between fatigue and cognitive performance in people 
with CFS. 
Research investigating how cognitive function is affected by fatigue in CFS 
patients has drawn mixed results.  One group found a negative correlation between 
fatigue and performance on tasks requiring spatial memory and verbal fluency in 20 
CFS patients.  However, no correlations were identified between fatigue and 
performance on six other measures of cognitive function (Joyce et al., 1996).  
Michiels et al. (1999) also found that increased fatigue was associated with poor 
performance on tasks of attention but not memory in a group of 29 CFS patients.  
Several other studies suggest that self-reported fatigue is unrelated to performance on 
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tasks of executive function, working memory, attention, information processing 
speed, and visual memory (Mahurin et al., 2004; Michiels et al., 1998; Short et al., 
2002; Vercoulen et al., 1998). 
When mental fatigue is evaluated independently from physical fatigue, the 
association between fatigue and cognitive performance is generally stronger.  For 
instance, in a study of 43 CFS patients, lower scores on CANTAB tasks of working 
memory, visual memory, and attention were identified among those who reported 
significant mental fatigue compared to patients without mental fatigue and healthy 
controls.  However, there were no between-group differences on measures of 
executive function, choice reaction time, and other visual memory tasks (Capuron et 
al., 2006).  In a combined sample of CFS patients and matched controls, another 
group identified an association between increased mental fatigue and slower 
response times on two CANTAB tests.  However, no significant correlations were 
observed between fatigue and other tests of visual memory, executive function, 
working memory, and attention.  In addition, only physical fatigue was correlated 
with slower movement times, and general fatigue was associated with poor 
performance on a visual memory task (Majer et al., 2008).   However, because these 
findings refer to CFS patients and controls as a group, the unique impact of fatigue in 
CFS patients in this study is unclear. 
One group investigated the impact of mental fatigue in young CFS patients.  
Researchers monitored the relationship between fatigue and reaction time on a trail-
making test throughout a treatment trial in a group of 19 adolescents with CFS.  
From baseline to follow-up, patient reports of decreased mental and total fatigue 
were associated with faster reaction times on task E, but not tasks A-C.  Changes in 
physical fatigue were unrelated to reaction time (Kawatani et al., 2011).  These 
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results suggest that, in young CFS patients, reaction time may improve in response to 
decreases in mental fatigue. 
The relationship between mental fatigue and cognitive impairment was also 
demonstrated in a neuroimaging study.  Nine CFS patients and 11 nonfatigued 
controls completed the PASAT and several nonfatiguing cognitive and motor tasks.  
Mental fatigue was associated with brain activity in the cerebella, temporal, cingulate 
frontal, and left posterior parietal cortex regions while participants completed the 
PASAT only.  In addition, the CFS patients exhibited significantly greater cortical 
and subcortical activity than controls while completing the PASAT.  There were no 
differences in brain activity between groups on the nonfatiguing tasks.  Group 
differences in neurological activity remained significant when anxiety, depression, 
and task performance were accounted for.  However, the differences became 
nonsignificant when mental fatigue was controlled for (Cook et al., 2007).  These 
results suggest that mental fatigue affects neurological function during demanding 
cognitive activity. 
Another group found that CFS patients are also particularly susceptible to the 
effects of acute fatigue.  Compared to 126 matched controls, 67 CFS patients 
achieved lower scores on a test of sustained attention, and the group differences 
became larger as acute fatigue increased throughout the assessment (Smith et al., 
1999). 
The impact of fatigue appears to be distinct from sleepiness.  This was 
demonstrated in a study involving 15 CFS patients without sleep disorders or 
clinically significant sleepiness, 15 sleep apnoea patients without significant fatigue, 
and 16 healthy participants.  Cognitive tests included the Auditory Verbal Learning 
Test and the Digit Span and Digit Symbol subsets from the WAIS.  Both patient 
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groups achieved lower scores than healthy controls on all tests other than Digit Span.  
Impairment on the Digit Span and Digit Symbol tests was most severe in the sleep 
apnoea patients.  Although the patients with sleep apnoea scored lower than both 
groups on the verbal memory task, only the CFS patients failed to increase the 
number of correctly recalled words over successive trials (Neu et al., 2011).  This 
suggests that fatigue and sleepiness are associated with distinct, but significant 
cognitive impairment. 
Together, the research suggests that fatigue is positively correlated with 
cognitive impairment in CFS patients.  However, the findings are highly variable.  
Greater clarity is gained by distinguishing mental fatigue from general or physical 
fatigue, with results suggesting that mental fatigue is associated with impairment on 
tasks that require working memory, visual memory, attention, and reaction time.  
Although an association between fatigue and poor reaction time was observed in one 
adolescent study, considerably more research is required before the relationship 
between fatigue and cognitive performance can be established in young CFS 
patients. 
 
Sleep Disturbance 
The adverse impact of sleep disturbance on cognitive function has been well 
documented in both adult and paediatric CFS samples.  Sleep disturbance is reported 
by around 81-95% of CFS patients (Becker et al., 2001; Sharpley, Clements, 
Hawton, & Sharpe, 1997; Unger et al., 2004), and disturbed sleep is known to 
generate many symptoms associated with CFS (Horne, 1988; Samkoff & Jacques, 
1991).  As such, some have suggested that cognitive impairment in CFS patients is 
caused by disturbances in sleep (Huller & Moser, 1990). 
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Although sleep disturbances are exceptionally common in CFS patients, 
primary sleep disorders are considered exclusionary in the CFS case definition 
(Fukuda et al., 1994).  Nonetheless, high incidences of undiagnosed sleep disorders 
have been identified in CFS patients.  Depending on the study, the prevalence of 
undiagnosed primary sleep disorders in CFS patients ranges anywhere between 0% 
and 81%.  Commonly diagnosed disorders include sleep apnoea, narcolepsy, restless 
leg syndrome/periodic limb movements, and insomnia or hypersomnia (Buchwald, 
Pasculay, Bombardier, & Kith, 1994; Fossey et al., 2004; Krupp, Jandorf, Coyle, & 
Mendelson, 1993; Le Bon et al., 2000; Manu et al., 1994; Morriss et al., 1993; 
Sharpley et al., 1997; Stores, Fry, & Crawford, 1998).  It is probable that the 
inconsistent findings are caused by differences in research settings, selection criteria, 
case definitions, and methods of excluding primary sleep disorders (Unger et al., 
2004). 
Objective assessment techniques provide considerable insight into the nature 
of sleep disturbance in CFS.  Using polysomnograph testing, one group found that 
compared to healthy controls, 20 CFS patients spent significantly longer in bed, slept 
less efficiently, and were awake for longer following sleep onset.  However, there 
were no significant between-group differences in total nocturnal sleep time.  
Abnormal polysomnographs were observed in seven CFS patients and one healthy 
control (Sharpley et al., 1997).  Another group identified abnormal polysomnograph 
results in 41% of 59 participants with chronic fatigue over a day-night sleep 
assessment (Buchwald et al., 1994).  Other common sleep quality problems 
identified in CFS patients include poor sleep efficiency, reduced sleep time, 
interrupted sleep, prolonged sleep latency, and reduced slow wave sleep (Sharpley et 
al., 1997; Togo et al., 2008; van Hoof, de Becker, Lapp, Cluydts, & De Meirleir, 
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2007).  These abnormalities remain evident when sleep and psychiatric disorders 
have been accounted for (Sharpley et al., 1997; Togo et al., 2008).  With the 
development of more advanced polysomnograph assessments, one group found that 
compared to matched healthy controls, 22 female CFS patients transitioned from 
REM to non-REM sleep less frequently.  However, the biological determinants of 
sleep duration in each stage were normal (Kishi, Struzik, Natelson, Togo, & 
Yamamoto, 2008).  Collectively, findings drawn from polysomnograph assessments 
suggest that patients with CFS experience significant disturbances in sleep quality. 
Researchers have given considerably less attention to the nature of sleep 
disturbance in young people with CFS.  In one of the few studies, actigraph 
assessments were used to monitor nighttime activity in 12 CFS patients aged 
between 12 and 16 and matched controls.  Compared to controls, the CFS group slept 
for considerably longer and were more likely to engage in long, uninterrupted sleep 
exceeding 10 hours (Ohinata et al., 2008).  However, because actigraphs detect sleep 
based on movement, it is possible that these results reflect differences in stillness 
rather than sleep.  In contrast, polysomnograph assessments revealed no differences 
in time spent asleep between 18 adolescents with CFS and matched healthy controls.  
However, the CFS patients slept less efficiently and had more frequent and longer 
sleep disruptions than controls (Stores et al., 1998). 
Disturbances in circadian rhythm function have also been identified in young 
CFS patients.  Using a saliva analysis, one group identified significantly higher 
melatonin levels in 13 adolescents with CFS compared to 15 age-matched controls 
when sleeping between midnight and 3:00am.  All CFS patients and only one control 
reported unrefreshing sleep (Knook, Kavelaars, Sinnema, Kuis, & Heijnen, 2000).  
Another group found that young CFS patients lacked a clear rhythm in circadian 
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variation of core body temperature.  In addition, compared to healthy controls, the 
CFS patients were delayed in reaching their lowest core body temperature and 
exhibited a lower amplitude of circadian core body temperature changes (Akemi, 
Takako, & Teruhisa, 2001).  These studies suggest that circadian rhythm 
desynchronisation might be closely related to sleep disturbance in young people with 
CFS. 
It is also important to note that even normal adolescent development is 
typically characterised by considerable changes in the timing and quantity of sleep 
and wakefulness.  In adolescence, normal changes in circadian rhythm frequently 
cause young people to experience ongoing phase delay, which is characterised by 
late sleep times and late awakenings (Carskadon, Acebo, & Jenni, 2004).  
Adolescents also typically experience a decline in slow wave sleep (Williams, 
Karacan, & Hursch, 1974; Williams, Karacan, Hursch, & Davis, 1972) and changes 
in wave frequency during non-REM sleep (Jenni, Achermann, & Carskadon, 2003).  
Moreover, psychosocial and life-style changes, such as increased autonomy, 
academic obligations, and late-night social events often interfere with behavioural 
sleep regulation (Carskadon et al., 2004). 
In summary, the research suggests that a significant portion of CFS patients 
experience disturbed sleep characterised by abnormal sleep architecture, poor sleep 
efficiency, interrupted sleep, unrefreshing sleep, reduced sleep time, prolonged sleep 
latency, and circadian rhythm disturbances.  Although research in paediatric 
populations is limited, adults and young people with CFS appear to experience 
similar levels of sleep disturbance.  Furthermore, there is clear evidence suggesting 
that disturbed sleep is common even among healthy adolescents.  As the following 
section will demonstrate, sleep disturbance can have a significant impact on 
92 
 
cognitive function and may even account for some of the cognitive deficits observed 
in CFS patients. 
To the authors’ knowledge, the relationship between sleep disturbance and 
cognitive function has only been assessed in CFS patients by one research group.  
The 67 CFS patients in this study were grouped according to the presence or absence 
of self-reported sleep disturbance.  Compared to healthy controls, the CFS patients 
who reported sleep disturbances achieved lower scores on tests of attention, free 
recall, and cognitive vigilance.  These differences could not be accounted for by 
fatigue, illness severity, illness duration, or anxiety.  However, no differences were 
observed between the CFS patients without sleep disturbances and healthy controls 
on any measure (Smith et al., 1996).  This study suggests that sleep disturbance may 
account for the cognitive deficits observed in CFS patients. 
Although the association between circadian rhythm function and cognitive 
performance is yet to be examined in CFS patients, circadian rhythm disruption is 
common in CFS patients (van Heukelom, Prins, Smits, & Bleijenberg, 2006; 
Williams et al., 2002), and research in healthy populations suggests that circadian 
desynchronicity is related to neuropsychological impairment.  In an experimental 
design, neuropsychological performance was examined in two groups of healthy 
participants while living in a laboratory for over one month.  The relationship 
between sleep-wakefulness and internal circadian time was intentionally disrupted in 
one group and maintained in the other.  In the desynchronised group, total sleep time, 
sleep latency, and rapid eye movement latency were shortened, and wakefulness 
following sleep onset increased.  Compared to the synchronised group, learning 
impairment was significantly greater in participants with disrupted sleep (Wright, 
Hull, Hughes, Ronda, & Czeisler, 2006).  Similarly, another group found that 
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participants who endure experimentally disturbed sleep-wake cycles exhibit 
impairments in concentration, learning capacity, and learning efficiency (Harrison, 
Jones, & Waterhouse, 2007).  These results suggest that a disrupted alignment 
between sleep-wakefulness and internal circadian rhythm is associated with impaired 
cognitive performance. 
If sleep disturbance affects cognitive function, it would be reasonable to 
expect that treatment for disturbed sleep would reduce the severity of cognitive 
impairment.  This hypothesis was tested in 59 cognitively impaired CFS patients who 
exhibited disturbed sleep on objective assessments.  Following treatment for sleep 
disorders, 90% of patients reported improvements in cognitive functioning.  Note 
however, that this study relied on subjective measures of cognitive function, and the 
researchers failed to detail the nature of the treatment or the outcome measures for 
the reported improvements (Buchwald et al., 1994). 
Cognitive deficits are likely to be a particular problem for young people with 
CFS given the high rates of sleep disturbances in healthy populations.  Based on 
correlational studies in healthy children, researchers have identified an association 
between inadequate sleep and deficits in attention, visual memory, visual scanning, 
and working memory (Dahl, 1996; Sadeh, Gruber, Raviv, 2002; Steenari et al., 
2003).  Many of these findings are also supported by experimental studies.  In a 
randomised controlled trial, 16 children aged between 10 and 14 were assigned to 
have 11 or five hours in bed over one night in a sleep laboratory.  Those with 
restricted sleep achieved lower scores on abstract learning and verbal creativity tasks 
than participants with extended sleep.  Less complex tasks involving memory, 
learning, and figural creativity were not affected by sleep restriction (Randazzo, 
Muehlbach, Schweitzer, & Walsh, 1998).  Similar results were found in a study of 77 
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children who were asked to reduce or increase their sleep by one hour over three 
consecutive nights.  Only the sleep-restricted group received lower scores on the 
Digit Forward test and a test of sustained attention compared to baseline.  However, 
there were no changes in either group on a test of visual scanning memory and 
another working memory task (Sadeh, Gruber, & Raviv, 2003). 
There is also evidence suggesting that sleep disturbance is associated with 
impaired academic performance.  For instance, results from a comprehensive survey 
completed by 3,120 adolescents revealed that on average, participants who were 
achieving a C grade or below were receiving approximately 25 minutes less sleep 
and went to bed 40 minutes later on school nights than students achieving B grades 
or above (Wolfson & Carskadon, 1998).  Similarly, in a community sample of 972 
primary school students, problems with school achievement were significantly more 
common among those with sleep difficulties, and 21% of poor sleepers had failed at 
least one year of school (Kahn et al., 1989).  Although the research is correlational, 
these results provide some indication that a disruption in regular sleep may interfere 
with academic performance.  As such, sleep disturbance may compound the issues 
associated with school absenteeism and cognitive impairment in young people with 
CFS.  
In summary, the research suggests that sleep disturbance is common in CFS 
patients and healthy adolescents.  Disturbed sleep and circadian rhythm 
desynchronisation may cause neuropsychological performance deficits, particularly 
on tests of attention, free recall, and cognitive vigilance.  In adolescents, sleep 
disturbances may also cause cognitive impairment on tasks involving abstract 
learning, verbal creativity, working memory, and sustained attention.  Moreover, 
correlational studies indicate that disturbed sleep is associated with poor performance 
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in academic settings.  However, these findings are based on preliminary research or 
studies in healthy populations, and it is unclear whether sleep disturbance contributes 
to academic decline in CFS patients.  Determining how sleep is related to cognitive 
dysfunction in young CFS patients may inform the process of developing treatments 
that target this debilitating symptom in CFS. 
 
Psychological Disturbance 
High rates of psychological distress have been consistently documented in 
CFS populations, with depression and anxiety among the most common complaints 
(see the Psychological Disturbance section in Chapter 2 for a discussion of the 
prevalence of psychological disturbances in CFS).  This has considerable 
implications for cognitive function in CFS patients, as there is a well-established 
relationship between psychological distress and neuropsychological performance. 
In healthy populations, the correlation between psychological adjustment and 
cognitive function has been summarised in several meta-analyses.  In a major review 
of 14 studies with participants who met the criteria for MDD, significant negative 
correlations were identified between symptom severity and neuropsychological 
performance on measures of episodic memory, executive function, and processing 
speed, but not semantic or visuospatial memory.  However, the effect sizes explained 
no more than approximately 10% of the variance (McDermott & Ebmeier, 2009).  In 
another meta-analysis of studies in young adults, clear deficits were observed in 
depressed patients on measures of executive function, attention, short-term and 
working memory, and psychomotor function.  There was also some evidence of 
disturbances in verbal memory and learning, although several other studies suggested 
that performance on these measures was unaffected.  In patients with anxiety 
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disorders, impairments were evident on measures of verbal episodic memory and 
executive function, and people with Panic Disorder were impaired on measures of 
divided attention, verbal memory, and learning, but not selective attention, visual 
memory, executive function, or concentration.  Executive function, attention, and 
long- and short-term memory were also impaired in participants with Obsessive-
Compulsive Disorder and Posttraumatic Stress Disorder (Castaneda, Tuulio-
Henriksson, Marttunen, Suvisaari, & Lönnqvist, 2008). 
An association has also been identified between cognitive function and stress.  
Longitudinal research indicates that prolonged cortisol elevation is associated with 
cognitive dysfunction on measures of learning and selective attention but not 
memory or divided attention (Lupien, Lecours, Lussier, & Schwartz, 1994; Seeman, 
1997).  Researchers have also identified a relationship between stress-induced 
elevations in cortisol and impaired declarative memory (Kirschbaum, Wolf, May, & 
Wippich, 1996; Lupien, 1997).   
Psychological disturbances also appear to affect academic performance.  For 
instance, in a large study involving 400 Iranian students aged between 15 and 19, a 
negative correlation was observed between Grade Point Average (GPA) and self-
reported depression (Yousefi, Redzuan, Mansor, Talib, & Juhari, 2009).  Similarly, 
in a sample of 164 participants, Deroma (2009) found that those with moderate 
depressive symptoms had significantly lower GPAs than those with normal or 
minimal depressive symptoms.  Another group found that 13 children with comorbid 
depression and epilepsy achieved lower scores on teacher grade reports than 38 
controls with epilepsy alone.  In addition, report scores improved in the depressed 
group following treatment for depression (Tosun et al., 2008).  In contrast, several 
others have found no relationship between achievement outcomes and indicators of 
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psychological adjustment (Abell, Zwick, & Wheeler, 2007; Vaidya & Mulgaonkar, 
2007; Yeh et al., 2007). 
Although these studies suggest that psychological disturbances affect 
cognitive performance, it is important to note that the findings are largely based on 
correlational relationships from cross-sectional research.  It is difficult to know 
whether the observed cognitive disturbances were caused by psychological distress 
or some other factor that is common to people who are suffering from psychiatric 
disturbances.  The data may also be confounded by the presence of unassessed 
comorbid psychological disorders. 
The relationship between psychological distress and cognitive impairment 
has also been investigated in CFS populations.  Wearden and Appleby (1997) 
divided 50 CFS patients into two groups based on the presence or absence of 
depression.  Only the depressed CFS group reported significantly greater levels of 
cognitive impairment than a group of healthy controls, and the depressed patients 
recalled significantly fewer items than the nondepressed patients on a free recall and 
cued verbal memory task.  Researchers have also found that once depressive 
symptoms have been partialled out, cognitive deficits in CFS patients are no longer 
significant.  For instance, Metzger and Denney (2002) found that group differences 
between CFS patients and controls on the Stroop task became nonsignificant when 
depression had been statistically accounted for.  Another group found that compared 
to healthy participants, patients with CFS achieved significantly lower scores on 
measures of immediate memory, delayed memory, and visuo-constructional tasks.  In 
addition, scores on measures of attention were significantly lower in the CFS group 
compared to patients with autoimmune thyroid disease.  However, when the effects 
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of depression were controlled for, all group differences, with the exception of 
attention, were no longer significant (Dickson et al., 2009). 
Findings from similar studies have been more ambiguous.  For instance, one 
group identified a significant relationship between both depression and anxiety and 
performance on the Digit Span Backward task, but not on measures of working 
memory, executive function, or reaction time (Michiels et al., 1998).  Similarly, 
Crowe and Casey (1999) found that depression severity was negatively correlated 
with scores on the PASAT but was unrelated to performance on tasks involving 
working memory, executive function, or attention.  Adding to the complexity, several 
studies show no evidence of a relationship between psychological disturbances and 
cognitive function in CFS patients (Claypoole et al., 2007; Dobbs et al., 2001; Joyce 
et al., 1996; Mahurin et al., 2004; Michiels et al., 1996; Michiels et al., 1999; Short et 
al., 2002; Vercoulen et al., 1998). 
The conflicting results could be partially accounted for by differences in the 
severity of depressive symptomatology between studies.  While some researchers 
excluded participants who met the diagnostic criteria for depression, others sought to 
recruit the most severely depressed patients.  For instance, Crowe and Casey (1999) 
intentionally included CFS patients with high symptom severity, chronicity, and 
impairment, and 65% of the Metzger and Denney (2002) sample scored above the 
clinical cut-off score for severe depression.  Conversely, in most studies suggesting 
that depressive symptoms and cognitive performance were unrelated, participants 
with comorbid depression were excluded and few participants reported severe 
depressive symptomatology (Claypoole et al., 2007; Joyce et al., 1996; Michiels et 
al., 1996; Michiels et al., 1999).  This suggests that in CFS patients, cognitive 
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impairment is associated with severe depressive symptoms or a diagnosable 
depressive disorder. 
Taken together, the research suggests that psychological disturbances are 
related to cognitive dysfunction.  In healthy populations, associations have been 
found between psychological distress and deficits on tests of executive function, 
attention, long-term memory, working memory, processing speed, learning, and 
academic achievement.  Similar relationships have been identified in CFS patients, 
although the research is limited and the results are variable.  The severity of 
psychological symptoms appears to be an important factor in determining the level of 
cognitive impairment, however this has not been investigated directly.  Although the 
research is largely correlational, it suggests that psychological symptoms have the 
potential to contribute to, or perhaps exacerbate cognitive dysfunction in patients 
suffering from CFS. 
 
Chapter Summary 
The research discussed in Chapter 3 suggests that CFS patients have deficits 
in several cognitive faculties.  To explore this further, the present chapter included an 
investigation of several symptoms common to CFS that have the potential to affect 
cognitive impairment.  In summary, although the research suggests that fatigue 
impedes cognitive performance in CFS patients, only one study included a paediatric 
sample, and the exact nature and extent of the relationship between fatigue and 
cognitive performance remains unclear due to the inconsistent findings between 
studies.  Disturbed sleep may increase or even account for the deficits observed in 
adult patients, and an association has been identified between sleep disturbance and 
impaired neuropsychological and academic performance in healthy adolescents.  
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Finally, although psychological distress may contribute to a decline in cognitive 
performance, this finding is less well established in CFS patients and is yet to be 
investigated in young patients. 
Investigating the range of factors contributing to cognitive impairment in 
CFS patients is made complex by several issues.  In particular, it is difficult to 
distinguish between the effects of the individual symptoms, and few studies have 
explored the unique contributions of each major variable.  Moreover, it is unclear 
whether cognitive decline is caused by the combination of these symptoms or by 
some unique feature of CFS.  In addition, given that most of the research is 
correlational, it is not clear whether these variables have a causal role in cognitive 
dysfunction.  Nonetheless, the cumulative evidence from research in healthy and 
clinical samples provides a persuasive argument for the importance of considering 
fatigue, sleep disturbance, and psychological distress in the study of cognitive 
function in CFS patients.  By inflating cognitive impairment, these symptoms all 
have the potential to magnify the negative impact of CFS in young populations. 
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Chapter 5: Research Proposal 
Despite rigorous research over several decades, CFS remains poorly 
understood.  An overview of the historical context from which CFS emerged reveals 
a multitude of conceptual transitions.  As such, research efforts and findings have 
been inconsistent, and little is known about the nature of CFS, particularly in young 
people.  Learning more about paediatric CFS is particularly important given that the 
prevalence rates are significant and course is prolonged for many young people.  In 
addition, CFS causes considerable impairment that uniquely affects young patients, 
interfering with several vital developmental domains at an especially vulnerable age. 
Establishing an effective treatment approach is limited by the exceptionally 
heterogeneous nature of CFS and poor understanding of the underlying aetiological 
factors.  As such, interventions may be most effective if designed to ameliorate the 
debilitating symptoms and reduce the functional impact of CFS.  One of the most 
prominent and destructive symptoms experienced by CFS patients is cognitive 
impairment.  Adults and young people with CFS perceive themselves to have a range 
of cognitive deficits, and many adult patients perform poorly on neuropsychological 
tests, including tests of executive function, attention, processing speed, and working 
memory.  If present in young patients, these deficits could cause a severe decline in 
academic performance and may lead to lifelong cognitive impairment.  Cognitive 
decline may also generate secondary problems, such as school absenteeism, learning 
difficulties, psychological distress, and disturbed social and emotional development.  
These factors may limit future educational attainment and career opportunities, and 
prevent patients from participating in regular activities that are important for 
adolescent development.  The overall affliction of CFS in young people is 
immeasurable. 
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Remarkably, almost no research has been designed to investigate objective 
cognitive function in young patients.  Further research is critical to forming an 
accurate conceptualisation of how CFS affects cognitive function in young people.  
Improved knowledge in this area could promote additional investigation into 
treatment or compensatory approaches for cognitive disturbances.  Due to the 
potentially devastating consequences of cognitive impairment in this population, 
research designed to understand and treat cognition may lead to considerable 
improvements in the quality of life of young CFS patients. 
Furthermore, it is important to account for other symptoms common in CFS 
that may affect performance on cognitive tasks.  Fatigue, sleep disturbance, and 
psychological distress all have the potential to inflate cognitive impairment, 
significantly magnifying the negative impact of CFS in young populations.  
Determining the nature of the relationship between these symptoms and cognitive 
impairment may lead to new insights regarding how to improve cognitive function in 
CFS patients.  If this is successful, this could reduce the impact of CFS in young 
populations considerably. 
The current research team recently investigated cognitive impairment in a 
group of 27 adolescents with CFS and 27 healthy controls.  All patients had their 
diagnosis confirmed by a paediatric specialist and were considered to have moderate 
to severe symptoms.  Participants completed comprehensive neuropsychological tests 
of executive function, attention, processing speed, and working memory from the 
CANTAB.  The WRAT-III was also included to provide a measure of academic 
achievement.  Although the CFS patients reported significantly higher levels of 
fatigue, sleep disturbance, psychological distress, school absenteeism, and cognitive 
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impairment, no differences were observed between patients and controls on any 
neuropsychological or academic test (Younis, 2009). 
These findings were considered unusual for a number of reasons.  First, much 
of the research in adults suggests that CFS patients perform poorly on these 
measures.  Although the results vary, studies that include sensitive measures of 
cognitive function rarely show a complete absence of impairment.  Second, the 
patients themselves reported significantly elevated levels of cognitive impairment.  
Third, the CFS group reported high levels of sleep disturbance, psychological 
distress, fatigue, and medication use.  Even in healthy populations, these factors are 
often sufficient to produce significant cognitive impairment.  There were no 
between-group differences in IQ, and the unexpected findings were unlikely to be 
caused by inaccurate diagnosis, low symptom severity, and insufficient breadth and 
sensitivity of the neuropsychological assessments. 
The unusual findings could be explained by differences in motivation 
between groups.  Throughout the assessment, the researchers observed that the CFS 
patients appeared to have higher levels of test motivation than the healthy controls.  
Specifically, the CFS group appeared to have more concern for their performance 
results, greater task focus, and greater interest in the research and assessment 
procedure.  If these subtle observations were representative of true differences 
between groups, it is possible that test motivation accounted for the comparable 
neuropsychological test scores between groups. 
Theoretically defined models of test-taking motivation support the hypothesis 
that motivation affects performance on cognitive tasks (Thelk, Sundre, Horst, & 
Finney, 2009; Wise & DeMars 2005; Wolf & Smith 1995).  Eklöf (2010) recently 
theorised that there are two central components that are important for motivated 
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action.  The expectancy component is the individuals’ belief in their ability to 
complete the task, and the task-value component refers to how personally valuable 
the task is to the individual.  This second component is comprised of four factors, 
including attainment value (importance of doing well), intrinsic value (interest in the 
task), utility value (usefulness of the task), and cost perceptions (amount of effort 
required).  These perceptions are hypothesised to influence performance by 
determining the examinees’ level of motivation, effort, and persistence. 
This theoretical model is supported by a wealth of research.  An association 
has been identified between academic performance and test motivation in school 
children (Brown & Walberg, 1993; Fortier, Vallerand, & Guay, 1995; Howse, Lange, 
Farran, & Boyles,  2003; Logan, Medford, & Hughes, 2010; Nishimura, Kawamura, 
& Sakurai, 2011; Preckel, Holling, & Vock, 2006; Schultz, 1993; Tavani & Losh, 
2003; Verkuyten, Thijs, & Canatan, 2001) and in young adults studying at tertiary 
institutions (Goodman et al., 2011; Hirschfeld, Lawson, & Mossholder, 2004; Hoyt, 
2001; Smith & Smith, 2002; Sundre & Kitsantas, 2004; Wise, Wise, & Bhola, 2006; 
Wolf & Smith, 1995).  High test-taking motivation is also associated with superior 
performance on a range of neuropsychological tests (Binder, Kelly, Villanueva, & 
Winslow, 2003; Brunstein, & Schmitt, 2004; Lindem, 2000; Mizuno, Tanaka, 
Fukuda, Imai-Matsumura, & Watanabe, 2011).  Importantly, the influence of test 
motivation appears to be highest in people with lower cognitive ability (Duckworth, 
Quinn, Lynam, Loeber, & Stouthamer-Loeber, 2011; Logan et al., 2010).  As such, 
the performance enhancing effects of motivation may be stronger in cognitively 
impaired CFS patients compared to healthy peers. 
According to Eklöf’s (2010) theory of test motivation, examinees will possess 
greater motivation if they believe that it is important to perform well, have greater 
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interest in the task, and find the task more useful.  In the study by Younis (2009), it is 
probable that these factors were stronger in the CFS group.  Participants with CFS 
had a vested interest in the research, as the study was designed to investigate their 
illness and was relevant to their symptom presentation.  It is likely that many patients 
were feeling desperate to find ways of managing their condition and believed that 
active involvement in the research could contribute to finding solutions.  In contrast, 
the controls were likely to have had little personal interest in the aims of the study, 
and the research had no personal consequences for them.  In consideration of this 
motivational theory and the cumulative results from research investigating the 
relationship between test motivation and cognitive performance, it is possible that the 
CFS group had higher levels of motivation that served to compensate for their 
cognitive deficits. 
Alternatively, the differences in motivation observed between CFS patients 
and controls in the Younis (2009) study could be attributable to stronger 
perfectionistic tendencies in the CFS group.  Among clinical professionals, 
researchers, and the general community, CFS patients are commonly perceived to be 
perfectionistic, conscientious people who maintain high personal standards by 
incessantly pushing themselves beyond their limits (Lewis, Cooper, & Bennett, 1994; 
Surawy, Hackmann, Hawton, & Sharpe, 1995). 
Perfectionism is generally considered to be a personality trait that 
encompasses adaptive and maladaptive components (Burns, 1980; Frost, Marten, 
Lahart, & Rosenblate, 1990; Gilman, Ashby, Sverko, Florell, & Varjas, 2005; 
Slaney, Rice, Mobley, Trippi, & Ashby, 2001).  Adaptive perfectionism is 
characterised by high personal standards (Frost et al., 1990), perfectionistic strivings 
for excellence (Rice & Slaney, 2002), and self-oriented perfectionism (Hewitt & 
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Flett, 1991; Stoeber & Kersting, 2007).  Conversely, maladaptive perfectionism is 
associated with concern over mistakes (Frost et al., 1990; Rice & Slaney, 2002), 
discrepancies between expectations and results (Slaney et al., 2001), socially-
prescribed perfectionism, and other-oriented perfectionism (Chang, 2006; Hewitt & 
Flett, 1991). 
Several studies suggest that CFS patients often present with high levels of 
adaptive and maladaptive perfectionistic traits.  One group found that, compared to 
controls, CFS patients reported higher levels of adaptive and maladaptive 
perfectionistic traits prior to and after developing CFS (Luyten, Van Houdenhove, 
Cosyns, & Van den Broeck, 2006).  An Australian group of researchers also found 
that compared to matched healthy controls, CFS patients scored higher on scales of 
maladaptive perfectionism, including doubts about actions, and concern over 
mistakes (White & Schweitzer, 2000).  Others have found that CFS patients report 
high levels of maladaptive but not adaptive perfectionism (Deary & Chalder, 2010), 
and a positive correlation has been identified between fatigue and maladaptive but 
not adaptive perfectionism in CFS patients (Kempke et al., 2011).  In contrast, Wood 
and Wessely (1999) found no differences between CFS patients and patients with 
rheumatoid arthritis on measures of maladaptive or adaptive perfectionism.  Another 
group found similar scores among CFS patients and healthy controls on all scales of 
perfectionism other than maladaptive perfectionism, which were lower in the CFS 
group (Blenkiron, Edwards, & Lynch, 1999).  Although the results are mixed, the 
preliminary evidence suggests that at least a subgroup of CFS patients present with 
high levels of perfectionism. 
A clear pattern emerging from the research indicates that adolescents and 
tertiary students who report high perfectionistic strivings and low perfectionistic 
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concerns achieve significantly higher academic scores than those who report the 
opposite pattern and those without perfectionism (Accordino, Accordino, & Slaney, 
2000; Bieling, Israeli, Smith, & Antony, 2003; Brown et al., 1999; Cox, Enns, & 
Clara, 2002; Enns, Cox, Sareen, & Freeman, 2001; Grzegorek, Slaney, Franze, & 
Rice, 2004; Nounopoulos, Ashby, & Gilman, 2006).  Researchers have also found 
that academic performance is positively correlated with self-oriented perfectionism 
(Blankstein & Winkworth, 2004; Dykstra, 2007) and negatively correlated with 
socially prescribed perfectionism (Dykstra, 2007; Flett, Blankstein, & Hewitt, 2009; 
Witcher, Alexander, Onwuegbuzie, Collins, & Witcher, 2007).  However, contrary to 
theory, a positive correlation has been identified between other-oriented 
perfectionism and tertiary academic performance (Flett et al., 2009; Witcher et al., 
2007).  In addition, others have that found academic outcomes are unrelated to 
discrepancy (Accordino, et al., 2000), self-oriented perfectionism, and socially 
prescribed perfectionism (Chang, 2006; Flett, Blankstein, & Hewitt, 2009).  
A handful of studies also suggest that perfectionism is associated with 
performance on neuropsychological assessments.  Researchers have identified 
positive correlations between perfectionistic strivings and test performance on tasks 
of reasoning, work performance, information processing speed, and simple letter-
detection (Stoeber, Chesterman, & Tarn, 2010; Stoeber & Kersting, 2007).  Slade, 
Coppel, and Townes (2009) also found that performance on measures of executive 
function, attention, and working memory was positively correlated with adaptive 
perfectionism and negatively correlated with maladaptive perfectionism. 
Although further research is required, current findings suggest that at least a 
subset of CFS patients have perfectionistic traits, and there is relatively consistent 
evidence suggesting that adaptive perfectionism is associated with improved 
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performance on academic and neuropsychological tests.  Maladaptive perfectionism 
is less clearly understood, although the limited findings suggest that maladaptive 
traits are negatively correlated with academic and neuropsychological test 
performance.  As such, it is possible that, in the Younis (2009) study, the CFS group 
had higher levels of adaptive perfectionism than the controls and that this served to 
compensate for their deficits in cognitive function. 
An alternate explanation for the comparable scores between groups is that the 
CFS patients were not given sufficient opportunity to become mentally fatigued 
throughout the assessment.  Some cognitive tests were administered approximately 
20 minutes from the beginning of the session, and the entire assessment was typically 
completed within two hours.  Questionnaires were also administered between the 
cognitive tasks, and rest breaks were offered to provide participants with an 
opportunity to recover from mental effort and fatigue.  The CFS patients may have 
been able to compensate for cognitive decline associated with fatigue through these 
regular mental breaks.  These factors may have protected participants from reaching 
the level of fatigue that could generate cognitive impairment in everyday settings. 
One final possibility for the unexpected findings is that adolescents might be 
invulnerable to the cognitive impact of CFS.  Although there is a large body of 
evidence suggesting that cognitive dysfunction is common in adults with CFS, it is 
not yet clear whether young sufferers experience such impairment.  It is possible that 
cognitive function remains intact in young people with CFS. 
In consideration of the present literature, a study was designed to investigate 
neuropsychological function and academic achievement in young people with CFS.  
In view of the findings from Younis’s (2009) study, the effects of test motivation and 
perfectionism on cognitive performance will also be considered. 
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Study Aims 
The study will involve a cross sectional, between groups comparison of 
young CFS patients and healthy controls.  The CFS group will consist of 12 to 21 
year-olds diagnosed according to the paediatric case definition (Appendix A).  An 
age and sex matched healthy control group will be included to provide a means of 
comparison. 
Until recently, paediatric CFS patients were diagnosed according to 
diagnostic criteria developed for adults.  However, this approach fails account for the 
unique presentation and developmental consequences of CFS in younger 
populations.  In order to compensate for this, several researchers used an adapted 
version of the adult definition, and it was not until recently that a specific paediatric 
case definition was developed.  Consequently, research has drawn inconsistent 
findings, and little is known about the unique implications of CFS in younger 
populations.  Research investigating the symptoms and impact of CFS in young 
patients using the paediatric case definition is urgently required to clarify these 
inconsistencies and build a unique understanding of paediatric CFS.  To contribute to 
the emerging research in young CFS patients, the following study includes a self-
report questionnaire that provides detailed information about illness onset, course, 
impact, and symptom frequency and severity.   
A large body of evidence suggests that adults with CFS report considerable 
cognitive impairment, however, little is known about how young patients perceive 
their cognitive ability.  CFS patients may be able to describe aspects of their 
cognitive function that are not directly assessable with neuropsychological tests.  As 
such, participants in the current study will complete questionnaires about the severity 
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and frequency of cognitive symptoms.  Neuropsychological measures provide a more 
objective method of assessing cognitive function, and research in adults suggests that 
CFS patients perform poorly on measures of executive function, attention, processing 
speed, and working memory.  However, few studies have included measures of 
neuropsychological function in young CFS patients.  As such, the following study 
will include a thorough assessment of cognitive performance using the CANTAB.  A 
brief measure of intelligence will also be administered to allow group differences in 
intelligence to be statistically controlled when assessing neuropsychological 
performance. 
If cognitive impairment is present among young CFS patients, learning and 
academic performance are also likely to be affected.  A small number of studies 
suggest that adolescents with CFS perform poorly at school, however academic 
performance has not been directly assessed in young patients under laboratory 
conditions.  As such, a measure of academic achievement involving reading and 
arithmetic will be administered to patients and controls. 
Based on observations by researchers in the Younis (2009) study, young 
people with CFS may have higher levels of test motivation than nonfatigued peers.  
Increased motivation may enhance cognitive performance, negating the effects of 
cognitive impairment.  As such, a self-report measure of test motivation will be 
included in order to investigate and control for the impact of motivation on cognitive 
performance.  Similarly, emerging research suggests that perfectionism is common 
among CFS patients and that perfectionism affects performance on cognitive tasks.  
To investigate this, the present study will include a brief self-report measure of 
adaptive and maladaptive perfectionism.  Any group differences on this measure will 
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be statistically controlled for when cognitive performance is compared between 
groups. 
Although it is clear that adults with CFS suffer from a number of cognitive 
disturbances, it is possible that young patients are less vulnerable to cognitive 
decline.  This supposition is supported by the findings from the Younis (2009) study.  
To assess whether adults and young people suffer from similar disturbances in 
cognitive function, the present study will include a comparison group of adult CFS 
patients drawn from a concurrent research project. 
The current literature suggests that young patients experience a range of 
debilitating symptoms such as fatigue, sleep disturbance, and psychological distress.  
However, the unique impact of these symptoms in young CFS patients is not well 
understood.  Given that these symptoms have the potential to affect cognitive 
performance, the current study will include self-report measures of fatigue, sleep 
disturbance, and psychological distress.  Researchers will conduct a statistical 
exploration of how these symptoms affect performance on neuropsychological and 
academic tests.  Fatigue will also be monitored throughout the assessment procedure 
to assess the extent to which participants become fatigued in response to ongoing 
cognitive activity.  Although this aspect of the study is exploratory, it is hoped that 
the findings will provide a starting point for future research. 
Frequent school absenteeism is exceptionally common in young CFS 
patients.  Long periods of absence from school may significantly affect academic 
achievement and psychosocial development.  As part of investigating the functional 
impact of CFS, participants in this study will be asked to report their recent school 
attendance. 
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Hypotheses 
The study will test the following hypotheses: 
1. young people with CFS will report higher levels of cognitive disturbance and 
perform significantly worse on neuropsychological tests that assess executive 
function, attention, information processing speed, and working memory than 
healthy controls; 
2. young people with CFS will perform significantly worse on tests of academic 
achievement than healthy controls; 
3. young people with CFS will rate themselves higher on a measures of test 
motivation and adaptive and maladaptive perfectionism than healthy controls 
4. in young people with CFS, high levels of self-reported motivation and adaptive 
perfectionism will predict greater performance, and high levels of self-reported 
maladaptive perfectionism will predict poorer performance on tests of  
neuropsychological function and academic achievement; 
5. when the variance from motivation and adaptive perfectionism is accounted for, 
the differences between CFS patients and controls on neuropsychological and 
academic tests will become larger,  and when the variance from maladaptive 
perfectionism is accounted for, the differences between CFS patients and 
controls on neuropsychological and academic tests will become smaller; 
6. adults and young people with CFS will perform similarly on measures of 
neuropsychological tests that assess executive function, attention, and working 
memory; 
7. young people with CFS will report higher rates of symptoms common to CFS, 
including sleep disturbance, psychological distress, and fatigue than healthy 
controls; 
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8. in young people with CFS, high ratings of sleep disturbance, psychological 
distress, and fatigue will predict poorer perceived cognitive disturbance and 
lower scores on tests of neuropsychological function and academic achievement;  
9. young people with CFS will report higher rates of school absenteeism than 
healthy controls; 
10. in young people with CFS, school absenteeism will be associated with lower 
scores on tests of academic achievement. 
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Chapter 6:  Study of Cognitive Function in Young People with CFS 
 
Method 
Participants.  The study included three participant groups: young people 
with CFS, young people without significant fatigue, and adults with CFS.  Eligible 
participants for the young CFS group included 13 to 21 year-olds diagnosed 
according to the Paediatric Case Definition (Jason et al., 2006; Appendix A).  
Patients meeting these criteria were invited to participate by their treating physician 
at a tertiary paediatric medical centre.  Of the 30 who were invited, five declined due 
to concern that the assessments would be overly fatiguing, and two declined without 
providing a reason.  The 23 participants who agreed were aged between 12 and 21, 
with a mean age of 17.3 (SD = 2.54) years.  Females dominated the group, 
accounting for 74% of the sample. 
Young people without CFS were recruited through advertisement and word 
of mouth.  A group of 23 healthy young people aged between 12 and 21 agreed to 
participate, although two of these participants failed to return the take-home surveys.  
The mean age was 17.4 (SD = 2.75), and females again accounted for 74% of the 
sample.  These participants were matched to the CFS group for age and sex. 
The adult CFS data was obtained from a concurrent study at the same tertiary 
institution.  The 37 adults were recruited via an established database of patients who 
had expressed an interest in research participation.  Females in this group accounted 
for 75.7% of the sample. 
All participants gave written informed consent, and written parental consent 
was obtained for participants under the age of 18 (Appendix B). 
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Diagnosis of CFS.  All young CFS participants met the 1994 Fukuda criteria 
(Fukuda et al., 1994) as well as the paediatric definition (Jason et al., 2006).  A 
leading paediatrician who is internationally recognised as an expert in adolescent 
CFS confirmed the diagnosis.  According to the Canadian definition, patients can be 
assigned to one of three illness categories.  Severe CFS is assigned if the criteria for 
all six symptom clusters are met; Moderate CFS is diagnosed if the criteria for five 
clusters are met, plus one of three symptoms from cluster six; and Atypical CFS is 
assigned if the criteria for four or less symptom clusters are met.  Appendix A 
includes a complete synopsis of the paediatric case definition. 
Seventeen young CFS participants (73.9%) met the criteria for Severe CFS, 
five (21.7%) met the criteria for Moderate CFS, and one (4.3%) met the criteria for 
Atypical CFS.  No participants in the healthy control group met the criteria for any 
diagnostic category.  The percentage of CFS patients who met the criteria for each 
symptom cluster is presented in Table 6.1. 
 
Table 6.1 
Percentage of CFS Participants Meeting Diagnostic Criteria Clusters 
Symptom cluster % 
Cluster I: Fatigue 100% 
Cluster II: Post-exertional malaise 100% 
Cluster III: Sleep 100% 
Cluster IV: Pain 95.7% 
Cluster V: Neurocognition 95.7% 
Cluster VI: Immune 73.9% 
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                   Neuroendocrine 82.6% 
                   Autonomic 65.2% 
 
 
Onset and duration of CFS.  Twenty CFS participants (87.0%) reported that 
an infectious illness precipitated their condition, and the remaining three (13.0%) 
identified severe stress as an illness trigger.  There was considerable variation 
between participants in the period of illness onset.  Some reported rapid onset over a 
period of 24 hours (4.3%) or approximately one week (13%), and a large proportion 
of patients reported a moderate onset period of around one month (43.5%) or 
between two and six months (30.4%).  Although no participants believed that their 
illness developed over a period of six to 24 months, 8.7% reported that onset 
occurred over a time spanning longer than two years.  No participants reported 
lifelong fatigue. 
The young CFS participants predominantly reported prolonged illness 
duration.  Illness length had spanned for more than four years in 34.8% patients, and 
another 30.4% believed that they had been ill for three to four years.  Those reporting 
an illness duration of one to two years accounted for 13.0% of the sample, and 21.7% 
claimed that they received their diagnoses within the preceding 12 months.  The 
average illness length for the group was 39.3 months (SD = 26.25).  No CFS 
participant believed that their illness was becoming worse, although 34.8% reported 
that it was unchanging.  CFS was described as fluctuating by 47.8% of participants, 
and a further 4.3% believed that their illness was characterised by periods of 
remission and relapse.  In contrast, 13% felt that they were improving. 
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Three healthy controls reported fatigue.  These participants attributed their 
fatigue to inadequate sleep, anxiety, or work.  The average duration of fatigue was 
was nine months (SD = 5.20) and none believed that it had lasted for more than 12 
months.  One participant reported that onset occurred within one month, and the 
other two believed that onset occurred over a period of one to two years.  All three 
stated that there was no change in the course of their fatigue. 
 
Illness characteristics.  Of the young CFS participants, 52.2% stated that 
they feel worse in response to physical activity, 34.8% reported that they feel worse 
before feeling better, and 13% stated that they initially feel better before feeling 
worse.  No participants believed that they exclusively feel better following activity.  
In response to a period of rest, 52.2% reported that their fatigue partially improves, 
and the remaining 47.8% reported that it does not improve at all.  To achieve a 
partial improvement, 39.1% reported that one day of rest is required, and 13.0% 
require one to three days.  All believed that their fatigue would return if they 
recommence activity, and 91.3% reported that they deliberately limit activity in order 
to avoid fatigue.  
Of the three fatigued healthy participants, one reported that they feel better 
following physical activity, another reported that they feel worse before feeling 
better, and the other believed that activity had no effect.  Two believed that rest 
generated a partial improvement in fatigue, and the other reported a complete 
improvement.  All three reported that one day of rest was required for their 
symptoms to improve and that fatigue would not reappear after returning to activity.  
Only one control claimed to limit activity regularly in order to avoid fatigue. 
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The CFS group were asked to record their three worst symptoms at illness 
onset and at the time of the assessment.  At onset, all participants reported that 
fatigue was one of their three worst symptoms.  The second most frequently reported 
symptom was headaches (56.5%), followed memory or concentration difficulties 
(39.1%) and pain (34.8%).  Less common symptoms included muscle soreness, cold 
and flu symptoms, low energy, sore or swollen throat, vomiting or nausea, and 
hyperactivity.  Symptoms reported at the time of the assessment were similar to those 
at onset, indicating that symptom presentation is consistent over time.  Again, the 
most common symptoms included fatigue (95.7%), followed by headaches (56.5%) 
and memory or concentration difficulties, pain, and dizziness (34.8% each).  One or 
two participants also reported muscle soreness, low motivation, cold and flu 
symptoms, sore or swollen throat, joint pain, irritability, and hyperactivity.  Most 
participants (87.0%) reported that their symptoms fluctuated over time. 
Of the CFS respondents, 73.9% believed that they typically contract illnesses 
more easily than their peers, and 82.6% felt that they take longer to recover from 
being ill.  In contrast, only 20% of the healthy control group felt that they catch 
illnesses more easily, and 15% believed that they take longer to recover than their 
peers. 
In both young groups, 73.91% were of secondary school age.  However, four 
CFS patients (20%) had ceased regular education and commenced home schooling 
due to the severity of their illness.  One control had received a lifelong home school 
education.  School absenteeism was considerable among the CFS participants.  Over 
a six month period, 61.1% had missed at least 15% of school, 33.3% missed 40-50%, 
and 22.2% missed more than 70%.  The average number of days missed was 35.65.  
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In contrast, only one healthy control had missed more than 15% of school and the 
average number of days missed by this group was just 4.81. 
 
Materials. 
CFS presentation.  All young participants completed the Pediatric Myalgic 
Encephalomyelitis/Chronic Fatigue Syndrome Questionnaire (PMCQ).  This tool 
was recently developed based on the paediatric case definition of CFS (Jason et al., 
2006).  It was selected to provide detailed information about illness onset, course, 
impact, and symptom frequency and severity.  The questionnaire covers a range of 
symptom clusters, including fatigue, sleep, pain, and cognitive and atypical 
symptoms.  Experts in childhood CFS recommend the PMCQ for gathering symptom 
data for paediatric CFS (Jason et al., 2008). 
 
Intellectual functioning.  An estimate of intellectual capacity was obtained 
using the Wechsler Abbreviated Scale of Intelligence (WASI).  This is a norm-
referenced test that provides an estimate of current and premorbid intellectual 
functioning (Psychological Corporation, 1999).  The WASI can be administered to 
individuals aged from six to 89 years (Psychological Corporation, 1999).  For 
children, the reliability coefficients for each subset range from .81 to .97 
(Psychological Corporation, 1999).  Due to time constraints, only the 15-20 minute 
short version of the test was administered.  This is in accordance with 
recommendations by Kaufman and Litchenberger (2006), who note that under 
research conditions, this approach yields a reliable and valid estimate of intellectual 
function. 
120 
 
The short version of the WASI includes the Vocabulary and Matrix 
Reasoning subtests.  For Vocabulary, participants are asked to verbally define several 
words of increasing difficulty.  This provides a measure of expressive language, 
word-recognition, and general knowledge.  The Matrix Reasoning task requires 
participants to evaluate a series of increasingly difficult patterns that contain a 
missing component, and then from a choice of five, select the component that 
belongs in the pattern.  This subtest provides a measure of abstract nonverbal 
reasoning (Psychological Corporation, 1999).  Schoenberg, Lange, Brickell, and 
Saklofske, (2007) argue that together, these subtests provide an adequate measure of 
premorbid intellectual functioning in children. 
 
Perceived cognitive function.  Perceived cognitive function was assessed 
using the Cognitive Functions subscale of the Modified Fatigue Impact Scale 
(MFIS), which is based on the original Fatigue Impact Scale (Fisk et al., 1994).  The 
cognitive subscale is a structured, self-report questionnaire consisting of 10 items 
rated on a five-point scale from never to almost always. 
The MFIS has a Cronbach's alpha of .80 and it has a history of successful use 
among patients with CFS (Jones, Gray, Frith, & Newton, 2011; Newton, Sheth, Shin, 
Pairman, Wilton, Burt, & Jones, 2009; Surawy, Roberts, & Silver, 2005).  It can also 
be used to discriminate between the effects of fatigue in CFS patients compared to 
patients with other fatigue-related disorders such as MS and essential hypertension 
(Fisk et al., 1994).  Although the MFIS has not been psychometrically validated in 
young populations, the questions are very easy to understand and the test has high 
face validity. 
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Neuropsychological functioning.  Neuropsychological function was assessed 
using the Cambridge Neuropsychological Test Automated Battery (CANTAB), a 
touch-screen computerised assessment tool (Cambridge Cognition, 2006).  
Participants were administered 11 individual subtests designed to measure executive 
function, attention information processing speed, and working memory.  All tasks are 
nonverbal and presented as simple geometric designs or shapes.  Language 
proficiency is only required to understand the verbal instructions provided by the 
administrator.  This battery can be completed in approximately 50 minutes. 
The CANTAB is a well validated instrument that has been successfully 
employed as a measure of cognitive function in individuals aged between four and 90 
years (Cambridge Cognition, 2006).  Independent studies also demonstrate that the 
CANTAB can be used effectively in CFS populations (Capuron et al., 2006; Joyce et 
al., 1996; Lawrie et al., 2000).  The following section presents a description of each 
subtest and the associated outcome measures included in the study. 
 
Motor Screening (MOT).  The MOT was administered at the beginning of the 
assessment to serve as an introduction to the touch screen system.  It takes 
approximately three minutes to complete.  Participants are required to touch a 
flashing cross as it appears in different locations on the screen.  Those unable to 
complete this task would be considered unsuitable to complete the remaining 
cognitive tests.  These results were not included in the evaluation of 
neuropsychological function. 
 
Stockings of Cambridge (SOC).  SOC measures frontal lobe function and 
provides an assessment of executive function, including spatial planning and problem 
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solving ability.  In the copy phase, participants are shown two displays that each 
contain three coloured balls.  By moving one ball at a time in the lower display, 
participants must copy the pattern shown in the upper display.  In the follow phase, 
participants are required to follow the computer’s movements of the balls in the 
upper display one at a time.  This phase provides a baseline measure of movement 
time. 
The outcome measure, SOC Problems Solved in Minimum Moves records the 
number of occasions that the examinee successfully completes a problem within the 
minimum number of possible moves.  This provides a succinct measure of planning 
capacity.  SOC Initial Thinking Time (Five Moves) represents the difference between 
the copy and follow conditions in time (milliseconds) taken to select the first ball.  
This provides a measure of planning time without variance from movement time.  
SOC Subsequent Thinking Time (Four Moves) measures time to complete the 
problem after the initial move has been made.  Again, this provides a measure of 
thinking time without variance from movement time.  The two measures of thinking 
time provide an estimate of information processing speed (Cambridge Cognition, 
2006). 
 
Big/little Circle (BLC).  In accordance with test recommendations 
(Cambridge Cognition, 2006), the BLC was administered as a training test of rule 
acquisition and reversal prior to completing the IED test.  For the first 20 trials, 
participants must touch the smaller of two circles displayed on the screen.  They are 
then asked to touch the larger circle for a further 20 trials.  These results were not 
included in the evaluation of neuropsychological function. 
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Intra-Extra Dimensional Set Shift (IED).  Following BLC, participants 
completed the IED, a complex test of rule acquisition and reversal.  Successful 
completion of the test requires visual discrimination as well as attentional 
maintenance, shifting, and flexibility.  The test involves two artificial dimensions: 
colour-filled shapes and white lines.  At the beginning, two colour-filled shapes and 
two white lines are presented and the participant must learn which one is correct by 
touching it and observing the computer’s feedback.  After six correct responses, the 
stimuli and/or rules are changed.  These changes are initially intra-dimensional, 
where the colour filled shapes remain the only relevant dimension, and later the shift 
becomes extra-dimensional, where the white lines become the only relevant 
dimension.  If the participant fails to learn a new rule after 50 trials, the test 
terminates (Cambridge Cognition, 2006). 
The outcome measure, IED Total Errors Adjusted represents overall task 
competence.  The score is based on the number of errors made throughout the entire 
task, adjusted to account for missed opportunities to make errors when participants 
fail to complete the task.  Lower scores represent a greater ability to respond 
effectively to rule changes by discriminating between visual stimuli and maintaining 
or shifting attention.  IED Block 6 Errors records the number of errors made before 
successfully completing an intra-dimensional shift: the shift of attention to a novel 
exemplar within a previously relevant perceptual dimension.  IED Block 8 Errors 
records the number of errors made to successfully complete an extra-dimensional 
shift: the shift of attention to a novel exemplar of a previously irrelevant perceptual 
dimension.  These measures provide a good indication of attentional flexibility.  IED 
Stages Completed represents the total number of successfully completed stages.  This 
score provides a measure of reversal learning and attentional flexibility. 
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Spatial Span (SSP).  SSP was administered to provide a primary test of 
working memory capacity.  In this task, examinees are presented with a pattern of 
white squares that briefly change colour in a variable sequence.  Participants must 
recall the sequence by touching the boxes in the correct order.  The number of boxes 
in a sequence increases from two to nine throughout the test.  SSP Span Length 
represents the longest sequence successfully recalled by the participant, and SSP 
Total Errors measures the number of times the participant selected an incorrect box 
out of a possible 97.  Both measures provide an indication of the participant’s ability 
to recall spatial information. 
 
Spatial Working Memory (SWM).  The SWM task requires participants to 
manipulate spatial information in working memory.  In being a self-ordered test, 
SWM also provides a measure of heuristic strategy.  The test begins with several 
coloured boxes displayed on the screen.  By touching the boxes and using a process 
of elimination, participants must find one blue token inside each box.  The number of 
boxes gradually increases from three to eight throughout the test, and the colour and 
position of the boxes are varied between trials to discourage stereotyped search 
strategies (Cambridge Cognition, 2006). 
SWM Total Errors records the number of times a box is selected that is 
certain not to contain a blue token.  This represents the participants’ ability to 
manipulate and recall information within working memory.  SWM Strategy provides 
an estimate of the participants’ ability to employ an efficient search strategy by 
following a sequence.  This score represents the number of times a participant begins 
a new search with a different box for the six and eight box problems.  A low score is 
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indicative of superior executive function.  SWM Mean Time to Last Response is a 
measure of processing speed that represents the average search time from the 
beginning of the trial to the final screen touch.  Scores for this outcome measure are 
derived from the second hardest task stage in order to minimise missing data caused 
by participants failing to reach the final stage. 
 
Pattern Recognition Memory (PRM).  PRM assesses visual pattern 
recognition memory in a two-choice forced discrimination paradigm.  Participants 
are presented with a series of 12 abstract patterns followed by 12 sets of two patterns.  
The examinee must select the pattern within each set that is identical to one of those 
presented in the initial phase.  The test patterns are presented in the reverse order to 
the original presentation.  This procedure is then repeated with 12 new patterns.  
PRM Percent Correct records the percentage of correct responses and, providing a 
good indicator of visual short-term memory. 
 
Spatial Recognition Memory (SRM).  SRM assesses visual spatial recognition 
memory in a two-choice forced discrimination paradigm.  The participant is 
presented with a white square that appears in a sequence of five different locations 
on the screen.  In the recognition phase, five pairs of squares are displayed 
sequentially and the participant is required to select one square in each pair that 
matches the location of those in the presentation phase.  The recognition locations 
are presented in the reverse order of the original display.  This sequence is repeated 
three more times, each time with five new locations.  SRM Percent Correct records 
the percentage of correct responses achieved by participants, providing an indication 
of visual-spatial short-term recognition memory. 
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Rapid Visual Information Processing (RVIP).  Sustained processing and 
attention was assessed using the RVIP subtest.  This measure is sensitive to 
dysfunction in the parietal and frontal lobes of the brain and is a reliable measure of 
general performance.  During this task, digits from two to nine appear in a 
pseudorandom order at the rate of 100 digits per minute.  Participants are required to 
detect three predetermined sequences of three digits (2-4-6, 3-5-7, and 4-6-8) and 
register their responses using a press pad.  Target sequences occur at a rate of 16 
every two minutes. 
RVIP A’ Target Sensitivity measures efficiency of detecting the 
predetermined sequences while accounting for response tendency.  Higher scores 
within the range of 0.00-1.00 represent greater accuracy in detecting sequences while 
avoiding false alarms (responding in the absence of a target sequence).  This 
provides a sensitive estimate sustained attention.  RVIP Mean Latency records the 
mean time taken to respond to a target sequence in milliseconds, providing a good 
indication of sustained attention and processing speed.  The scores for both outcome 
measures are calculated from the final three task stages.  
 
Reaction Time (RTI).  RTI measures attention and speed of response to visual 
stimuli.  The task is divided into five stages that require increasingly complex chains 
of responses.  In each stage, the participant must respond to a suddenly appearing 
yellow dot by using a press-pad, touching the screen, or both.  Five-Choice Reaction 
Time provides an indication of attention by recording the speed that the participant 
releases the press pad in response to a stimulus appearing in one of five locations.  
Performance on this measure is also dependant on processing speed. 
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Academic performance.  The Wide Range Achievement Test, 4th Edition 
(WRAT-4; Wilkinson & Robertson, 2006) is a norm-referenced, individually 
administered measure of academic skills.  Adequate validity and reliability has been 
established using a stratified sample of more than 3,000 individuals aged between 
five and 94 years.  Immediate retest reliability coefficients range from .78 to .89 for 
an age-based sample, and it has been validated against a variety of achievement and 
cognitive ability tests (Wilkinson & Robertson, 2006).  Standardised assessment 
scores are available to allow researchers to compare their results to same-age peers.  
In the present study, participants completed the Word Reading and Math 
Computation subtests, which together take approximately 20 minutes to administer.  
The Word Reading task requires respondents to read aloud an increasingly difficult 
list of words, providing a measure of word recognition and decoding ability.  Math 
Computation comprises of 40 increasingly difficult written mathematic questions that 
cover a wide spectrum of problem types. 
 
Motivation.  In the final stage of the assessment procedure, participants were 
asked to rate their level of test motivation using the Student Opinion Scale (SOS; 
Sundre & Moore, 2002).  This instrument produces two factors, Effort and 
Importance, each comprising of five test items that are rated on a five-point likert 
scale.  The Effort scale assesses the level of effort and persistence exerted during task 
completion, and the Importance scale measures the personal relevance or importance 
of the tasks.  This component structure is consistent with current motivational 
theories (Pintrich & De Groot, 1990), which suggest that willingness to produce 
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effort is dependent upon perceived task importance and a disposition to perform the 
work required for task completion. 
There is strong evidence for the reliability and validity of the SOS.  It has 
been administered to over 15,000 students in a range of assessment contexts, 
consistently producing reliability estimates in the .80s for the Total score and 
component scales (Sundre & Moore, 2002).  In addition, positive correlations have 
been found between the SOS and test performance scores, and SOS scores are 
reliable in distinguishing between consequential and nonconsequential test 
conditions (Sundre & Moore, 2002).  Although it was originally designed and 
validated for use in tertiary students, the SOS is appropriate for use in adolescents 
due to its simplicity and high face validity. 
 
Perfectionism.  Perfectionistic traits were assessed using the Almost Perfect 
Scale-Revised (APS-R; Slaney et al., 2001).  Participants were asked to rate how 
they perceive themselves using a five-point likert scale on a series of 23 questions.  
The APS-R comprises of two adaptive perfectionism scales: Standards and Order, 
and one scale of maladaptive perfectionism: Discrepancy. 
The APS-R has satisfactory convergent validity, with item structure 
coefficients ranging from .49 to .83.  Strong internal consistency has been identified 
for Order (.86), Standards (.85), and Discrepancy (.92; Slaney et al., 2001).  
Correlations have also been identified between the APS-R Standards scale and the 
Personal Standards scale on the Multidimensional Perfectionism Scale (MPS-1), as 
well as between APS-R Order and the MPS-1 Organization scale.  In addition, a 
correlation has been found between the Discrepancy scale and the MPS-1 scale of 
Concern over Mistakes and Doubts about Actions (Frost et al., 1990). 
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Initially, the APS-R was psychometrically validated in adolescents and adults 
aged upwards from 17 years (Slaney et al., 2001), however psychometric data has 
since been produced for younger individuals.  In a study of 376 adolescents in grades 
six to eight, a two-factor solution for the APS-R was produced, yielding Cronbach's 
alphas of .75 for Standards and .87 for Discrepancy.  A test-retest reliability 
assessment involving 150 of these participants revealed significant correlations for 
Standards (r = .72) and Discrepancy (r = .67).  Convergent and discriminant validity 
has also been established against the Behavioral Assessment System for Children 
(Locicero, 2001). 
 
Psychological functioning.  A measure of psychological adjustment was 
obtained using the Depression Anxiety Stress Scale (DASS; Lovibond & Lovibond, 
1995).  This instrument is a self-report measure consisting of 14 items for three 
related negative affective states, producing a total of 42 questions.  The Depression 
scale assesses dysphoria, hopelessness, devaluation of life, self-deprecation, lack of 
interest or involvement, anhedonia, and inertia.  The Anxiety scale assesses 
autonomic arousal, skeletal muscle effects, situational anxiety, and subjective 
experience of anxious affect.  The Stress scale is sensitive to levels of chronic 
nonspecific arousal, including difficulty relaxing, nervous arousal, and being easily 
upset or agitated, irritable or overreactive, and impatient.  Using a four-point scale, 
participants are asked to rate the extent to which they have experienced each 
state within the past week. 
Based on a sample of 2,914 participants, alpha coefficients for the three 
scales were identified as .91 for Depression, .84 for Anxiety, and .90 for Stress.  The 
Depression and Anxiety subscales also show good convergent validity with other 
130 
 
measures designed to discriminate between these factors (Lovibond & Lovibond, 
1995).  High validity and reliability scores for the DASS have been identified in 
adolescent populations (Tully, Zajac, & Venning, 2009), and these scores are 
consistent with earlier research in adult populations (Antony, Bieling, Cox, Enns, 
& Swinson, 1998). 
Participants were also administered the Inventory of Depressive 
Symptomatology–Self-Report (Australian version; IDS-SR; Rush, Carmody, & 
Reimitz, 2000; Rush, Gullion, Basco, Jarrett, & Trivedi, 1996).  This is a 30-item 
self-report questionnaire designed to assess the severity of depressive 
symptomatology according to the diagnostic criteria for a Major Depressive Episode 
(American Psychiatric Association, 2000).  Using a four-point scale, respondents are 
required to record their experience of depressive symptoms over the past seven days.  
The IDS-SR has good internal reliability (coefficient alpha = .85) and is correlated 
with both the Hamilton Rating Scale for Depression (r = .67) and the Beck 
Depression Inventory (r = .78). 
 
Sleep disturbance.  The Pittsburgh Sleep Quality Index (PSQI; Buysse, 
Reynolds, Monk, Berman, & Kupfer, 1989) was employed to provide an estimate of 
disturbance.  This self-rated questionnaire produces seven component scores, 
including subjective sleep quality, sleep latency, sleep duration, habitual sleep 
efficiency, sleep disturbance, use of sleeping medication, and daytime dysfunction.  
These scores can be summed to yield a global PSQI score.  The seven components 
represent standardised measures of factors routinely assessed in patients with sleep 
disturbances.  Completion requires approximately five to 10 minutes.  The test 
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developers suggest that the PSQI is best used as a screening tool for distinguishing 
between cases and controls (Buysse et al., 1989). 
Internal consistency was demonstrated in a sample of healthy participants and 
individuals with sleep disorders or depression.  The global score produced a 
Cronbach’s alpha of .83, and correlations between the global score and component 
scales ranged between .35 and .76.  The global score correctly identified 88.5% of all 
patients and controls, and the component scales significantly differentiated between 
diagnostic groups.  Test-retest reliability was .85 for the global score and .65–.84 for 
the component scales (Buysse et al., 1989). 
The International CFS Study Group recommends the PSIQ as a measure of 
sleep disturbance in CFS patients (Reeves et al., 2003), and the International 
Association of CFS Paediatric Case Definition Working Group recommends it for 
use in paediatric populations  (Jason et al., 2006).  Although there is no published 
psychometric data for adolescent populations, the PSIQ has been used effectively in 
research with young people (Cheung & Wong, 2011; Mesquita & Reimão, 2007, 
2010).  It is also a reasonably straightforward questionnaire with high face validity. 
 
Fatigue.  The severity of physical and mental fatigue was assessed using the 
Chalder Fatigue Scale (Chalder et al., 1993).  This self-report instrument includes 14 
questions rated on a four-point scale.  It produces a total fatigue score and two 
component scores representing physical and mental fatigue.  The scale was validated 
in a sample of 274 patients at a primary care clinic.  The split-half reliability was .86 
for physical fatigue and .85 for mental fatigue, and the Cronbach’s alpha for 
individual items ranged from .88 to .90 (Chalder et al., 1993).  The reliability and 
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validity of the Chalder Fatigue Scale has also been demonstrated in CFS populations  
(Jason et al., 1997; Morriss, Wearden, & Mullis, 1998). 
Although it has not been psychometrically validated in paediatric 
populations, several researchers have used the Chalder Fatigue Scale effectively in 
adolescents and young adults (Fukuda et al., 2010; Taylor, Lee, Kramer, Shirashi, & 
Kielhofner, 2011).  It is also recommended as a measure of fatigue in young CFS 
populations by researchers with considerable experience in paediatric CFS (Gledhill 
& Garralda, 2006). 
In the present study, changes in fatigue severity were monitored at five 
intervals throughout the assessment using a Visual Analogue Scale (VAS; Appendix 
C).  Participants were asked to draw a mark on a blank line to indicate how they were 
presently feeling from no fatigue to worst possible fatigue.  The VAS has good 
reliability and validity (Brunier, & Graydon, 1996; Kos, Nagels, D'Hooghe, 
Duportail, & Kerckhofs, 2006; Kwok & Pope, 2010; Wolfe, 2004), and has been 
used effectively in paediatric populations (Dudzic, Szymusiak, McCormick, & 
Miller, 2011; Huguet, Stinson, & McGrath, 2010; Staes, Stappaerts, Vertommen, & 
Nuyen, 2000). 
 
Procedure.  Participants eligible to join the CFS group were provided with 
plain language statements by their treating paediatrician (Appendix B).  These 
statements included information about the nature and purpose of the study, as well as 
the possible risks and benefits of participating.  The adolescents or their parents then 
contacted the researcher to schedule an assessment time.  Young people without CFS 
were recruited through advertisement and word of mouth.  Basic information 
statements were posted in public areas, including universities, public transport areas, 
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and medical centres.  Eligible participants were also informed of the study through 
people associated with the university and research team.  Following this, the young 
person or their parent contacted the researcher, who provided them with the plain 
language statement and invited them to arrange an assessment time. 
Assessments were largely completed within a University laboratory, although 
some were conducted at the participants’ home due to transportation issues.  The 
testing procedure was conducted over two to three hours, depending on the 
participant’s performance and fatigue levels.  A second set of questionnaires that 
require approximately one hour were given to participants to complete in their own 
time.  After returning the final questionnaires, participants received a small 
reimbursement for their time and travel expenses.  The study was approved by the 
relevant Human Ethics Committees, and all data were de-identified and stored on a 
secure server at Deakin University. 
 
Testing protocol.  Before the assessment commenced, the test administrator 
discussed the plain language statements with the participants and their parents (for 
those under the age of 18) to ensure that all parties understood what was required for 
participation.  Participants were then asked to sign the consent form (Appendix B). 
Participants were required to rate their current fatigue levels at the beginning 
of the assessment, at three equal intervals throughout the procedure, and again at the 
end.  Initially, participants completed a standardised measure of intelligence 
followed by a series of questionnaires designed to assess current psychological 
adjustment and perceived cognitive function.  The intelligence test was administerd 
first in order to prevent poor permance due to state fatigue in the CFS group.  The 
questionnaires administered next as a means of inciting fatigue in response to mild 
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mental effort.     Participants were encouraged to ask questions if they did not 
understand any of the material.  A brief measure of academic ability was then 
administered, followed by series of neuropsychological tasks delivered via a touch 
screen tablet computer.  The order of the neuropsychological tests was rotated to 
control for the effects of fatigue.  Finally, participants completed a detailed 
assessment of present fatigue levels and test motivation.  In the weeks following the 
assessment, participants completed questionnaires concerning symptom severity, 
sleep disturbance, and perfectionism. 
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Results 
All assessments were conducted between January 2010 and October 2011.  
Data missing at random accounted for less than 1% of the dataset and there were 
only three instances of data not missing at random (all associated with symptom 
severity).  Due to the limited sample size and the scarcity of missing data, maximum 
likelihood estimators were used to estimate all missing data. 
Using the recommendations made by Tabanick and Fidell (2001), all data 
were screened and treated for outliers and violations of normality, linearity, and 
homoscedasticity.  Significant outliers were rescored to one unit more extreme than 
the next most extreme figure.  Square root transformations were performed on DASS 
Stress total, Global PSQI, IDS total, CANTAB RVIP A’ Target Sensitivity 
(reflected), CANTAB SOC Problems Solved in Minimum Moves, (reflected), 
CANTAB SSP Total Errors, APS-R Standards total (reflected), APS-R Order total, 
and VAS Time 5 (reflected).  Log transformations were performed on PMCQ 
Frequency of Fatigue Symptoms, PMCQ Severity of Other Symptoms, DASS 
Anxiety Total, DASS Depression Total, CANTAB IED Block 8 Errors, CANTAB 
IED Total Errors Adjusted, CANTAB SOC Initial Thinking Time, and CANTAB 
SRM Percent Correct (reflected).  An inverse transformation was also performed on 
PMCQ Frequency of Pain Symptoms. 
Two healthy control participants did not return the surveys that were to be 
completed following the on site assessment procedure.  These cases were thus 
excluded from analyses conducted on CFS symptoms, sleep disturbance, or 
perfectionism. 
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To avoid repetition, note that all MANOVA analyses in this study were 
assessed with group (CFS versus healthy controls) as the independent variable (IV) 
and were tested according to Pillai’s Trace. 
 
Presenting symptomatology.  The results of the PMCQ were evaluated to 
explore the differences between CFS patients and healthy controls in the frequency 
and severity of CFS symptoms.  The descriptive statistics presented in Table 6.2 and 
Table 6.3 depict clear patterns indicating that, as would be expected, the young CFS 
group reported more frequent and severe symptoms than the controls on all clusters. 
 
Table 6.2 
Group Means and Standard Deviations for CFS Symptom Cluster Frequencies 
 Controls (n = 21) CFS (n = 23) 
Symptom cluster M SD M SD 
Sleep 0.26 0.60 3.5 0.67 
Fatigue 0.47 0.77 1.6 0.79 
Pain 0.14 0.26 1.13 0.73 
Cognitive  0.11 0.26 1.67 0.91 
Other Symptoms 0.07 0.13 0.97 0.66 
 
With the five clusters entered as dependent variables (DVs), a significant 
main effect of group was detected for symptom frequency using a MANOVA, 
F(5,38) = 52.97, p< .001.  Evaluation of univariate ANOVAs revealed significant 
effects for all symptom clusters: Sleep, F(1,42) = 279.28, p< .001; Fatigue, F(1,42) = 
33.75, p< .001; Pain, F(1,42) = 48.78, p< .001; Cognitive Dysfunction, F(1,42) = 
57.44, p< .001; Other Symptoms, F(1,42) = 38.29, p< .001. 
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Table 6.3 
Group Means and Standard Deviations for CFS Symptom Cluster Severity 
 Controls (n = 21) CFS (n = 23) 
Symptom cluster M SD M SD 
Sleep 0.43 0.99 7.67 1.47 
Fatigue 0.98 1.73 3.79 1.86 
Pain 0.39 0.74 2.96 1.93 
Cognitive 0.22 0.56 3.97 2.26 
Other Symptoms 0.17 0.33 2.37 1.64 
 
A second MANOVA revealed that young people with CFS reported 
significantly higher CFS symptom severity than healthy controls, F(5,38) = 68.76, 
p< .001.  Follow-up univariate ANOVAs indicated that the CFS patients reported 
significantly higher severity levels for Sleep, F(1,42) = 358.84, p< .001; Fatigue, 
F(1,42) = 26.66, p< .001; Pain, F(1,42) = 32.77, p< .001; Cognitive Dysfunction, 
F(1,42) = 54.54, p< .001; and Other Symptoms, F(1,42) = 61.02, p< .001. 
 
Hypothesis 1: between-group differences in cognitive function.  
Perceived cognitive function.  The results from the MFIS were compared 
between groups to test the hypothesis that young people with CFS would perceive 
themselves to be more cognitively impaired than the healthy controls.  The 
descriptive statistics indicate that the CFS group rated themselves higher than the 
healthy controls on all items (Table 6.4). 
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Table 6.4 
Group Means and Standard Deviations for Perceived Cognitive Disturbance 
 Controls (n = 23) CFS (n = 23) 
Test item M SD M SD 
MFIS Total 7.76 10.65 27.78 0.63 
Less Alert 0.96 0.88 2.65 1.11 
Difficulty Paying Attention for Long Periods 1.35 1.03 3.13 0.81 
Unable to Think Clearly 1.00 0.90 2.83 1.03 
Forgetful 1.35 1.03 2.57 0.99 
Difficulty Making Decisions 1.43 1.24 2.48 1.16 
Less Motivated to do Thinking Activities 0.91 0.90 2.57 1.04 
Difficulty Finishing Thinking Related Tasks 0.96 1.07 2.83 1.23 
Difficulty Organising Thoughts 1.00 1.04 2.87 1.06 
Slowed Thinking 0.61 0.89 2.61 1.23 
Difficulty Concentrating 1.09 0.85 3.26 0.69 
Note. Figures represent raw scores from a likert scale. MFIS= Modified Fatigue Impact Scale. 
 
Using a MANOVA, a significant multivariate effect of group was detected 
for the 10 MFIS items, F(10,35) = 7.90, p< .001.  Follow-up univariate ANOVAs 
revealed significant effects for all 10 items: Less Alert, F(1,44) = 32.34, p< .001; 
Difficulty Paying Attention for Long Periods, F(1,44) = 42.51, p< .001; Unable to 
Think Clearly, F(1,44) = 40.85, p< .001; Forgetful, F(1,44) = 16.71, p< .001; 
Difficulty Making Decisions, F(1,44) = 8.69, p = .005; Less Motivated to do 
Thinking Activities, F(1,44) = 33.30, p< .001; Difficulty Finishing Thinking Related 
Tasks, F(1,44) = 30.36, p< .001; Difficulty Organising Thoughts, F(1,44) = 36.38, 
p< .001; Slowed Thinking, F(1,44) = 39.72, p< .001; and Difficulty Concentrating, 
F(1,44) = 91.06, p< .001.  As predicted, the CFS group perceived themselves to have 
significantly greater levels of cognitive impairment compared to the controls. 
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Executive function.  It was hypothesised that young people with CFS would 
achieve lower scores than healthy controls on tests of executive function.  This 
prediction was assessed using the CANTAB outcome measures for executive 
function on the IED, SOC, and SWM subtests.  The descriptive statistics in Table 6.5 
indicate that compared to controls, the CFS participants made more errors and 
performed less well on all measures of executive function excluding SWM strategy. 
 
Table 6.5 
Group Means and Standard Deviations for Executive Function 
Controls (n = 23) CFS (n = 23) 
CANTAB outcome measure M SD M SD 
IED Block 6 Errors 0.17 0.39 0.65 0.78 
IED Block 8 Errors 6.61 9.29 10.04 11.23 
IED Total Errors Adjusted 17.17 17.42 40.35 48.80 
IED Stages Completed 8.83 0.58 7.61 2.27 
SOC Problems Solved in Minimum Moves 9.22 1.59 8.78 2.17 
SWM Strategy 28.83 6.73 31.43 6.05 
Note. IED= Intra-Extra Dimensional Set Shift; SOC= Stockings of Cambridge; SWM= Spatial 
Working Memory.  
 
Using a MANOVA, a significant main effect of group was detected, F(6,39) 
= 2.48, p = .040, and follow-up ANOVAs revealed significant effects for IED Block 
6 Errors, F(1,44) = 7.01, p = .011; IED Total Errors Adjusted, F(1,44) = 6.60, p = 
.014; and IED Stages Completed, F(1,44) = 6.21, p = .017.  No between-group 
differences were detected for IED Block 8 Errors, F(1,44) = 1.32, p = .256; SOC 
Problems Solved in Minimum Moves, F(1,44) = 0.34, p = .562; and SWM Strategy 
F(1,44) = 1.91, p = .174.  Consistent with the hypothesis, the data indicate that, 
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compared to the healthy controls, the CFS group performed less well on executive 
function overall.  However, the CFS and healthy control groups performed similarly 
on three of the six individual outcome measures for executive function. 
 
Attention.  The hypothesis that CFS participants would perform more poorly 
than controls on neuropsychological measures of attention was assessed through 
investigation of the CANTAB outcome measures for RTI and RVIP.  The descriptive 
statistics in Table 6.6 indicate that compared to controls, the CFS group reacted more 
slowly in response to visual stimuli on RTI, but faster on RVIP.  The CFS patients 
were also less proficient in detecting target sequences and avoiding false alarms on 
RVIP. 
   
Table 6.6 
Group Means and Standard Deviations for Attention 
Controls (n = 23) CFS (n = 23) 
CANTAB outcome measure M SD M SD 
a RTI 5-Choice Reaction Time 308.09 55.97 395.32 176.50 
RVIP A’ Target Sensitivity 0.92 0.04 0.89 0.05 
a RVIP Mean Latency 440.26 104.41 420.05 54.36 
Note. RTI= Reaction Time; RVIP= Rapid Visual Information Processing. 
a Scores are in msec 
 
A significant overall between-group difference for attention was detected 
using a MANOVA, F(3,41) = 3.75, p = .018.  Evaluation of univariate ANOVAs 
revealed significant effects for RTI 5-Choice Reaction Time, F(1,44) = 5.10, p = 
.029, and RVIP A’ Target Sensitivity, F(1,41) = 4.25, p = .045.  However there were 
no group differences for RVIP Mean Latency F(1,41) = 0.68, p = .415.  Consistent 
with the hypothesis, the data indicate that, compared to the healthy controls, the CFS 
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group demonstrated poorer overall attention.  However, both groups achieved similar 
scores on one of the three outcome measures for attention. 
 
Information processing speed.  It was predicted that young CFS participants 
would perform more poorly on measures of information processing speed compared 
to healthy controls.  This hypothesis was evaluated through investigation of the 
CANTAB results for SOC Initial Thinking Time, SOC Subsequent Thinking Time, 
and SWM Mean Time to Last Response.  The descriptive statistics presented in 
Table 6.7 reveal mixed results.  Compared to the healthy control group, the CFS 
participants appeared to spend less time thinking prior to starting the SOC task, but 
more time thinking throughout task completion.  The CFS group also appeared to 
respond more slowly than controls on SWM. 
 
Table 6.7 
Group Means and Standard Deviations for Information Processing Speed 
Controls (n = 23) CFS (n = 23) 
CANTAB outcome measure M SD M SD 
SOC Initial Thinking Time 10376.54 9648.55 7058.65 6788.99 
SOC Subsequent Thinking Time 1510.26 2667.29 1818.98 2960.28 
SWM Mean Time to Last Response 21539.73 4015.84 22354.07 3375.75 
Note. Scores are in msec. SOC= Stockings of Cambridge; SWM= Spatial Working Memory. 
 
However, a significant main effect for group was not detected using a 
MANOVA F(3,42) = 0.96, p = .421.  Contrary to the hypothesis, this suggests that 
CFS participants and healthy controls performed similarly on tasks that assess 
information processing speed. 
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Working memory.  It was predicted that young CFS participants would 
perform more poorly than healthy controls on measures of working memory.  The 
descriptive statistics presented in Table 6.8 indicate that the CFS participants 
achieved lower scores on SSP memory span, made more errors on SSP and SWM, 
and made fewer correct responses on SRM and PRM.  
 
Table 6.8 
Group Means and Standard Deviations for Working Memory 
Controls (n = 23) CFS (n = 23) 
CANTAB outcome measure M SD M SD 
SSP Span Length 7.30 1.11 6.57 1.27 
SSP Total Errors 14.17 7.44 14.83 6.18 
SWM Total Errors 16.91 14.74 25.83 20.87 
SRM Percent Correct 82.17 5.80 74.57 10.54 
PRM Percent Correct 91.26 12.92 80.80 8.94 
Note. SSP= Spatial Span; SWM= Spatial Working Memory; SRM Spatial Recognition Memory 
Pattern Recognition Memory. 
 
Using a MANOVA, a significant main effect of group was detected F(5,40) = 
3.81, p = .006, indicating that working memory performance was  significantly 
different between groups.  Follow-up ANOVAs revealed that the CFS group 
achieved significantly lower scores than controls on SSP Span Length F(1,44) = 
4.42, p = .041.  However, the group differences were not significant for SSP Total 
Errors F(1,44) = 0.21, p = .649 and SWM Total Errors F(1,44) = 2.80, p = .101.  
Significant group effects were detected for SRM Percent Correct, F(1,44) = 6.35, p = 
.015 and PRM Percent Correct, F(1,44) = 10.21, p = .003.  Although these findings 
are not entirely consistent, together they indicate that the young CFS participants 
performed less well on working memory tasks than the healthy controls. 
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Hypothesis 2: between-group differences in academic achievement.  The 
Reading and Math Computation component scores from the WRAT-4 were assessed 
to test the prediction that young CFS participants would perform less well on 
academic tests than healthy controls.  The descriptive statistics presented in Table 6.9 
indicate that the CFS group achieved higher scores on both measures, and this 
difference was identified as significant using MANOVA, F(2,43) = 4.84, p = .013.  
Evaluation of univariate ANOVAs revealed significant effects for both Reading, 
F(1,44) = 7.12, p = .011 and Math Computation, F(1,44) = 9.04, p = .004.  Contrary 
to the hypothesis, these results indicate that the CFS participants achieved higher 
scores on measures of academic ability than the healthy controls. 
 
Table 6.9 
Group Means and Standard Deviations for Academic Performance 
 Controls (n = 23) CFS (n = 23) 
WRAT-4 measure M SD M SD 
Reading 97.35 14.75 110.04 17.41 
Math Computation 86.13 16.17 99.17 13.10 
Note. Scores are standard scores with a mean of 100 and SD of 15. 
 
Hypothesis 3: between-group differences in test motivation and 
perfectionism. 
Motivation.  It was hypothesised that, compared to healthy controls, young 
people with CFS would report higher levels of test motivation.  SOS Total provides a 
composite measure of overall test motivation and encompasses two outcome 
measures, Importance and Effort.  The descriptive statistics presented in Table 6.10 
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indicate that the CFS participants rated themselves higher than controls on all 
indicators. 
A significant effect of group was identified using a between groups 
MANOVA, F(2,43) = 5.39, p = .008.  However follow-up ANOVAs revealed a 
significant group difference for Effort, F(1,44) = 9.99, p< .003 but not for 
Importance, F(1,44) = 3.27, p = .077.  Consistent with the hypothesis, the data 
indicate that compared to controls, the CFS group rated themselves as more 
motivated in completing the assessments overall.  However, both groups rated the 
importance of the assessments equally. 
 
Table 6.10 
Group Means and Standard Deviations for Test Motivation 
 
Controls (n = 23) CFS (n = 23) 
Measure M SD M SD 
SOS Importance 12.39 2.68 13.78 2.54 
SOS Effort 14.52 2.17 16.43 1.93 
SOS Total 26.91 3.78 30.22 3.66 
Note. Figures represent the summation of likert scale socres. SOS= Student Opinion Scale. 
 
Perfectionism.  The results of the APS-R were evaluated to test the 
hypothesis that young people with CFS would report higher levels of perfectionism 
than controls.  The descriptive statistics in Table 6.11 indicate that the CFS 
participants rated themselves lower on the adaptive scales of Standards and Order, 
and higher on the maladaptive scale of Discrepancy. 
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Table 6.11 
Group Means and Standard Deviations for Test Perfectionism 
 
Controls (n = 21) CFS (n = 23) 
Measure M SD M SD 
APS-R Standards   16.57 4.61 14.48 4.28 
APS-R Order 10.33 3.95 9.35 2.69 
APS-R Discrepancy 18.29 13.57 25.86 11.98 
Note. Figures represent the summation of likert scale socres. APS-R= The Almost Perfect Scale- 
Revised.  
 
No significant differences were identified between groups on the adaptive 
scales using a MANOVA, F(2,41) = 1.33, p = .275.  Similarly, an independent 
samples t-test of APS-R Discrepancy indicated that young CFS participants did not 
differ significantly from healthy controls on self-ratings of maladaptive 
perfectionism t(42) = 1.97, p = .056.  This indicates that, contrary to the research 
hypothesis, the CFS patients and healthy controls perceived themselves to have 
similar levels of perfectionism. 
 
Hypothesis 4: predictive value of motivation and perfectionism.  In the 
interests of completeness, and despite the lack of hypothesised differences between 
groups on perfectionism and motivation, the relationship between these variables and 
cognitive function was followed through with, in the CFS group only.  The rationale 
for only using CFS participants was based on previous discussions in the literature 
where CFS patients have been noted to be higher in terms of perfectionism and 
conscientiousness (Lewis et al,. 1994; Suraway et al., 1995).  As such, the focus of 
the analysis changed from being on whether differences in cognitive performance 
were related to differences in motivation and perfectionism (when there were none) 
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to examining whether perfectionism and motivation had any relationship to 
performance in a CFS population. 
A series of multiple and simple linear regressions were conducted to 
determine how well motivation and perfectionism predicted performance on 
measures of academic achievement and neuropsychological function in CFS patients.  
For each multiple regression, SOS Total and APS-R Standards and Order were 
entered as IVs to represent motivation and adaptive perfectionism respectively.  The 
IVs were assessed for multicollinearity.  Tolerance was .448 or above for all 
variables, indicating that multicollinearity is unlikely to be a problem.  Not 
surprisingly, a significant correlation was detected between the Standards and Order 
perfectionism scales, r(22) = .523, p = .005.  SOS Total was also correlated with 
Standards, r(22) = -.596, p = .001 and Order r(22) = .-690, p< .001.  However, the 
strength of these correlations is not indicative of multicollinearity. 
 
Neuropsychological function.  A series of eight standard multiple linear 
regressions were employed to examine how well neuropsychological performance 
could be predicted by motivation and adaptive perfectionism.  A single variable from 
the CANTAB was entered as the DV in each analysis.  These variables were the 
eight outcome measures that significantly differentiated the CFS and healthy control 
groups. 
The regression analyses were all nonsignificant: IED Block 6 Errors, adjusted 
R² = -.135, F(3,22) = 0.13, p = .941; IED Total Errors Adjusted, adjusted R² = -.107, 
F(3,22) = 0.29, p = .830; IED Stages Completed, adjusted R² = -.107, F(3,22) = 0.29, 
p = .831; RTI 5-Choice Reaction Time, adjusted R² = -.098, F(3,22) = 0.34, p = .795; 
RVIP A’ Target Sensitivity, adjusted R² = -.036, F(3,22) = 0.75, p = .537; SSP Span 
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Length, adjusted R² = -.108, F(3,22) = 0.29, p = .836; SRM Percent Correct, adjusted 
R² = .038, F(3,22) = 1.29, p = .306; PRM Percent Correct, adjusted R² = -.008, 
F(3,22) = 0.94, p = .441.  In contrast to the hypothesis, these results indicate that 
self-rated motivation and adaptive perfectionism did not predict performance on tests 
of neuropsychological functioning. 
A series of eight simple linear regression analyses were employed to examine 
how well neuropsychological performance could be predicted by maladaptive 
perfectionism.  In each analysis, APS-R Discrepancy was the IV and a single 
variable from the CANTAB was entered as the DV.  Again, these variables were the 
eight CANTAB outcome measures that significantly differentiated the CFS and 
healthy control groups. 
All analyses were nonsignificant: IED Block 6 Errors, adjusted R² = -.041, 
F(1,22) = 0.12, p = .726; IED Total Errors Adjusted, adjusted R² = .030, F(1,22) = 
1.68, p = .209; IED Stages Completed, adjusted R² = .064, F(1,22) = 2.51, p = .128; 
RTI 5-Choice Reaction Time, adjusted R² = .025, F(1,22) = 1.57, p = .224; RVIP A’ 
Target Sensitivity, adjusted R² = -.038, F(1,22) = 0.19, p = .665; SSP Span Length, 
adjusted R² = .007, F(1,22) = 1.15, p = .296; SRM Percent Correct, adjusted R² = -
.040, F(1,22) = 0.16, p = .690; PRM Percent Correct, adjusted R² = .008, F(1,22) = 
1.17, p = .291.  Contrary to expectations, self-rated maladaptive perfectionism did 
not predict performance on tests of neuropsychological functioning in the CFS 
group. 
Academic achievement.  Standard multiple linear regressions were employed 
to test the hypothesis that higher levels of motivation and adaptive perfectionism 
would predict better performance on tests of academic achievement.  WRAT-4 
Reading and Math Computation were entered as single DVs in two respective 
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analyses.  Both were nonsignificant: Reading, adjusted R² = -.072, F(3,22) = 0.51, p 
= .684; Math Computation, adjusted R² = -.089, F(3,22) = 0.40, p = .753.  Contrary 
to expectations, motivation and adaptive perfectionism were not predictors of 
academic achievement in the CFS group. 
Two simple linear regressions were conducted to test the hypothesis that 
higher levels of maladaptive perfectionism would predict poorer performance on 
tests of academic achievement.  APS-R Discrepancy was the predictor, and WRAT-4 
Reading and Math Computation were entered as DVs in each respective analysis.  
Contrary to expectations, APS-R Discrepancy was not a significant predictor of 
Reading, adjusted R² = -.024, F(1,22) = 0.00, p = .999 or Math Computation, 
adjusted R² = .002, F(1,22) = 1.10, p = .300.   
 
Hypothesis 5: between-group differences in cognitive function when 
motivation and perfectionism are accounted for.  It was predicted that when the 
variance from motivation and adaptive perfectionism is accounted for, the 
differences between CFS patients and controls on the neuropsychological and 
academic tests would increase.  Conversely, it was hypothesised that when the 
variance from maladaptive perfectionism is accounted for, the differences between 
CFS patients and controls on the neuropsychological and academic tests would 
become smaller.  However, motivation and perfectionism were not significant 
predictors of neuropsychological or academic test performance.  As such, it was 
unnecessary to assess group differences in cognitive function while accounting for 
motivation and perfectionism. 
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Hypothesis 6: neuropsychological function in adults and young people 
with CFS.  It was predicted that adults and young people with CFS would perform 
similarly on measures of neuropsychological function.  To test this hypothesis, 
results from the CANTAB were compared between the young CFS patients and a 
group of adult patients drawn from a concurrent research project.  Because this 
project was addressing a different research question than the current one, not all 
outcome measures used in the current study were available for the adult patients.  
The descriptive statistics in Table 6.12 indicate that both groups performed similarly, 
with a pattern of somewhat superior performance in the young patients on all tasks 
excluding IED Total Errors Adjusted and SWM Strategy.  A between-groups 
MANOVA revealed a significant effect of group for executive function F(4,55) = 
3.31, p = .017, and follow-up univariate ANOVAs indicated that the between-group 
differences were significant for IED Total Errors, F(1, 58) = 6.24, p = .015 but not 
IED Stages Completed, F(1,58) = 0.69, p = .410.  The univariate results were also 
significant for SOC Problems Solved in Minimum Moves, F(1,58) = 5.97, p = .018 
but not for SWM Strategy, F(1,58) = 0.13, p = .720.  In contrast, the MANOVA 
results were not significant for attention, F(2,55) = 1.66, p = .220 or working 
memory F(2,55) = 0.40, p = .673.  Contrary to expectations, this suggests that the 
young CFS patients performed significantly better than the adult patients on tests of 
executive function.  Consistent with the hypothesis however, the data indicate that 
adults and young people with CFS performed similarly on measures of attention and 
working memory. 
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Table 6.12 
Group Means and Standard Deviations for Neuropsychological Function 
Adult CFS (n = 37) Young CFS (n = 23) 
Measure M SD M SD 
Executive function 
IED Total Errors Adjusted 19.65 10.65 28.76 38.07 
IED Stages Completed 8.05 1.86 8.22 1.75 
SOC Problems Solved in  
Minimum Moves 
7.24 2.49 9.00 1.90 
SWM Strategy 32.30 10.43 30.13 6.47 
Attention 
RTI 5-Choice Reaction Time 378.18 66.96 351.70 136.77 
RVIP A’ Target Sensitivity 0.88 0.17 0.90 0.05 
Working memory 
SRM Percent Correct 73.24 21.32 78.37 9.25 
PRM Percent Correct 83.88 17.25 86.03 12.19 
Note. IED= Intra-Extra Dimensional Set Shift; SOC= Stockings of Cambridge; SWM= Spatial 
Working Memory; RTI= Reaction Time; RVIP= Rapid Visual Information Processing; SRM Spatial 
Recognition Memory PRM= Pattern Recognition Memory;  
 
Hypothesis 7: between-group differences in symptoms common to CFS. 
Sleep disturbance.  The results of the PSQI were compared between groups 
to test the prediction that young people with CFS would report higher levels of sleep 
disturbance than healthy controls.  The group means and standard deviations 
presented in Table 6.13 portray a clear pattern supporting this hypothesis. 
A significant multivariate effect of group was detected for the PSQI using a 
MANOVA, F(7,36) = 3.38, p = .007.  However, only four of the seven univariate 
ANOVAs for the individual components were significant.  No significant between-
group differences were observed for Subjective Sleep Quality, F(1,42) = 3.01, p = 
.090 and Sleep Latency, F(1,42) = 0.85, p = .361.  However, the groups differed 
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significantly on Habitual Sleep Efficiency, F(1,42) = 7.28, p = .010; Sleep 
Disturbance, F(1,42) = 8.22, p = .006; Use of Sleeping Medication, F(1,42) = 15.23, 
p< .001; and Daytime Dysfunction, F(1,42) = 14.07, p = .001.  In contrast, no 
significant differences were observed for Sleep Duration, F(1,42) = 0.05, p = .829.  
Although the results were mixed, the data indicate that the CFS group reported 
greater levels of disturbed sleep than the controls overall. 
 
Table 6.13 
Group Means and Standard Deviations for Sleep Disturbance 
      Controls (n = 21)        CFS (n = 23) 
Sleep measure M SD M SD 
Global PSQI 4.71 2.90 8.91 4.63 
Subjective Sleep Quality 1.00 0.77 1.43 0.73 
Sleep Latency 1.24 1.00 1.52 1.04 
Habitual Sleep Efficiency 0.10 0.30 0.74 1.05 
Sleep Disturbance 0.71 0.56 1.22 0.60 
Use of Sleeping Medication 0.05 0.22 1.30 1.46 
Daytime Dysfunction 0.95 0.86 1.96 0.77 
Sleep Duration 0.67 1.02 0.74 1.18 
Note. PSQI= Pittsburg Sleep Questionairre. 
 
Psychological distress.  Between-group comparisons of the DASS and IDS-
SR results were conducted to assess the hypothesis that young people with CFS 
would report higher levels of psychological distress than healthy controls.  These 
descriptive statistics in Table 6.14 suggest that, compared to controls, the CFS group 
reported greater levels of stress, anxiety, and depression. 
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Table 6.14 
Group Means and Standard Deviations for Psychological Distress 
 Controls (n = 23) CFS (n = 23) 
Measure M SD M SD 
DASS Stress  8.96 6.68 13.78 8.80 
DASS Anxiety 3.96 4.69 10.26 7.82 
DASS Depression 5.17 8.14 10.39 7.31 
IDS-SR total 13.39 13.15 28.96 12.53 
Note. Figures represent the summation of likert scale socres. DASS= Depression Anxiety Stress 
Scale; IDS-SR The Inventory of Depressive Symptomatology- Self Report 
 
Using a MANOVA with the DASS and IDS-SR component scores entered as 
DVs, a significant difference was identified between groups, F(4,41) = 6.23, p< 
.001.  Evaluation of univariate ANOVAs indicated that the CFS group rated 
themselves higher on all measures of psychological distress: DASS Stress, F(1,44) = 
4.35, p = .043; DASS Anxiety, F(1,44) = 10.88, p = .002; DASS Depression; F(1,44) 
= 9.95, p = .003; and IDS-SR, F(1,44) = 22.85, p< .001.  Consistent with the 
hypothesis, these results indicate that the CFS group scored higher on a measure of 
psychological distress than the healthy controls. 
It is useful to evaluate psychological distress according to clinical standards.  
Lovibond and Lovibond (1995) provide criteria for categorising the DASS 
components into mild, moderate, severe, and extreme.  The percentage of CFS and 
control participants who fell within these categories is presented in Table 6.15.  
Similarly, the percentage of participants falling within different severity categories 
on the IDS-SR (Rush et al., 1996) is presented in Table 6.16.  Compared to controls, 
the CFS group is represented less frequently in the normal to mild range, and more 
frequently in the moderate to severe or extreme range of psychological distress.  The 
significance of these differences was assessed with Fisher’s exact test.  No 
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significant differences were identified for DASS Stress (p = .433).  However, the 
CFS group rated themselves significantly higher than controls on DASS Anxiety (p = 
.033), DASS Depression (p = .002), and IDS-SR Depression (p< .001). 
 
 Table 6.15 
Percentage of Participants Meeting the Criteria for Various Distress Levels From 
the DASS 
ªn = 23. 
 
Table 6.16 
Percentage of Participants Meeting the Criteria for Categories of Depression From 
the IDS-SR 
Category Controls (n = 23) CFS (n = 23) 
Normal 73.9% 0.7% 
Mild 13.0% 30.4% 
Moderate 0.0% 30.4% 
Moderate-Severe 0.0% 13.0% 
Severe  13.0% 17.4% 
 
 
Fatigue.  The hypothesis that young people with CFS would report higher 
levels of fatigue than healthy controls was assessed through investigation of the 
 Stress  Anxiety  Depression 
Category Controlsª CFSª  Controlsª CFSª  Controlsª CFSª 
Normal 82.6% 60.9%  87.0% 47.8%  87.0% 43.5% 
Mild 8.7% 13.0%  0.0% 0.0%  0.0% 17.4% 
Moderate 4.3% 8.7%  4.3% 21.7%  4.3% 34.8% 
Severe 4.3% 17.4%  8.7% 21.7%  0.0% 0.0% 
Extreme 0.0% 0.0%  0.0% 8.7%  8.7% 4.3% 
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Chalder Fatigue Scale and the VAS.  The descriptive statistics (Table 6.17) indicate 
that compared to healthy controls, the CFS patients reported higher levels of fatigue 
on all outcome measures. 
 
Table 6.17 
Group Means and Standard Deviations for Fatigue 
 Controls (n = 23) CFS (n = 23) 
Measure M SD M SD 
aChalder Fatigue Scale Total  15.96 3.55 21.87 5.69 
aChalder Fatigue Scale- Physical Fatigue 9.39 2.15 12.61 3.53 
aChalder Fatigue Scale- Mental Fatigue 6.57 2.33 9.26 2.77 
bVAS Time 1 2.78 2.42 4.00 1.85 
bVAS Time 2 3.11 2.26 4.48 1.63 
bVAS Time 3 3.20 2.50 5.30 1.88 
bVAS Time 4 3.72 2.57 6.26 2.13 
bVAS Time 5 4.37 2.96 7.41 1.89 
Note. VAS= Visual Annaloge Scale 
a Scores are a summation of likert scale scores. 
b Scores on a 10cm visual analogue scale  
 
A MANOVA for the Chalder Fatigue Scale revealed a significant group 
difference in overall fatigue, F(2,43) = 8.74, p<001, and follow-up ANOVAs were 
significant for Physical Fatigue, F(1,44) = 13.97, p = .001 and Mental Fatigue, 
F(1,44) = 12.76, p< .001. 
A repeated measures ANOVA was conducted to assess group differences in 
fatigue throughout the test-taking period.  Group was entered as the between-subjects 
variable, and the five VAS fatigue scores were entered as the within-subjects 
variables.  A significant between-groups effect of fatigue was detected, F(1,44) = 
8.12, p = .007, indicating that there was an overall difference between CFS patients 
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and controls on the VAS fatigue scores.  The within-groups effect of time was also 
significant F(1.65,72.56) = 28.85, p< .001, indicating that the fatigue scores changed 
significantly over time.  In addition, the interaction between group and time was 
significant, F(1.65,72.56) = 9.91, p< .001.  In combination with the group means in 
Table 6.17, this suggests that both groups became more fatigued over time and the 
group differences became larger throughout the assessment.  As predicted, these 
results indicate that the CFS group rated themselves as more fatigued than the 
healthy controls throughout the testing procedure. 
 
Hypothesis 8: predictive value of symptoms common to CFS.  In every 
multiple linear regression conducted for this hypothesis, the same three IVs were 
included to represent each symptom domain.  The Global PSQI score represented 
sleep disturbance, IDS total was selected for psychological distress, and VAS Time 5 
represented fatigue symptoms.  These variables demonstrated the most significant 
difference between groups for each symptom domain.  To assess multicollinearity, 
the correlations among the predictor variables were examined.  Although most 
correlations are positive and significant (as shown in Table 6.18), none are large 
enough to suggest that multicollinearity is likely to be a problem.  Tolerance was also 
acceptable, ranging between .497 and .745, indicating that multicollinearity is 
unlikely among these variables. 
Perceived cognitive disturbance.  A standard multiple linear regression was 
employed to investigate the hypothesis that perceived cognitive disturbance could be 
predicted by symptoms common to CFS.  MFIS Total was entered as the DV.  The 
analysis was nonsignificant, adjusted R² = .138, F(3,22) = 2.17., p = .125. 
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Table 6.18 
Correlations Between Predictor Variables for the Regression Models 
Measure Global PSQI IDS total VAS Time 5 
Global PSQI 1 .421* .184 
IDS total .421* 1 .460* 
VAS Time 5 .184 .460* 1 
Note. PSQI= Pittsburg Sleep Questionaire; IDS= Inventory of Depressive Symptomatology; VAS= 
Visual Annaloge Scale.   
*Correlation is significant at the 0.05 level (2-tailed). 
**Correlation is significant at the 0.01 level (2-tailed). 
 
 
Neuropsychological performance.  Seven standard multiple linear 
regressions were conducted to examine how well cognitive performance could be 
predicted by sleep disturbance, psychological distress, and fatigue.  In each analysis, 
a single variable from the CANTAB was entered as the DV.  These variables were 
the eight outcome measures that significantly differentiated the CFS and healthy 
control groups. 
All regression analyses were nonsignificant: IED Block 6 Errors, adjusted R² 
= .029, F(3,22) = 1.21, p = .330; IED Total Errors Adjusted, adjusted R² = .022, 
F(3,22) = 1.17, p = .349; IED Stages Completed, adjusted R² = .082, F(3,22) = 1.65, 
p = .211; RTI 5-Choice Reaction Time, adjusted R² = .043, F(3,22) = 1.33, p = .295; 
RVIP A’ Target Sensitivity, adjusted R² = -.021, F(3,22) = 0.85, p = .483; SSP Span 
Length, adjusted R² = -.064, F(3,22) = 0.56, p = .650; SRM Percent Correct, adjusted 
R² = .034, F(3,22) = 1.26, p = .318; PRM Percent Correct, adjusted R² = .075, 
F(3,22) = 1.59, p = .225.  Contrary to the hypothesis, symptoms common to CFS 
were not significant predictors of neuropsychological function. 
 
Academic achievement.  Two standard multiple linear regressions were 
employed to examine how well academic achievement could be predicted by sleep 
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disturbance, psychological distress, and fatigue.  The WRAT-4 Reading and Math 
Computation components were entered as the DV in each respective analysis.  Both 
regression analyses were nonsignificant: Reading, adjusted R² = .031, F(3,22) = 1.23, 
p = .325; Math Computation, adjusted R² = -.127; F(3,22) = 0.17, p = .912.  Table 
6.19 displays the beta weights and corresponding t-tests for each analysis.  Contrary 
to the hypothesis, this suggests that symptoms common to CFS did not predict 
performance on measures of academic achievement. 
 
Table 6.19 
Multiple Linear Regression Results for Predicting Academic Achievement From 
Symptoms Common to CFS 
Symptom measure β df t p 
WRAT-4 Reading 
Global PSQI 0.33 22 1.46 0.16 
IDS total -0.35 22 -1.4 0.18 
VAS Time 5 -0.29 22 -1.2 0.24 
WRAT 4-Math Computation 
Global PSQI .117 22 0.49 .633 
IDS total .021 22 0.08 .940 
VAS Time 5 .135 22 0.52 .608 
Note. PSQI= Pittsburg Sleep Questionaire; IDS= Inventory of Depressive Symptomatology; VAS= 
Visual Annaloge Scale; WRAT-4= Wide Range Achievement Test- 4th Ed. 
 
Hypothesis 9: between-group differences in school absenteeism. 
It was hypothesised that young participants with CFS would report higher 
rates of school absenteeism than the healthy control group.  An independent samples 
t-test was employed to evaluate group differences in school absenteeism.  Six 
participants in each group (26.09%) were not of school age and were thus excluded 
from the analysis.  A significant between-group difference was detected in the 
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number of days absent from school t(42) = 5.23, p< .001.  Over a six-month period, 
the CFS group missed an average of 35.65 days, while the controls missed only 4.81 
days.  The participants were grouped according to the percentage of days missed 
(Table 6.20).  Using Fisher’s exact test, a significant between-group difference in the 
percentage of days absent was detected (p< .001).  Consistent with the hypothesis, 
this indicates that the rate of school absenteeism was higher in the CFS group 
compared to healthy controls.   
 
Table 6.20 
Percentage of School Days Missed in School-Aged Participants 
Days missed CFS (n = 17) Controls (n = 16) 
0 0 8 
0-19% 3 7 
20-39% 1 0 
40-59% 6 1 
60-80% 2 0 
>80% 5 0 
 
Hypothesis 10: school absenteeism and academic achievement.  A 
Pearson’s correlation coefficient was employed to assess the hypothesis that school 
absenteeism would be negatively correlated with performance on measures of 
academic achievement.  Contrary to the hypothesis, school absenteeism was not 
significantly correlated with WRAT-4 Reading, r = -.263, n = 23, p = .225, or 
WRAT-4 Math Computation, r = .047, n = 23, p = .833. 
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Discussion 
This study had three major aims.  First, it was designed to assess whether 
young CFS patients would report greater cognitive impairment and perform more 
poorly than healthy controls on measures of neuropsychological function and 
academic achievement.  The second aim was to investigate whether test motivation 
and perfectionism would be higher in young CFS patients compared to controls, and 
whether these differences would affect neuropsychological and academic test 
performance.  Finally, the study was designed to assess whether young people with 
CFS would report higher levels of symptoms common to CFS compared to 
nonfatigued peers and whether these factors would predict perceived cognitive 
function and neuropsychological and academic test performance.  These aims were 
investigated in a sample of 23 young people with CFS aged from 12 to 21, and 23 
healthy controls matched for age and gender. 
As expected, the CFS group reported greater levels of cognitive impairment 
and performed more poorly on a number of neuropsychological tasks compared to 
controls.  However, the CFS group achieved higher scores than controls on the 
academic tests.  Although the CFS patients rated themselves higher on a level of test 
motivation, both groups reported similar levels of perfectionism, and neither 
motivation or perfectionism were significant predictors of neuropsychological or 
academic test performance.  Finally, the CFS patients reported higher levels of sleep 
disturbance, psychological distress, and fatigue than controls, although, surprisingly, 
these factors were not related to perceptions of cognitive function or performance on 
neuropsychological or academic tests.  Beginning with a description of the 
participants, the following section contains a detailed discussion of each research 
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hypothesis, followed by a consideration of the study limitations and directions for 
future research. 
 
Participants.  Detailed information about CFS symptoms was derived from 
the PMCQ.  As expected, the CFS patients reported significantly and substantially 
greater symptom frequency and severity than the controls on each symptom cluster, 
including Sleep, Fatigue, Pain, Cognitive, and Other Symptoms.  Consistent with 
epidemiological studies in paediatric patients (Krilov et al., 1998; Lines, 2004; 
Richards et al., 2006; Sankey et al., 2006), the most frequently reported trigger for 
CFS was an infectious illness, followed by stress.  Similar to previous research 
(Carter et al., 1995; Dougall, Baum, & Jenkins, 1998; Patel et al., 2003), there was 
considerable variability in illness onset and duration between patients.  However, on 
average, the period of onset and duration was somewhat longer compared to earlier 
studies (Carter et al., 1995; Rangel et al., 2003; Sankey et al., 2006).  The majority of 
patients reported a moderate onset period spanning between one and six months, and 
almost two-thirds reported that they had been unwell for more than three years.  
Consistent with previous research, the participants primarily described their illness as 
fluctuating, or, characterised by periods of remission and relapse (Krilov et al., 1998; 
Sankey et al., 2006). 
Functional impairment was considerable: most patients reported that CFS 
caused a significant reduction in activity and school attendance.  Consistent with 
previous research suggesting that paediatric CFS patients typically limit physical 
activity (Crawley & Sterne, 2009; Kennedy et al., 2010), almost all CFS participants 
reported feeling worse following physical activity and intentionally limited their 
activity to avoid fatigue.  The majority of participants reported that fatigue was their 
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worst symptom, followed by headaches and then memory or concentration 
difficulties.  Similarly, Sankey et al. (2006) found that fatigue and headaches were 
the most commonly reported symptoms in a paediatric CFS sample, although 
concentration difficulties were less frequently reported than sleep disturbance.  Rates 
of school absenteeism were also comparable to previous research (Garralda & 
Rangel, 2004; Gray, 2001; Sankey et al., 2006).  Most patients missed a substantial 
quantity of school, and some attended no school altogether.  Similar to earlier 
research (Bell et al., 2001; Crawley & Sterne, 2009; van Geelen et al., 2010), the 
students in this study missed approximately one-third of school on average over a 
period of six months.  Collectively, the data suggest that the course, presentation, and 
functional impact of CFS described by patients in the current study are largely 
comparable to previous research.  As such, it is probable that this sample is 
representative of paediatric CFS patients. 
 
Hypothesis 1: between-group differences in cognitive function.   
Perceived cognitive function.  In support of the hypothesis, the CFS patients 
perceived themselves to be significantly more cognitively impaired than the controls.  
All CFS patients reported cognitive symptoms on the PMCQ, and compared to 
controls, the CFS patients reported more frequent and severe symptoms associated 
with memory, concentration, comprehension, and divided attention.  On the MFIS, 
the CFS patients reported greater impairment than controls on every test item.  This 
is indicative of difficulties with everyday tasks that require sustained attention, 
concentration, thinking, memory, and processing speed. 
The incidence of perceived cognitive impairment in the CFS group is high 
compared to previous studies in young patients.  For instance, one group found that 
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33% of 58 young CFS patients reported cognitive difficulties (Krilov et al., 1998).  
Lines, 2004 also found that, of 20 young CFS patients, 60% reported poor 
concentration and 20% reported memory difficulties.  Conversely, no disturbances in 
attention, thinking, or academic performance were reported by a group of 35 female 
adolescents with CFS (van Middenthorp et al., 2001).  The discrepancy between 
these findings and the current study could be explained by differences in the nature 
of the questionnaires used.  Specifically, while the present study included detailed 
questionnaires designed to assess a range of cognitive functions, previous findings 
were largely derived from a single question within a symptom checklist.  As such, 
the earlier studies may not have captured the range and depth of cognitive 
disturbances experienced by young CFS patients.  Supporting this explanation, 
results drawn from detailed cognitive questionnaires in adult samples are comparable 
to the current study (Becker et al., 2001; Jason, Taylor et al., 2002; Smith et al., 
1993; Vercoulen et al., 1998). 
The nature of cognitive impairment reported by patients in this study is 
consistent with previous research.  For instance, studies in adults suggest that the 
most common cognitive complaints include problems with sustained attention, 
concentration, thinking speed, and memory (DeLuca et al., 1995; Michiels et al., 
1996; Michiels et al., 1999; Ray, Phillips et al., 1993; Smith et al., 1996; Vercoulen 
et al., 1998).  Similarly, research in paediatric patients suggests that young people 
often report impairments in focussed attention, sustained attention, memory, and 
concentration (Haig-Ferguson et al., 2009; Lines, 2004). 
In support of the hypothesis, the results suggest that adolescents and young 
adults with CFS perceive themselves to have frequent and severe cognitive 
impairment in a range of functions.  These disturbances may affect performance in 
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everyday settings, potentially disrupting scholastic activity (Fröjd et al., 2008; 
Kovacs & Goldston, 1991).  However, previous literature suggests that self-report 
measures of cognitive function may overestimate impairment or detect deficits that 
are only apparent under specific conditions (Cope et al., 1995; Ray et al., 1993; Short 
et al., 2002; Vercoulen et al., 1998), and as such, objective neuropsychological tests 
were employed to gain a more complete understanding of cognitive function in 
young CFS patients. 
 
Neuropsychological function.  Consistent with the hypothesis, the CFS 
group achieved lower scores than controls on measures of executive function, 
attention, and working memory.  However, between-group differences were not 
observed for all outcome measures, and information processing speed appeared to be 
unaffected by CFS.  Although these results were not entirely consistent with 
expectations, they are similar to findings from previous research in adults. 
As expected, the CFS patients and controls achieved comparable scores on a 
test of intelligence, performing within the average range.  This finding is consistent 
with previous studies (Claypoole et al., 2007; DiClementi et al., 2001; Grafman et 
al., 1993; Johnson et al., 1998; Krupp et al., 1994; Lawrie et al., 2000; Majer et al., 
2008; Short et al., 2002) and suggests that intellectual functioning remains intact in 
young CFS patients.  As such, there was no need to control for intelligence when 
assessing group differences in cognitive function.  
 
Executive function.  Overall, the CFS patients did not perform as well as 
controls on measures of executive function.  The CFS group achieved lower scores 
on IED Block 6 Errors, IED Total Errors Adjusted, and IED Stages Completed.  This 
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suggests that compared to the healthy controls, the CFS patients had poor attentional 
flexibility and were less able to shift attention within a previously relevant perceptual 
dimension.  However, there were no group differences on IED Block 8 Errors, 
suggesting that the CFS patients were able to shift their attention to a previously 
irrelevant perceptual dimension.  In addition, the CFS patients and controls obtained 
similar scores on SOC Problems Solved in Minimum Moves and SWM Strategy.  
This suggests that the CFS patients could plan and problem solve as effectively as 
controls. 
The IED results parallel an earlier study involving 20 adult CFS patients and 
20 matched healthy controls.  Three CFS patients failed the intradimensional reversal 
stage (IED Block 6 Errors) compared to one control (Joyce et al., 1996), and there 
were no significant differences between groups in the number of errors made on the 
extradimensional shift stage (IED Block 8 Errors).  In contrast, other studies show no 
differences between CFS patients and healthy controls in overall performance on 
IED in paediatric (Younis, 2009) and adult samples (Capuron et al., 2006; Majer et 
al., 2008; Morriss et al., 2002). 
Supporting the present study, many researchers have also discovered that 
adults and young people with CFS are able to plan and problem solve on the SOC 
task with a similar level of proficiency as healthy controls (Capuron et al., 2006; 
Joyce et al., 1996; Majer et al., 2008; Morriss et al., 2002; Santamarina-Perez et al., 
2011; Younis, 2009).  Similar results have been identified with other measures of 
planning and problem solving in both adults (Busichio et al., 2004; Tiersky et al., 
1998) and paediatric patients (Haig-Ferguson et al., 2009).  In contrast, the 
nonsignificant results for SWM Strategy appear to be anomalous.  Several studies 
suggest that adult CFS patients typically employ a less efficient search strategy on 
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SWM than nonfatigued peers and CFS patients with low mental fatigue (Capuron et 
al., 2006; Joyce et al., 1996; Majer et al., 2008).  Further, the patients in this study 
reported significant psychological distress, and there is evidence to suggest that 
depressed adults achieve low scores on SWM Strategy (Elliott, Sahakian, McKay, & 
Herrod, 1996; Weiland-Fiedler et al., 2004). 
In consideration of the findings from previous research, the results suggest 
that like adults, young CFS patients have difficulty performing tasks that require 
attentional flexibility but are able to plan and problem solve as effectively as 
nonfatigued peers.  However, contrary to findings from studies in adults, the CFS 
patients and controls achieved similar scores on SWM Strategy.  Although it is 
possible that young CFS patients are less susceptible to deficits in their capacity to 
employ an effective cognitive strategy, firm conclusions should be withheld until 
further research is conducted. 
These findings have some important implications for young people with CFS.  
Patients with poor cognitive flexibility may have difficulty generating ideas, making 
decisions, regulating behaviour, and adapting to change (Shouten, Oostrom, Peters, 
Berloop, & Jennekens-Schinkel, 2007; Stahl & Pry, 2005).  Treatments designed to 
assist young patients to compensate for or overcome these difficulties may reduce the 
functional impact of CFS by enabling patients to engage flexibly with their 
environment.  Conversely, these results suggest that it may be unnecessary to focus 
interventions on improving planning and problem solving ability in young CFS 
patients. 
 
Attention.  As expected, the CFS group obtained lower scores than controls 
on tasks designed to assess attention.  Specifically, the CFS patients performed more 
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poorly on RTI 5-Choice Reaction Time and RVIP A’ Target Sensitivity but not 
RVIP Mean Latency.  This suggests that compared to controls, CFS patients were 
slower to react when a choice was presented and were less accurate but not slower on 
a visual continuous performance task.  These results indicate that the CFS patients 
had difficulty maintaining attention. 
These findings are largely consistent with previous research in adults with 
CFS .  For instance, researchers have found that CFS patients are slower to respond 
than healthy controls on choice reaction tasks (Crowe & Casey, 1999; DeLuca et al., 
2004).  Another group found that CFS patients with high self-reported mental fatigue 
obtained significantly lower RVIP accuracy scores compared to healthy controls and 
CFS patients without significant mental fatigue (Capuron et al., 2006).  Majer et al. 
(2008) also found comparable RVIP Mean Latency scores between a group of CFS 
patients and healthy controls.  Furthermore, children and adolescents with CFS have 
been found to perform more poorly than healthy controls on other measures of 
sustained, switching, and divided attention (Haig-Ferguson et al., 2009; Kawatani et 
al., 2011; Tomoda, et al., 2007).  One group also found that alternative attention, but 
not selective attention, improved significantly in children with CFS following a 
combined CBT/pharmacological intervention (Kawatani et al., 2011).  In contrast 
however, others have identified no differences between adult CFS patients and 
healthy participants on choice reaction tasks (Capuron et al., 2006; Mahuran et al., 
2004; Majer et al., 2008), or RVIP accuracy (Majer et al., 2008).   
In view of the hypotheses and findings from previous research, the results 
suggest that young CFS patients have difficulty maintaining attention.  However, 
they may be able to process information at regular speeds when they attend to the 
required information.  Attention deficits could affect how young people function in 
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everyday life in a number of ways.  CFS patients with poor attention at school may 
be less able to follow instructions or perform academic tasks over long periods, 
particularly during an exam.  This could affect grades and limit opportunities for 
further education and career attainment.  If it is known that young people with CFS 
suffer from attentional deficits, compensatory measures could be implemented in 
educational environments.  For example, teachers could provide students with rest 
breaks, limit task duration, provide instructions in stages, and allow more time for 
students to respond.  Interventions such as these could ease the disadvantage that 
patients experience at school, reducing the functional impact of CFS in young 
people. 
 
Information processing speed.  Contrary to expectations, there were no 
significant differences between the CFS and healthy control groups on measures of 
information processing speed.  The outcome measures included SOC Initial Thinking 
Time, SOC Subsequent Thinking Time, and SWM Mean Time to Last Response.  
This suggests that the CFS patients processed information on tasks of executive 
function and working memory at regular speeds. 
This finding is inconsistent with much of the previous research in adults with 
CFS.  For instance, Morriss et al. (2002) found that CFS patients spent longer periods 
thinking and planning on SOC compared to healthy controls, and several others have 
found that adult CFS patients process information within memory more slowly than 
controls on SWM (Capuron et al., 2006; Majer et al., 2008).  Similar results have 
also been identified using other tests that require rapid processing speed, such as 
Digit Symbol Coding (Busichio et al., 2004; Dickson et al., 2009; Michiels et al., 
1996; Neu et al., 2011), the PASAT (Busichio et al., 2004; DeLuca et al., 1997; 
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Tiesky et al., 1998), and the Stroop test (Mahurin et al., 2004; Michiels et al., 1998; 
Ray et al., 1993; Smith et al., 1993).  Moreover, this study conflicts with the theory 
supported by many authors, that CFS patients approach challenging cognitive tasks 
by reducing speed in order to improve accuracy (DeLuca et al., 2004; Michiels et al., 
1998; Ray et al., 1993). 
However the results of this study are consistent with a significant portion of 
the previous research in adults .  For instance, several authors found no significant 
differences between CFS patients and healthy controls in initial or subsequent 
thinking time on the SOC (Capuron et al., 2006; Joyce et al., 1996; Majer et al., 
2008).  Many have also found that CFS patients and healthy controls search through 
memory at similar speeds (Capuron et al., 2006; Joyce et al., 1996; Majer et al., 
2008; Morriss et al., 2002).  Comparable rates of processing speed between CFS 
patients and controls have also been identified for the PASAT (Constant et al., 2011) 
and the Stroop test (Daly et al., 2001; Marcel et al., 1996; Short et al., 2002).  Haig-
Ferguson et al. (2009) also found that young CFS patients scored within the normal 
range on the WISC-IV Symbol Search test. 
Together with the unexpected findings in this study, the substantial 
inconsistencies among the previous research make it difficult to form conclusions.  
The myriad of contradictory results suggest that processing speed is a complex 
function that may be vulnerable to the effects of other cognitive processes or 
unmeasured participant variables.  It is important to note that although the results did 
not support the hypothesis, findings from several studies with similar assessment 
tools suggest that processing speed remains intact in adult CFS patients (Capuron et 
al., 2006; Joyce et al., 1996; Majer et al., 2008; Morriss et al., 2002).  This supports 
the conclusion that young CFS patients are able to process information as rapidly as 
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nonfatigued peers.  However, further research is required to determine the source of 
the research inconsistencies before this conclusion can be confirmed. 
 
Working memory.  As expected, the CFS patients performed more poorly than 
the healthy controls on tests of working memory.  The CFS group achieved lower 
scores on SSP Span Length, SRM Percent Correct, and PRM Percent Correct.  This 
suggests that CFS group had difficulty recalling information from spatial memory 
and correctly identifying visual targets from memory.  In contrast, no differences 
between groups were apparent on the number of errors made for SSP and SWM.  
However, on average, the CFS patients made 25.83 errors on SWM while the healthy 
controls only made 16.91.  The absence of a significant effect despite this substantial 
difference could be due to the high variability of the scores, particularly in the CFS 
group.  Perhaps only a subgroup of CFS patients had difficultly recalling visuospatial 
information. 
These results are consistent with much of the previous research in adults.  For 
instance, Majer et al. (2008) found that compared to controls, CFS patients were less 
accurate on SRM and had longer response latencies on PRM, but both groups made a 
similar number of errors on SWM.  Joyce et al. (1996) also found that CFS patients 
recalled significantly fewer sequences on SSP (Span Length) than matched healthy 
controls, and Morriss et al. (2002) identified similar error rates between a small 
group of CFS patients and healthy controls on SWM and SSP.  One group also found 
that children with CFS perform more poorly than healthy peers on measures of 
spatial working memory but not short-term memory (Kawatani et al., 2011).  
However, these findings are inconsistent with several other studies.  For instance, in 
the study by Joyce et al. (1996), the CFS group made significantly more between- 
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but not within-search errors than controls on SWM.  This finding was replicated in a 
more recent study with CFS patients who reported significant mental fatigue 
(Capuron et al., 2006).  Results from some of the same studies also indicate that CFS 
patients and controls perform equally well on SRM and PRM (Capuron et al., 2006; 
Joyce et al., 1996; Morriss et al., 2002), and one group found no improvements in 
spatial working memory following a combined CBT/pharmacological intervention 
for CFS in young patients.  Haig-Ferguson et al. (2009) also found that young CFS 
patients scored within the normal range on the WISC-IV Digit Span and Letter-
Number Sequencing tests. 
In consideration of the collective findings from previous research, the results 
for working memory were not unexpected.  However, the inconsistent findings in 
these studies make it difficult to form conclusions.  The present study suggests that 
young CFS patients have difficulty recalling information from spatial memory and 
correctly identifying visual targets from memory, although they are able to 
manipulate visuospatial information in working memory.  However, given the 
inconsistencies among the previous research, these findings must be replicated before 
such conclusions can be confirmed. 
Deficits in working memory may affect young CFS patients in several ways.  
Poor working memory can have a considerable impact on learning, particularly in 
academic settings (Curtis & D'Esposito, 2003), limiting students’ capacity to 
remember instructions and complete learning or assessment activities.  Disturbances 
in working memory may also cause further deficits in attention (Fukuda & Vogel, 
2009).  These factors could affect performance at school and cause associated 
problems with motivation and self-esteem.  By introducing compensatory measures 
in schools, such as providing written instructions and allowing more time to 
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complete activities, students with CFS may be able to overcome the effects of 
working memory impairment at school.  This could reduce the functional impact of 
CFS in young people considerably. 
 
Further examination of the neuropsychological test results.  Although the 
results are consistent with much of the previous research, a number of findings were 
unexpected and it is important to explore the various possible explanations.  Contrary 
to the hypotheses, the CFS patients did not demonstrate impairment on any measure 
of processing speed or on some measures of executive function, attention, and 
working memory.  These findings are inconsistent with the CFS patients’ self-
reported indications of deficits in planning, processing speed, attention, and working 
memory.  In addition, other symptoms associated with significant cognitive 
dysfunction, including psychological distress, fatigue, and sleep disturbance (see 
Chapter 4: Psychological Disturbance), were all more common in the CFS patients. 
Nonsignificant or atypical results in CFS research are sometimes attributable 
to inadequate diagnostic approaches or a failure to identify CFS subgroups.  
However, each patient in the current study had their diagnosis confirmed by a 
specialist CFS paediatrician, and although the patients were not subgrouped 
according to distinguishing illness characteristics, all were recruited from the same 
tertiary centre and there was considerable homogeneity in illness course and 
presentation among the participants.  Nonetheless, some patients may have had 
cognitive deficits that were masked by the performance of the whole group.  
Alternatively, although the sample appeared to be representative of the young CFS 
population, the participants may represent an unidentified subgroup that is resistant 
to or does not present with impairment in certain functions. 
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Nonsignificant findings in CFS research can sometimes be caused by the 
nature of the neuropsychological assessment tool.  Previous literature suggests that 
CFS patients often have subtle impairments that can only be detected with an 
exceptionally sensitive assessment tool.  However, the CANTAB is a precise 
measure of cognitive function that is capable of detecting slight deficits.  For 
example, in a sample of patients with Obsessive-Compulsive Disorder, scores on 
SWM and SOC were distinguishable between patients based on illness subtype 
(washers, checkers, obsessionals, and mixed symptom profile; Nedeljkovic et al., 
2009).  Another group found that performance on IED was sensitive to the effects of 
short-term treatment for depression with ginkgo biloba (Hartley, Heinze, Elsabagh, 
& File, 2003).  Moreover, all subtests in the current study have been used 
successfully in previous research to distinguish between adult CFS patients and 
healthy controls (Capuron et al., 2006; Joyce et al., 1996; Majer et al., 2008; Morriss 
et al., 2002).  As such, it appears doubtful that the CANTAB lacked adequate 
sensitivity for detecting cognitive impairment. 
The inherent variability of CFS may be responsible for some of the 
unexpected findings.  Most CFS patients described their illness as fluctuating or 
characterised by periods of remission and relapse.  It is well established that CFS 
symptoms vary according to recent activity, including physical or mental exertion 
(Fuentes, Hunter, Strauss, & Hultsch, 2001), and many patients elected to participate 
during the school holidays in order to avoid significant interference with school.  As 
such, the participants may have been less affected by severe symptoms and ongoing 
mental effort at the time of the study than during a regular school term.  Therefore, 
typical levels of cognitive impairment may not have been captured due to the timing 
of the assessment. 
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The nonsignificant results may also be attributed to a lack of statistical power 
relating to the sample size and high variability of scores.  These factors may have led 
to insufficient statistical power for detecting mild impairment.  However, significant 
differences in cognitive function have been detected in adult CFS patients using 
similar statistical procedures with comparable sample and effect sizes (Joyce et al., 
1996; Lawrie et al., 2000).  Therefore, it seems unlikely that the nonsignificant 
findings were caused exclusively by inadequate power. 
Akin to the research in adults, this study revealed a discrepancy between self-
perceived cognitive function and neuropsychological test performance.  The CFS 
patients reported disturbances on tasks that require planning, processing speed, and 
working memory despite receiving similar scores to controls on some of the 
CANTAB items assessing these functions.  Although it is possible that CFS patients 
overestimate or overgeneralise their impairment, there are several alternative 
explanations for the discrepancies. 
The study may not have captured a number of true deficits due to the 
significant differences between the laboratory setting and naturalistic environments.  
Supporting this, research suggests that the more a laboratory test represents everyday 
cognitive tasks, the higher the correlation between self-reported cognitive function 
and neuropsychological test performance (Bennet-Levy & Powell, 1980; Sunderland 
et al., 1986).  Participants in the current study were asked to describe their usual 
cognitive function during complex tasks that involve the simultaneous use of 
multiple cognitive faculties in everyday settings (Wearden & Appelby, 1996).  
Further, performance within naturalistic environments such as school may be 
particularly susceptible to the effects of distraction, divided attention, fatigue, 
sleepiness, low effort, or negative beliefs about cognitive capacity (Devolder & 
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Pressley, 1991).  In addition, educational or work environments are often repetitive 
and require ongoing cognitive demands and learning over extended periods.  In 
contrast, the assessments in the current study measured isolated cognitive functions 
using simple-to-follow tasks in a quiet laboratory environment.  The assessment 
setting was also a novel, time-limited environment, and participants were required to 
maintain focus over short periods.  Therefore, deficits normally present in naturalistic 
settings may not have been apparent in the current laboratory study. 
The discrepant findings between the self-report and neuropsychological 
assessments could also be related to motivational differences between groups.  
Consistent findings from previous research suggest that test performance is 
positively correlated with motivation (Brown & Walberg, 1993; Eklöf, 2010; Logan 
et al., 2010; Nishimura et al., 2011; Preckel et al., 2006), and the influence of test 
motivation is highest in people with lower cognitive ability (Binder et al., 2003; 
Duckworth et al., 2011; Logan et al., 2010).  In the current study, the CFS group 
reported greater test-taking effort than controls, although both groups considered the 
assessments to be similarly important.  However, motivation was not a significant 
predictor of cognitive performance.  Nonetheless, test motivation theory suggests 
that motivation will be higher if examinees believe that it is important to perform 
well, have greater interest in the task, and find the task more useful (Eklöf, 2010).  It 
is probable that the CFS patients were particularly interested and invested in the 
research given that it related to their poorly understood health situation.  Moreover, 
CFS patients may be particularly unmotivated to perform well in everyday settings 
due to the fatigue caused by ongoing mental effort or demoralisation due to the 
effects of their condition (Weardern & Appleby, 1996).  Conversely, it is reasonable 
to expect that the controls would perform normally in everyday settings.  For the 
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CFS patients, increased motivation to perform well in the study may have masked 
cognitive deficits that would usually be present in everyday settings. 
It is also important to consider the possible factors that may have increased 
the differences in neuropsychological performance between patients and controls.  
One possibility is that the CFS group represented a subgroup of patients with higher 
levels of illness severity than the total population of young CFS patients.  All patients 
were recruited from a paediatric tertiary care clinic that specialises in CFS.  It is 
likely that these patients or their parents opted to receive tertiary care due to the 
severity of their condition, and research in adult studies suggests that tertiary patients 
have higher levels of impairment than those managed in community settings (Jason 
et al., 2003).  Therefore, the sample may have represented patients suffering from 
more severe symptoms and greater levels of cognitive impairment compared to the 
wider paediatric CFS population. 
In summary, the nonsignificant findings were not likely to be caused by 
inaccurate diagnoses, inadequate sensitivity of the assessment tool, or insufficient 
power.  However, it is possible that certain impairments were not detected due to the 
timing of the assessments, differences between the laboratory and naturalistic 
environments, and motivational factors.  Conversely, the deficits found could be 
exaggerated if the particular participants in this study represented patients with 
greater illness severity than the general young CFS population.  Nevertheless, it is 
reasonable to propose that young CFS patients suffer from impairments in cognitive 
flexibility, attention, and working memory, but not planning and problem solving, 
processing speed, and visuospatial manipulation in working memory. 
These findings have considerable implications for young people with CFS.  
Impaired cognitive flexibility, attention, and working memory may inhibit learning 
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within academic and nonacademic contexts.  Patients may have difficulty generating 
ideas, making decisions, regulating behaviour, adapting to change, following 
instructions, and maintaining performance on academic tasks.  This could affect 
performance at school and limit opportunities for further education and career 
attainment, leading to associated problems with motivation, identity, and self-esteem.  
If it is known that young people with CFS suffer from cognitive deficits, 
compensatory measures could be implemented in educational and work 
environments, and treatments could be specifically designed to improve cognitive 
function.  Interventions such as these could significantly reduce the functional impact 
of CFS in young people. 
 
Hypothesis 2: between-group differences in academic achievement.  
Contrary to the hypothesis, the CFS group obtained higher scores than controls on 
academic tests of reading and arithmetic.  This was particularly surprising given that 
the CFS group reported substantially higher rates of school absenteeism and 
performed worse on measures of cognitive function than controls.  These results are 
also inconsistent with previous research.  For instance, Patel et al. (2003) found that a 
group of 36 CFS-affected students received an average of three out of 10 passes at 
school over an 18-month period.  Of these patients, 25% achieved one to four passes 
and 30.6% failed to receive a single pass grade or sit their examinations.  Another 
group found that 70% of participants with CFS had failed at least one year of study 
since illness onset and only 33% felt that their grades were in accordance with their 
capacity (Van Hoof et al., 2009).  Sankey et al. (2006) also reported that 19 of 28 
young CFS patients felt that their illness had significantly affected their education or 
career plans. 
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These inconsistencies could be explained by differences in the methods of 
data collection used.  In previous research, impaired academic performance was 
identified using self-report measures designed to assess long-term achievement in 
school settings.  In contrast, the participants in this study performed a small set of 
academic tasks under laboratory conditions.  It is possible that CFS patients 
overestimate their impairment on academic tasks or that academic function is directly 
related to achievement capacity rather than school absenteeism.  As such, the present 
study may be accurate in suggesting that academic function is unaffected by CFS. 
However, there are other possible explanations for the discrepant findings.  
One possibility is that compared to laboratory conditions, cognitive performance in 
school settings may be more susceptible to distraction, divided attention, fatigue, 
sleepiness, and negative self-beliefs about cognitive capacity (Devolder & Pressley, 
1991).  Given that the CFS patients in the current study were less proficient on tests 
of attention and reported higher rates of fatigue, sleep symptoms, and psychological 
distress than the controls, the patient group might be especially vulnerable to 
cognitive disturbances at school.  Such disturbances may not be apparent in a 
laboratory where these factors exert less influence.  Furthermore, the participants in 
the current study were required to maintain focus for short periods and perform 
mentally effortful tasks over a few hours rather than an entire school day.  There is 
some evidence to suggest that following prolonged mental effort, CFS patients are 
more likely to exhibit cognitive impairment than healthy controls (Smith et al., 
1999).  Therefore, although performance deficits may be normal for the CFS patients 
in a school environment, their performance within a laboratory test situation might 
approach their premorbid capacity. 
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As discussed within the evaluation of Hypothesis 1, the unexpected findings 
could also be explained by between-group differences in test motivation.  Findings 
from previous research consistently suggest that academic performance is positively 
correlated with motivation in school settings (Brown & Walberg, 1993; Eklöf, 2010; 
Logan et al., 2010; Nishimura et al., 2011; Preckel et al., 2006).  The CFS group 
believed that they exerted greater test-taking effort than controls, although both 
groups described the assessments as similarly important and motivation was not a 
significant predictor of academic performance.  However, compared to controls, 
there may have been a greater discrepancy in the CFS patients’ motivation to 
perform well in the study compared to school.  Therefore, the study may have failed 
to detect impairments that are only apparent in the context of motivational deficits in 
a natural school environment. 
It is also worth noting that the CFS patients had very high rates of school 
absenteeism.  It seems reasonable to expect that missing significant quantities of 
school would limit learning opportunities and lead to poorer academic performance.  
Although a causal relationship has not been identified, there is evidence to suggest 
that increased school absenteeism is associated with poor academic performance in 
clinical populations (Belachew et al., 2011; Breuner, Smith, & Womack, 2004; 
Krenitsky, 2007).  The incongruity between these findings and those of the current 
study could be explained by the effect of the CFS treatment intervention.  All 
patients involved in the study were treated at a clinic that has a focus on minimising 
the impact of CFS on education.  As part of treatment, the patients often develop 
achievable educational goals and are given appropriate resources that allow them to 
continue their education.  In addition, psychoeducation, psychotherapy, and 
medication are generally used to address psychological symptoms and sleep 
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disturbance in order to minimise functional impairment.  These factors may have 
protected the patients in this study from significant disruptions in education.  It is 
possible that academic decline would be more apparent in young CFS patients who 
are not involved in such intervention programs. 
In consideration of the inconsistent results between this study and findings 
from previous research, it is difficult to form conclusions regarding how CFS affects 
academic performance in adolescents.  Perhaps this study accurately suggests that 
academic performance is not affected by CFS in young patients.  However, this 
conclusion may be limited to this particular subgroup of patients due to the nature of 
their treatment intervention.  Alternatively, although academic performance may be 
affected by CFS in a school environment, true deficits may not have been detected 
due to the nature of the laboratory environment or motivational factors.  Further 
research conducted in a range of settings with varied populations is required to 
investigate these alternatives before the impact of CFS on academic achievement can 
be determined. 
 
Hypothesis 3: between-group differences in test motivation and 
perfectionism.   
Motivation.  As expected, the CFS group perceived themselves to be more 
motivated in completing the assessments than the healthy controls.  However, 
although the CFS group scored higher on test-taking effort, both groups rated the 
importance of doing well equally.  This is perhaps not surprising given that the 
Importance scale refers to how interested examinees are in their results, and since the 
participants were aware that their results would not be revealed, both groups did not 
rate the importance of doing well highly. 
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The significant between-group difference in test-taking effort has important 
implications for interpreting the academic and neuropsychological test results.  
Theoretical models of test motivation suggest that motivation affects performance on 
cognitive tasks (Eklöf, 2010; Thelk et al., 2009; Wise & DeMars, 2005; Wolf & 
Smith, 1995), and these models are supported by a wealth of research on academic 
performance (Brown & Walberg, 1993; Eklöf, 2010; Goodman et al., 2011; 
Hirschfeld et al., 2004; Hoyt, 2001; Logan et al., 2010; Nishimura et al., 2011; 
Preckel et al., 2006; Smith & Smith, 2002; Sundre & Kitsantas, 2004; Wise et al., 
2006; Wolf & Smith, 1995) and neuropsychological function (Binder et al., 2003; 
Brunstein & Schmitt, 2004; Lindem, 2000; Mizuno et al., 2011).  Further, the impact 
of test motivation appears to be strongest in people with low cognitive ability 
(Duckworth et al., 2011; Logan et al., 2010).  The higher rates of test motivation 
reported by the CFS group in the current study may have enhanced their cognitive 
performance relative to the controls.  Therefore, between-group differences in 
motivation may need to be accounted for when evaluating the neuropsychological 
and academic test results (this is considered further in the discussion of Hypothesis 
4). 
 
Perfectionism.  Contrary to the hypothesis, the CFS patients and controls 
reported similar levels of adaptive and maladaptive perfectionism.  This finding is 
inconsistent with much of the previous research.  Several studies suggest that self-
reported maladaptive perfectionistic traits are more common in adults with CFS 
compared to nonfatigued peers (Deary & Chalder, 2010; Luyten et al., 2006; White 
& Schweitzer, 2000), and a positive relationship has been identified between fatigue 
severity and maladaptive perfectionism in CFS patients (Kempke et al., 2011).  
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Conversely, one group found that CFS patients actually reported less maladaptive 
perfectionism than healthy controls (Blenkiron et al., 1999), and Wood and Wessely 
(1999) found no differences in self-reported maladaptive perfectionism between CFS 
patients and patients with rheumatoid arthritis.  For adaptive perfectionism, the 
results were perhaps more consistent with previous research.  Although one group 
found that adaptive perfectionistic traits were more common in CFS patients 
compared to healthy controls (Luyten et al., 2006), others researchers found no 
differences between adult CFS patients and nonfatigued peers (Deary & Chalder, 
2010; Blenkiron et al., 1999), and one group found that adaptive perfectionism was 
unrelated to fatigue in CFS patients (Kempke et al., 2011). 
Given the paucity of previous research, the results in the present study are 
difficult to interpret.  It is worth noting that the mean Discrepancy scores were 25.86 
and 18.29 for the CFS patients and healthy controls respectively, and this difference 
almost reached significance (p = .056).  These results might reflect true group 
differences that were not detected due to insufficient statistical power.  Alternatively, 
this study may be accurate in suggesting that young people with CFS do not have 
elevated levels of maladaptive perfectionism.  Further research is required before 
either conclusion can be confirmed.  The results for adaptive perfectionism are 
somewhat less unusual.  Together with the previous research, this study suggests that 
young people with CFS do not have higher levels of adaptive perfectionism than 
nonfatigued peers.  Again however, this conclusion needs to be verified through 
further research. 
 
Hypothesis 4: predictive value of motivation and perfectionism. 
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Neuropsychological function.  A series of eight standard multiple linear 
regressions were employed to examine how well neuropsychological performance 
could be predicted by motivation and adaptive perfectionism.  In contrast to the 
hypothesis, none of the analyses were significant, indicating that self-rated 
motivation and adaptive perfectionism were not predictors of performance on tests of 
executive function, attention, or working memory.  Similarly, maladaptive 
perfectionism was not a significant predictor of neuropsychological performance on 
any measure. 
Although research in this area is scarce, previous studies in motivation 
suggest that these findings are atypical.  For instance, positive correlations have been 
identified between motivation and performance on tasks of attention and working 
memory in healthy participants (Mizuno et al., 2011; Piedmont, 1988).  Further, in a 
study of patients with a mild head injury, an association was identified between 
motivation and high scores on measures of executive function and working memory 
(Binder et al., 2003).  Lindem (2000) also found that poor test motivation was 
correlated with diminished performance on tasks of attention, executive function, and 
memory in 240 Gulf War veterans.  In contrast, the current findings were consistent 
with other research.  For instance, in a study involving 30 depressed patients and 
matched healthy controls, no relationship was identified between induced motivation 
and performance on tests of attention and working memory tasks (Richards & Ruff, 
1989).  Similarly, another group found no differences between motivated and 
unmotivated participants with a mild brain injury on a range of measures designed to 
assess executive function and working memory (Orey, Cragar, & Berry, 2000). 
A recent study in people suffering from severe burnout may provide a clue to 
understanding why motivation failed to predict cognitive performance in the young 
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CFS patients.  At baseline, participants with burnout performed more poorly than 
controls on a challenging attention task.  However, after motivation was induced 
through positive performance feedback and financial incentives for good results, 
improvements in performance were only observed in the control group (Dam, 2011).  
This suggests that although increased motivation may enhance cognitive 
performance among healthy individuals, people suffering from fatigue and effort 
intolerance, such as CFS patients, may be impervious to motivational interventions. 
In contrast to the current study, previous research in healthy populations 
suggests that adaptive perfectionism is associated with improved neuropsychological 
function and maladaptive perfectionism is associated with poor neuropsychological 
function (Slade et al., 2009; Stoeber et al., 2010; Stoeber & Kersting, 2007).  
However, only two studies known to the author included measures of the cognitive 
domains assessed in the current study.  In one of these, a positive correlation was 
identified between personal standards and attention using the Stroop test (Kobori & 
Tanno, 2005).  In the second study, researchers found that adaptive perfectionism 
was positively correlated with attention and negatively correlated with executive 
function, and maladaptive perfectionism was negatively correlated with attention and 
executive function.  No relationship was identified between either type of 
perfectionism and working memory (Slade et al., 2009).  Findings from the small 
collection of previous studies do not provide compelling evidence that perfectionism 
predicts performance on tasks of executive function, working memory, and attention.  
Therefore, the present study may accurately reflect the relationship between these 
cognitive domains and perfectionism in young CFS patients.  However, much more 
research is required before this conclusion can be confirmed. 
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Alternatively, methodological issues may have accounted for the 
nonsignificant findings for both motivation and adaptive perfectionism.  A regression 
analysis assumes that important unmeasured IVs are not correlated with the 
measured IVs.  If there is a significant negative correlation between a measured and 
unmeasured IV, the coefficient will be underestimated.  In the current study, 
motivation or perfectionism may have been negatively correlated with unmeasured 
variables, such as parental expectations or patient resilience, causing the correlation 
between the predictors and cognitive performance to become small or nonsignificant.  
In addition, statistical power was limited due to the small size of the sample.  
Tabanick and Fidell (2001) recommend that, assuming a medium sized relationship 
between the IVs and the DV (β = .20 and α = .05), the number of cases should be at 
least 104 plus the number of IVs in the analysis.  In the current study, this equation 
equals 106, substantially more than the actual CFS sample size of 23.  As such, 
power may have been insufficient for detecting a significant result. 
In view of the inconsistent findings among the previous research and the 
possible alternative explanations for the nonsignificant findings in the current study, 
firm conclusions cannot be made.  Although the results suggest that motivation and 
perfectionism are not predictors of neuropsychological performance in young CFS 
patients, further research is required before conclusions can be drawn. 
 
Academic achievement.  Contrary to the hypothesis, self-reported motivation 
and adaptive perfectionism did not predict performance on the academic 
assessments.  Similarly, maladaptive perfectionism was not a significant predictor of 
reading or mathematic ability. 
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In contrast, several previous studies in healthy schoolchildren suggest that 
there is a positive relationship between motivation and academic performance 
(Fortier et al., 1995; Howse et al., 2003; Logan et al., 2010; Preckel et al., 2006; 
Schultz, 1993; Tavani & Losh, 2003; Verkuyten et al., 2001).  Researchers have also 
identified significant positive correlations between test motivation and academic 
performance in young adults studying at tertiary institutions (Goodman et al., 2011; 
Hirschfeld et al., 2004; Hoyt, 2001; Smith & Smith, 2002; Sundre & Kitsantas, 2004; 
Wise et al., 2006; Wolf & Smith, 1995).  The measures of motivation and academic 
performance used in these studies were similar to those in the present study.   
Findings from the current study are also inconsistent with earlier research 
investigating the relationship between perfectionism and academic performance.  
Several researchers have identified positive correlations between adaptive 
perfectionism and GPA (Accordino et al., 2000; Nounopoulos et al., 2006).  Higher 
academic scores have also been observed in tertiary students with high perfectionistic 
strivings and low perfectionistic concerns, compared to those who report the opposite 
pattern or no perfectionism (Bieling et al., 2003; Brown et al., 1999; Cox et al., 2002; 
Enns et al., 2001; Grzegorek et al., 2004; Rice & Slaney, 2002).  Equally, in a sample 
of 166 students from grades six to eight, a negative correlation was identified 
between APS-R Discrepancy and GPA (Nounopoulos et al., 2006).  A number of 
studies also suggest that academic performance and socially prescribed perfectionism 
are negatively correlated (Dykstra, 2007; Flett et al., 2009; Witcher et al., 2007).  
However, other researchers have found no relationship between maladaptive 
perfectionism and academic performance in samples of tertiary (Brown et al., 1999) 
and secondary students (Accordino et al., 2000). 
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Although much of the previous research conflicts with the current study, the 
relationship between perfectionism and academic performance has not yet been 
investigated in young CFS patients.  Therefore, this study may be accurate in 
suggesting that perfectionism is unrelated to academic performance in young people 
with CFS.  Perhaps the cognitive impact of other illness characteristics masks the 
effect of perfectionism.  It is also worth noting that almost every preceding study 
supporting the relationship between maladaptive perfectionism and academic 
performance refers to socially prescribed perfectionism, a fundamentally different 
construct to the measure in the current study that assesses the perceived discrepancy 
between personal standards and performance. 
It is possible that methodological issues accounted for the nonsignificant 
findings for both motivation and perfectionism.  As noted in the neuropsychological 
section, there may have been a negative relationship between the measured and 
unmeasured IVs, causing the regression coefficient to become small or 
nonsignificant.  Further, statistical power may have been insufficient due to the 
limited sample size.  Alternatively, the nonsignificant findings could be explained by 
homogenous scores on the motivational or perfectionistic scales.  Specifically, if the 
CFS patients all scored similarly on these measures, motivation and perfectionism 
could not be used to make predictions about other variables.  However, the raw data 
and standard deviations are indicative of considerable heterogeneity between the 
participants, suggesting that motivation and perfectionism were distinguishable 
variables within the sample. 
In summary, the previous research investigating the relationship between 
motivation and academic performance almost unanimously conflicts with this study, 
and the results among the paucity of prior research in perfectionism are largely 
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inconsistent.  As such, it is difficult to form any conclusions.  Although the results 
suggest that there is no relationship between academic ability and motivation or 
perfectionism in young CFS patients, further research is required to verify these 
findings. 
 
Hypothesis 5: between-group differences in cognitive function when 
motivation and perfectionism are accounted for.  It was predicted that after 
controlling for the variance from motivation and adaptive perfectionism, the 
differences between CFS patients and controls on neuropsychological and academic 
tests would become larger.  Conversely, it was predicted that when the variance from 
maladaptive perfectionism is accounted for, the differences between CFS patients 
and controls on neuropsychological and academic tests would become smaller.  
These hypotheses were developed in accordance with previous research and 
theoretically derived suppositions suggesting that high levels of motivation and 
perfectionism are common in CFS patients and that these factors affect performance 
on cognitive tasks.   
However, many findings were inconsistent with these original assumptions.  
In contrast to expectations, no significant differences were observed between groups 
on either measure of perfectionism.  Further, motivation and perfectionism did not 
predict neuropsychological or academic test performance.  In consideration of these 
findings, it was considered unnecessary to assess group differences in cognitive 
performance while accounting for motivation and perfectionism. 
 
Hypothesis 6: neuropsychological function in adults and young people 
with CFS.  It was predicted that adults and young people with CFS would perform 
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similarly on neuropsychological measures of executive function, attention, and 
working memory.  Contrary to the hypothesis, the young CFS patients achieved 
higher scores than the adult group on tests of executive function, including IED Total 
Errors and SOC Problems Solved in Minimum Moves.  However, as expected, no 
between group differences were detected for IED Stages Completed, SWM Strategy, 
and measures of attention and working memory.  This suggests that compared to the 
adult patients, the young people with CFS had superior skills in cognitive flexibility 
and problem solving but were similarly impaired on measures of sustained attention 
and visual working memory. 
Among the published literature, there appears to be no research involving a 
comparison of neuropsychological performance between adults and young people 
with CFS.  As such, the present results need to be replicated before conclusions can 
be made.  These findings could be attributable to a range of extraneous participant 
and researcher variables that are specific to this study.  Nonetheless, the results raise 
some interesting questions regarding how CFS might uniquely affect young patients.  
The superior performance of the younger group on tasks of executive function is 
inconsistent with findings in the general population.  Researchers have established 
that attentional flexibility and problem solving ability continues to develop 
throughout adolescence and early adulthood (Asato, Terwilliger, Woo, & Luna, 
2010; Huizinga, Burack, & Molen, (2010; Konrad et al., 2005; Kuhn, & Pease, 
2006).  Furthermore, healthy adults generally perform better than adolescents on 
measures of executive skill (Ikeda, Okuzumi, Kokubun, & Haishi, 2011; Mäntylä, 
Carelli, & Forman, 2007; Manzi, Nessler, Czernochowski, & Friedman, 2011; 
Wendelken, Munakata, Baym, Souza, & Bunge, 2012). 
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The incongruity between these findings and those of the present study could 
reflect true differences between CFS patients and the general population.  It is 
possible that young CFS patients are less vulnerable to cognitive decline than adults 
with CFS.  This is supported by a recent study involving a group of healthy 
participants and children and adolescents/adults with high-functioning autism (HFA).  
Although executive function improved with age in the healthy group, no differences 
were observed between the child and adult HFA groups (Kuschner, Bodner, & 
Minshew, 2009).  Similarly, another group found that performance on measures of 
executive control and cognitive flexibility improved with age in healthy participants 
but not in participants with Attention Deficit Hyperactivity Disorder (Gualtieri & 
Johnson, 2006).  Furthermore, cerebral plasticity is more pronounced during 
maturation than in the adult brain (Kolb, 1995), and young people are better at 
adapting to neurological damage than adults (Müller, Rothermel, Behen, & 
Chugani).  Combined with the previous research, this study raises the possibility that 
compared to adults, young CFS patients are more resilient to cognitive decline.  
However, further research is required to determine whether CFS affects cognitive 
function differently in adult and paediatric patients. 
 
Hypothesis 7: between-group differences in symptoms common to CFS. 
Sleep disturbance.  In support of the hypothesis, the CFS group reported 
significantly higher rates of sleep disturbance than the controls.  The average global 
PSQI score was 8.91 for the CFS group and 4.71 for the controls.  This suggests that 
the CFS patients were suffering from a moderate level of sleep disturbance.  
Similarly, previous studies in adults with CFS indicate that global PSQI scores 
typically range from 7.1 to 10.17 (Mariman et al., 2011; Neu et al., 2007; Roberts et 
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al., 2009) and these scores are approximately double those of nonfatigued peers 
(Kerr et al., 2008; Roberts et al., 2004). 
A greater depth of understanding can be derived through examination of the 
individual indices on the PSQI.  Compared to controls, the CFS participants scored 
significantly higher on four of the seven outcome measures for sleep disturbance.  
Firstly, CFS patients reported poorer sleep efficiency.  Even though the CFS group 
spend longer periods in bed than controls, a smaller proportion of that time is spent 
asleep.  Secondly, the CFS group scored higher on the Sleep Disturbance index.  
High scores on this measure are indicative of symptoms associated with a 
diagnosable sleep disorder, such as breathing problems, disturbed dreams, pain, and 
physical discomfort.  Thirdly, the CFS group used sleeping medication more often 
than controls.  Almost half of the CFS patients stated that they regularly use 
pharmacological treatments to manage sleep compared to none of the healthy 
participants.  It is worth noting that sleeping medication may have affected the scores 
on the other PSQI components.  In particular, sleeping medication may reduce the 
severity of symptoms associated with Habitual Sleep Efficiency, Sleep Latency, and 
Sleep Duration.  Finally, the CFS patients reported greater dysfunction during the 
day than the controls.  High scores on this measure suggest that daytime activity is 
impeded by sleepiness and poor enthusiasm for getting things done. 
Even though the CFS patients scored higher on the Sleep Efficiency and 
Sleep Disturbance indices, ratings on the Sleep Quality index were similar between 
groups.  Furthermore, self-ratings on the Sleep Latency index were comparable 
between groups.  This suggests that even though the CFS patients were awake for a 
larger proportion of their time in bed (as indicated by the Habitual Sleep Efficiency 
index), they did not take longer to get to sleep than controls.  Finally, scores on the 
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Sleep Duration index indicated that the perceived length of time spent asleep was 
comparable between groups.  Given that the CFS patients reported that they spend 
significantly more time in bed than controls, this suggests that the CFS group are 
awake for much of their time spent in bed after initially going to sleep.  It is not 
known whether they are attempting to sleep throughout this time or are just aiming to 
rest. 
Many of these findings are consistent with previous research.  For instance, 
poor sleep efficiency among CFS patients has been observed in several adult studies 
(Morriss et al., 1993; Sharpley et al., 1997; Whelton, Salit, & Moldofsky, 1992), as 
well as one study in adolescents (Stores et al., 1998).  Similarly high rates of 
perceived sleep disturbance have also been identified in adult CFS patients (Krupp et 
al., 2003; Unger et al., 2004).  In contrast, use of sleeping medication was more 
common among the patients in this study compared those in previous research, where 
the incidence of medication use is closer to 20% (Boneva, Lin, Maloney, Jones, & 
Reeve, 2009; Jones, Nisenbaum, & Reeves, 2003).  However, the PSQI does not 
specify medication type, and similarly high rates of medication use have been 
observed among adult CFS patients when nontraditional sleeping medications are 
included in the assessment (Vercoulen, Swanink, Fennis, & Galama, 1996).  Like the 
patients in this study, adults with CFS also report high rates of daytime sleepiness 
and dysfunction (Creti et al., 2010; Neu et al., 2008; Sharpley et al., 1997).  Finally, 
Sharpley et al. (1997) found that adult CFS patients and healthy controls reported 
comparable sleep durations. 
Contrasting this study, other researchers have found that CFS patients have 
an extended sleep latency onset (Creti et al., 2010; Fischler et al., 1997; Unger et al., 
2004; Whelton et al., 1992) and believe that the quality of their sleep is poor (Neu et 
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al., 2007; Sharpley et al., 1997).  These inconsistencies could be a consequence of 
differences in question construction.  For example, in contrast to the other PSQI 
indices and questionnaires used in similar studies, the Sleep Quality index is derived 
from a single question.  This highly subjective approach may fail to capture the range 
of sleep difficulties experienced by young CFS patients.  Alternatively, considering 
that changes in sleep patterns and behaviours are characteristic of adolescent 
development, the healthy participants may have also felt that they suffer from 
disturbances in sleep quality and latency.  In support of this, the descriptive statistics 
indicate that both groups scored highly on these measures.  Although it is also 
possible that young CFS patients do not experience problems with sleep quality or 
latency, further research is required to explore the alternative explanations and 
clarify the inconsistencies between this study and earlier research.  
Together with the findings from previous research, these results suggest that 
young CFS patients have lower sleep efficiency, sleep disturbance, use of sleeping 
medication, and daytime dysfunction.  These factors could contribute to and indeed 
exacerbate the debilitating symptoms associated with CFS, such as cognitive 
impairment, fatigue, lowered mood, postexertional malaise, and school absenteeism.  
However, these results suggest that like adults, young CFS patients do not sleep for 
longer periods than nonfatigued peers.  This supports the conceptualisation of CFS as 
a disorder of excessive fatigue rather than sleepiness.   
 
Psychological distress.  Consistent with the hypothesis, the young CFS 
patients reported significantly higher levels of depression, anxiety, and stress than the 
controls.  Group differences in psychological adjustment were also evaluated relative 
to clinical standards.  According to severity criteria for the DASS (Lovibond & 
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Lovibond, 1995), the CFS patients predominantly scored in the normal or mild range 
for depression, anxiety, and stress.  A further 40% fell in the moderate to extreme 
range for depression and anxiety, and about one-third reported moderate to severe 
stress.  In contrast, 82-87% of the healthy controls scored in the normal range for 
each psychological component, and no more than 8.7% were in the severe to extreme 
range.  According to clinical criteria for the IDS-SR (Rush et al., 1996), 
approximately 60% of all CFS patients scored in the moderate to severe range for 
depressive symptoms compared to just 13% of controls.  However, the scores on the 
IDS-SR could be inflated in the CFS group due to the higher proportion of questions 
pertaining to sleep disturbance on this measure.  The between-group differences in 
the proportion of participants meeting the criteria for the clinical severity categories 
were significant for all measures other than Stress.  Elevated levels of depression and 
anxiety have been consistently observed in both adult (Wessely et al., 1998; Wilson 
et al., 2001) and paediatric CFS populations (Carter et al., 1995; Garralda & Rangel, 
2004; Rangel et al., 2003; Smith et al., 2003; van Geelen et al., 2010), and CFS has 
been linked with an impaired stress response (Demitrack et al., 1991; Hatcher & 
House, 2003). 
Together with the findings from previous studies, these results suggest that 
young CFS patients experience elevated levels of depression, anxiety, and stress.  
This finding has considerable implications for young people with CFS.  Further to 
the suffering experienced as a direct consequence of psychological distress, research 
suggests that psychological disturbances can cause psychosocial impairment and 
behavioural problems (McCauley, Katon, Russo, Richardson, & Lozano, 2007; 
Rossen, 1997).  Moreover, poor psychological adjustment has been linked to 
impaired academic and neuropsychological performance (Castaneda et al., 2008; 
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Dickson et al., 2009; Lupien et al., 1994; Metzger & Denney, 2002; Rossen, 1997; 
Wearden & Appleby, 1997).  As such, psychological distress may serve to 
exacerbate functional impairment and amplify any existing cognitive disturbances in 
young CFS patients. 
 
Fatigue.  As expected, the CFS patients reported greater levels of fatigue 
than controls.  Following the testing procedure, the CFS patients reported greater 
levels of physical and mental fatigue on the Chalder Fatigue Scale than the controls.  
The mean physical fatigue score was 12.61 for the CFS group and 9.39 for the 
controls, and mental fatigue was 9.26 and 6.57 for the CFS and control groups 
respectively.  These scores are comparable to those found in adult patients (Kerr et 
al., 2008; Roberts et al., 2004) and suggest that young CFS patients have a larger 
increase in fatigue following cognitive activity than nonfatigued peers.  This finding 
is supported by the VAS, which was administered several times throughout the 
testing procedure in order to monitor subjective changes in fatigue.  Compared to 
controls, the CFS patients reported higher levels of fatigue throughout the 
assessment, and although both groups became more fatigued over time, the 
magnitude of the change was significantly larger in the CFS group.  This suggests 
that compared to controls, the CFS patients became more fatigued in response to 
mental effort.  The current author is not aware of any studies in CFS patients that 
included an assessment for monitoring changes in fatigue levels throughout mental 
activity. 
These results suggest that young CFS patients become progressively more 
fatigued in response to mental effort.  This has considerable implications for young 
patients.  Since fatigue is associated with impaired cognitive performance (Capuron 
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et al., 2006; Cook et al., 2007; Kawatani et al., 2011; Majer et al., 2008), young CFS 
patients may become increasingly impaired throughout the completion of mental 
activity.  Therefore, acute fatigue could exacerbate the existing cognitive deficits in 
young CFS patients, causing further disruptions to education and learning.  Further, 
fatigue may amplify other problems associated with CFS, such as low mood, social 
withdrawal, and school absenteeism. 
 
Considerations for Hypothesis 7.  In summary, the results suggest that young 
CFS patients experience high levels sleep disturbance, psychological distress, and 
fatigue.  These factors could contribute to, and indeed exacerbate the debilitating 
symptoms associated with CFS, such as postexertional malaise, poor health-related 
quality of life, and psychosocial impairment.  This may serve to worsen functional 
impairment, particularly in terms of cognitive and educational development.  
However, these conclusions should be considered with caution.  The data were 
collected using self-report measures, which are subject to common limitations such 
as response style, social desirability bias, poor self-awareness, and dishonesty.  
Further, given that the CFS participants were recruited from a tertiary clinic, there is 
a possibility that the sample represented a subgroup of patients with more severe 
symptoms than the wider CFS population. 
  
Hypothesis 8: predictive value of symptoms common to CFS.  A series of 
regressions were employed to assess how well sleep disturbance, psychological 
distress, and fatigue predicted perceived cognitive disturbance, neuropsychological 
function, and academic achievement.  For each analysis, three IVs were entered to 
represent each symptom domain.  Global PSQI, IDS total, and VAS Time 5 were 
196 
 
selected to represent sleep disturbance, psychological distress, and fatigue 
respectively.  These variables were selected as they demonstrated the most 
significant group differences of all measures for each symptom domain.  Contrary to 
the hypothesis, CFS patients with greater sleep disturbance, psychological distress, 
and fatigue were not more likely to report cognitive impairment or receive lower 
scores on measures of neuropsychological function or academic achievement. 
These results are inconsistent with much of the previous literature.  Sleep 
disturbance is present in almost all CFS patients (Becker et al., 2001; Fukuda et al., 
1994; Sharpley et al., 1997; Unger et al., 2004), and a relationship has been identified 
between neuropsychological performance and sleep disturbance in adult CFS patients 
(Smith et al., 1996) and healthy paediatric populations (Dahl, 1996; Randazzo et al., 
1998; Sadeh et al., 2002; Steenari et al., 2003).  Moreover, one group found that, 
following treatment for sleep disorders, 90% of 59 cognitively impaired CFS patients 
reported improvements in cognitive functioning (Buchwald et al., 1994).  Smith et al. 
(1996) also found that although CFS patients with disturbed sleep achieved lower 
scores than healthy controls on assessments of attention and memory, no differences 
were observed between the controls and CFS patients without sleep disturbances.  
Attention and working memory are also commonly impaired in healthy people who 
endure experimentally disturbed sleep (Harrison et al., 2007; Sadeh et al., 2003; 
Wright et al., 2006).  In contrast, Randazzo et al. (1998) found that performance on 
memory tasks was not affected by experimentally restricted sleep in a sample of 
healthy children. 
Sleep disturbance also appears to be associated with impaired academic 
performance.  In a study involving 3,120 healthy students, Wolfson and Carskadon 
(1998) found that those who achieved a C grade or below received less sleep and 
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went to bed later than those who received higher grades.  In another large sample of 
972 primary school students, 21% of those considered to be poor sleepers had failed 
at least one year of school, and academic performance difficulties were significantly 
more common among the students with disturbed sleep (Kahn et al., 1989). 
Psychological distress is also particularly common in young CFS patients 
(Garralda and Rangel; 2004; Gray et al., 2001; van Geelen et al., 2010), and 
researchers have found that when the effects of depression are partialled out, 
differences between CFS patients and controls on measures of memory, executive 
function, and attention become nonsignificant (Dickson et al., 2009; Krupp et al., 
1994; Metzger & Denney, 2002).  Moreover, one group found that depressed CFS 
patients perceived themselves to be more impaired than healthy controls on a range 
of cognitive tasks, while nondepressed CFS patients and healthy controls reported 
comparable levels of impairment.  The depressed CFS group also achieved lower 
scores on verbal memory tasks than CFS patients without depression (Wearden & 
Appleby, 1997).  However, consistent with the current research, a number of other 
studies suggest that psychological distress and cognitive function are unrelated 
(Claypoole et al., 2007; Dobbs et al., 2001; Joyce et al., 1996; Mahurin et al., 2004; 
Michiels et al., 1996; Michiels et al., 1999; Short et al., 2002; Vercoulen et al., 
1998).  One group also found that depressive symptoms were not related to deficits 
in reaction time on a measure of alternative attention in a group of children and 
adolescents with CFS (Kawatani et al., 2011).  
There is also evidence of an association between psychological adjustment 
and academic performance.  Researchers have identified a relationship between GPA 
and depression in tertiary (Deroma, 2009) and secondary students (Yousefi et al., 
2009).  One group also found that depressed students with epilepsy achieved lower 
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teacher rated scores than students with epilepsy alone, and significant improvements 
in scores were reported following treatment for depression (Tosun et al., 2008).  In 
contrast, Buddington (2002) found that GPA was negatively correlated with stress, 
but not self-esteem or depression, and others have found that academic outcomes are 
unrelated to indicators of psychological adjustment (Abell et al., 2007; Vaidya & 
Mulgaonkar, 2007; Yeh et al., 2007). 
The relationship between fatigue and cognitive impairment in CFS patients is 
not well established.  Several studies suggest that fatigue is unrelated to performance 
on neuropsychological tests, including tests of executive function, attention, and 
working memory (Mahurin et al., 2004; Michiels et al., 1998; Short et al., 2002; 
Vercoulen et al., 1998).  Even when a relationship has been observed, only a small 
number of cognitive functions appear to be affected.  For instance, one group found a 
negative correlation between fatigue and spatial working memory but not other 
measures of working memory and executive function (Joyce et al., 1996).  Similarly, 
Michiels et al. (1999) identified an association between fatigue and poor 
performance on tasks of attention but not memory in a group of 29 CFS patients.  
Capuron et al. (2006) also found that compared to healthy controls and CFS patients 
without significant mental fatigue, mentally fatigued CFS patients performed less 
well on CANTAB tests of working memory, visual memory, and attention, but not 
executive function and other visual memory tasks.  In a sample of children and 
adolescents, one group identified a negative correlation between mental fatigue and 
reaction time on a test of alternative attention but not selective attention or spatial 
working memory (Kawatani et al., 2011). 
In the context of the inconsistencies among the previous research, it is 
difficult to interpret the nonsignificant findings in the present study.  It is possible 
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that the data accurately reflect an absence of a relationship between symptoms 
associated with CFS and perceived cognitive disturbance, academic achievement, 
and neuropsychological function.  As discussed, this conclusion is supported by 
some of the previous literature.  Alternatively, methodological issues might account 
for some of the unexpected findings.  As mentioned in the discussion of Hypothesis 
4, there may have been a negative relationship between measured and unmeasured 
IVs, causing the regression coefficient to become small or nonsignificant.  Further, 
the limited sample size and variability of scores may not have produced sufficient 
statistical power for detecting a significant result.  Given that most participants in the 
CFS group had considerable sleep disturbance, psychological distress, and acute 
fatigue, the variability of scores on these measures would have been low, and as 
such, a large sample size would be necessary to achieve sufficient statistical power. 
It is also important to note that the CFS patients actually scored higher than 
the controls on the academic assessments.  If the CFS group were not more likely to 
perform worse on the academic tasks, it follows that symptoms associated with CFS 
would not predict academic performance.  Therefore, the possible explanations for 
the atypical findings discussed for Hypothesis 2 may also explain why academic 
performance was unrelated to CFS symptoms.  Specifically, the results could reflect 
a true absence of academic impairment that had not been captured by previous 
research due to data collection methods.  Alternatively, the nonsignificant findings 
could be caused by differences between laboratory and environmental settings, 
motivational patterns, or the nature of the patients’ treatment intervention that 
focused on minimising the impact of CFS on academic achievement. 
In summary, the present study suggests that sleep disturbance, psychological 
distress, and fatigue do not predict perceived cognitive impairment, 
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neuropsychological function, or academic achievement in young CFS patients.  In 
consideration of the collective results from previous research, these findings were not 
entirely unexpected.  Although several studies suggest that these symptoms are 
associated with impaired cognitive performance, a number of other studies indicate 
that they are unrelated.  These inconsistencies make it difficult to form firm 
conclusions, and further research is required to clarify the contrast between this study 
and findings from earlier research.  If certain symptoms predict cognitive 
performance, it may be possible to improve cognitive function by ameliorating the 
symptoms directly.  In the absence of curative treatments for CFS, this may be an 
effective method of reducing illness burden in young patients. 
 
Hypothesis 9: between-group differences in school absenteeism.  As 
predicted, the school-aged CFS patients reported significantly higher rates of school 
absenteeism than the healthy controls.  Over a period of six months, the CFS group 
missed 35.65% of school, while the controls missed 4.81%.  Only one healthy 
control missed more than 20% of school compared to 14 (82.35%) of the CFS 
patients.  These results are consistent with previous research.  For instance, van 
Geelen et al. (2010) found that a group of 41 CFS patients missed 33% of classes 
over one month.  In a larger sample of 211 young CFS patients, 11% attended school 
full-time, 49% attended 20% or less, 62% attended 40% or less, and 28% did not 
attend school at all (Crawley & Sterne, 2009).  Similarly, Garralda & Rangel (2004) 
found that 39% of 28 CFS patients missed between 15-50% of school.   
Together with the previous research, these results suggest that young CFS 
patients often miss a considerable amount of school.  This may lead to substantial 
academic and psychosocial disturbances as well as secondary problems in 
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psychological adjustment and identity formation.  The impact of CFS may thus be 
significantly reduced if patients are provided with appropriate support and resources 
to promote maximum school attendance. 
 
Hypothesis 10: school absenteeism and academic achievement.  Contrary 
to the hypothesis, no relationship was identified between school absenteeism and 
academic performance on measures of reading and arithmetic.  This is inconsistent 
with findings from research in clinical populations.  Several studies suggest that 
increased school absenteeism is associated with poor academic performance in a 
range of areas (Belachew et al., 2011; Breuner et al., 2004; Krenitsky-Korn, 2011; 
Krenitsky, 2007). 
There are a few possible explanations for the inconsistent findings.  As 
discussed for Hypothesis 2, most CFS participants were treated in a clinic that had a 
particular focus on minimising the impact of CFS on academic achievement.  This 
approach may have protected patients in this study from the typical academic 
consequences of school absenteeism.  Alternatively, the current study differs from 
previous research in that achievement was assessed directly rather than obtaining 
data from school grades.  It is likely that absence from school would have a more 
profound effect on grades associated with the specific content learned during a 
school term than on general mathematic or reading ability.  Further research with a 
diverse sample of CFS patients and a range of assessment methods is required to 
clarify the inconsistencies between these findings and those from previous research. 
 
Limitations and directions for further research.  There are several study 
limitations that should be considered carefully when interpreting the findings.  First, 
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a nonprobability sampling method was adopted for both samples.  The CFS patients 
were recruited from a single suburban childrens’ hospital in Australia, and most 
patients had been treated by the same paediatrician.  This sampling method was 
selected to avoid one of the largest issues in conducting research with young CFS 
patients, diagnostic accuracy.  The necessity of using medical practitioners to 
perform diagnostic tests, along with the recent subclassification of CFS for paediatric 
patients, has meant that previous studies were often restricted to a sample of 
participants with CFS-like symptoms or young people diagnosed according to adult 
criteria.  The recruitment method in the current study was selected to circumvent this 
issue.   
However, a potential consequence of using a limited sampling pool is that 
the participants may not accurately represent the diverse population of young CFS 
patients.  Patients receiving treatment at suburban tertiary settings may be different 
from those treated in the community and those living in regional locations.  
Therefore, these findings may be less applicable to other patient groups, such as 
those with less severe symptoms or those from dissimilar cultural or socioeconomic 
backgrounds.  Moreover, the CFS participants were generally receiving treatment 
with a particular focus on minimising the impact of CFS on education, which may 
have protected participants from academic decline.  In future studies, these issues 
could be addressed by including patient samples from a range of treatment and 
nontreatment settings. 
Similarly, an availability sampling method was employed to recruit the 
nonfatigued participants.  Candidates were invited to participate via general 
advertising and direct contact with the research team.  This method of data collection 
was chosen due to the lack of available volunteers.  Although efforts were made to 
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select participants from a range of socioeconomic and cultural backgrounds, this 
approach may have caused some degree of self-selection or character biases that 
could have influenced performance and motivation.  A major consequence of using 
nonprobability methods is that the probability of obtaining a representative sample is 
unknown, and caution is warranted when making inferences about the results to the 
entire young CFS population. 
Due to limitations in time, funding, and participant availability, the study 
was cross-sectional in design.  As such, the results reflect the performance and 
responses of participants at a single time-point.  However, most CFS patients 
described their illness as fluctuating or characterised by periods of remission and 
relapse, and illness severity is known to vary according to circumstances and 
activity.  Several CFS patients elected to participate during the school holidays in 
order to avoid significant interference with school, and it is likely that many others 
chose to participate when their symptoms were less severe or when they were less 
affected by other activity.  Under these circumstances, the participants’ capacity to 
perform cognitive tasks may have been uncharacteristically high at the time of the 
study.  Therefore, the data may depict the lower range of symptom severity and 
cognitive impairment for this particular patient group, reducing the probability of 
identifying between-group differences.  This issue could be addressed in future 
research by restricting assessment periods or repeating assessments at different times 
to ensure that participants are tested over a range of symptom fluctuation levels. 
The correlational design of the study does not allow causal relationships to 
be established among variables.  For instance, lower neuropsychological 
performance scores in the CFS group does not confirm that CFS causes performance 
deficits.  Alternative factors such as medication use or comorbid illnesses could also 
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account for such results.  However, although the precise nature of the relationships 
between variables cannot be identified, causal relationships can be assumed to some 
degree using the sound theoretically derived conceptualisations of interactions 
among variables. 
Self-report questionnaires were employed to assess CFS symptoms, fatigue, 
sleep disturbance, psychological distress, perfectionism, and motivation.  
Questionnaires were selected in favour of objective assessments due to the already 
arduous and time-consuming nature of the cognitive tests included in the study.  
However, self-report measures are subject to common limitations, such as variable 
response styles, social desirability biases, poor self-awareness, and dishonesty.  Self-
report measures may also be influenced by the participants’ emotional state and 
energy at the time of survey completion.  Although there is no reason to assume that 
the participants in this study were especially susceptible to any one type of bias, the 
limits of data collected using subjective methods must be acknowledged and taken 
into consideration when interpreting the results.  Wherever possible, studies in the 
future should include objective assessments of CFS symptom severity, fatigue, sleep 
disturbance, psychological disturbance, perfectionism, and motivation.   
A number of the unexpected findings could be explained by limitations that 
potentially reduced the probability of detecting significant results.  For instance, 
despite immense recruitment efforts, the final sample size was relatively small, and 
there was considerable within group variability on several outcome measures.  These 
factors limit statistical power, reducing the probability of detecting significant 
effects.  However, group differences were detected on several measures, and 
significant results have been reported in similar research with comparable sample 
sizes and standard deviations.  Therefore, it seems unlikely that the nonsignificant 
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findings were caused exclusively by sample size and score variability.  Nonetheless, 
future studies would benefit from including larger samples. 
Some of the unexpected findings could be attributable to the setting in 
which the research was conducted.  In accordance with certain test specifications, the 
assessments were performed within a laboratory.  However, the nature of this setting 
may have caused participants to perform differently to how they normally function in 
naturalistic environments.  In real world settings, cognitive performance may be 
vulnerable to the effects of distraction, divided attention, fatigue, and sleepiness.  
This may have been a particular problem for the patients in the current study given 
their high rates of fatigue, sleep disturbance, and attention difficulties.  Everyday 
settings are also often monotonous and involve learning and recalling information 
over periods of days or weeks.  In contrast, participants in the current study were 
required to complete tests of isolated cognitive functions using simple-to-follow 
tasks in a quiet laboratory environment.  The assessment setting was also a novel, 
time-limited environment that required short periods of cognitive activity and focus.  
Further, the CFS patients may have been more motivated to perform well in the study 
compared to at school.  As a consequence of these factors, the participants may have 
adopted an approach to performing cognitive tasks that differs from their usual 
methods, and they may have applied ongoing effort despite factors that inhibit their 
efforts under usual circumstances, such as fatigue and postexertional malaise.  
Therefore, the study may not have detected impairments that would normally be 
apparent in everyday settings.  In order to control for these factors, future studies 
should be designed to assess functions that are similar to the demands of everyday 
cognitive tasks, and these assessments should be conducted in an environment that 
closely replicates naturalistic settings. 
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This study provides a potential opportunity for further research aimed at 
determining methods for reducing the impact of CFS in young people.  Impaired 
cognitive flexibility, attention, and working memory could affect performance at 
school and limit opportunities for further education and career attainment, leading to 
associated problems with motivation, identity, and self-esteem.  Further research 
could be designed to assess the effectiveness of interventions developed to treat or 
compensate for these cognitive deficits.  Interventions such as these could 
significantly reduce the functional impact of CFS in young people. 
 
Conclusion.  This study provides an important contribution to the limited 
research in paediatric CFS.  It presents a detailed description of the symptoms and 
impact of CFS diagnosed according to the paediatric definition and provides insight 
into the nature of how CFS affects neuropsychological and academic performance in 
young people.  Previous research in CFS is limited and inconsistent due to the 
ongoing conceptual developments and epidemiological variability, particularly in 
young patients.  Given that the cause of CFS remains unknown, treatments are often 
focused on minimising the impact of CFS by addressing the most debilitating 
symptoms.  In young CFS patients, cognitive impairment is a common symptom that 
can cause devastating consequences in several functional and developmental 
domains.  Therefore, research in this area is critical for developing appropriate 
treatments and reducing the impact of CFS in young populations. 
The findings suggest that young people with CFS perceive themselves as 
cognitively impaired and have deficits in executive function, attention, and working 
memory.  However, the CFS patients did not demonstrate impairment on academic 
tests, and academic performance was unrelated to the high rates of school 
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absenteeism.  The CFS patients reported higher levels of motivation than controls, 
however both groups scored similarly on a measure of perfectionism, and motivation 
and perfectionism did not predict neuropsychological or academic test performance.  
Compared to adults with CFS, the young participants scored higher on a test of 
executive function, but were similarly impaired on measures of attention and 
working memory.  The young CFS patients reported higher rates of sleep 
disturbance, psychological distress, and fatigue than controls, although these 
symptoms did not predict cognitive performance.  Further research with a large, 
diverse sample of young CFS patients within a range of environments is required to 
verify these findings and clarify some of the inconsistencies between this study and 
previous research.  Combined with the existing research, this study provides 
opportunities for developing new, focused interventions and might form a 
contribution to future research in young CFS patients.                                                                      
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Appendix A                                                                              
Definition of ME/CFS for Children (Jason et al., 2008) 
 
I. Clinically evaluated, unexplained, persistent or relapsing chronic fatigue over the 
past 3 months that: 
A. Is not the result of ongoing exertion 
B. Is not substantially alleviated by rest 
C. Results in substantial reduction in previous levels of educational, social and 
personal activities 
D. Must persist or reoccur for at least three months 
II. The concurrent occurrence of the following classic ME/CFS symptoms, which 
must have persisted or recurred during the past three months of illness (symptoms 
may predate the reported onset of fatigue). 
A. Post-exertional malaise and/or post-exertional fatigue.  
With activity (it need not be strenuous and may include walking up a flight 
of stairs, using a computer, or reading a book), there must be a loss of 
physical or mental stamina, rapid/sudden muscle or cognitive fatigability, 
post-exertional malaise and/or fatigue and a tendency for other associated 
symptoms within the patient’s cluster of symptoms to worsen. The 
recovery is slow, often taking 24 hours or longer. 
 
B. Unrefreshing sleep or disturbance of sleep quantity or rhythm disturbance.  
May include prolonged sleep (including frequent naps), disturbed sleep 
(e.g.,  inability to fall asleep or early awakening), and/or day/night reversal. 
 
C. Pain (or discomfort) that is often widespread and migratory in nature.  
x At least one symptom from any of the following: Myofascial and/or 
joint pain (Myofascial pain can include deep pain, muscle twitches, 
or achy and sore muscles. Pain, stiffness, or tenderness may occur 
in any joint but must be present in more than one joint and lacking 
edema or other signs of inflammation.)  
x Abdominal and/or head pain (May experience eye pain/sensitivity 
to bright light, stomach pain, nausea, vomiting, or chest pain. 
Headaches often described as localized behind the eyes or in the 
back of the head. May include headaches localized elsewhere, 
including migraines.)                          
D. Two or more neurocognitive manifestations: 
x Impaired memory (self-reported or observable disturbance in ability 
to recall information or events on a short-term basis) 
x Difficulty focusing (disturbed concentration may impair ability to 
remain on task, to screen out extraneous/excessive stimuli in a 
classroom, or to focus on reading, computer/work activity, or 
television programs) 
x Difficulty finding the right word 
x Frequently forget what wanted to say 
x Absent mindedness  
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x Slowness of thought 
x Difficulty recalling information 
x Need to focus on one thing at a time 
x Trouble expressing thought 
x Difficulty comprehending information 
x Frequently lose train of thought 
x New trouble with math or other educational subjects 
 
E. At least one symptom from two of the following three categories: 
1. Autonomic manifestations: Neurally mediated hypotension, postural 
orthostatic tachycardia, delayed postural hypotension, palpitations with 
or without cardiac arrhythmias, dizziness, feeling unsteady on the feet–
disturbed balanceshortness of breath. 
2. Neuroendocrine manifestations: Recurrent feelings of feverishness 
and cold extremities, subnormal body temperature and marked diurnal 
fluctuations, sweating episodes, intolerance of extremes of heat and 
cold, marked weight change-loss of appetite or abnormal appetite, 
worsening of symptoms with stress. 
3. Immune manifestations: Recurrent flu-like symptoms, non-exudative 
sore or scratchy throat, repeated fevers and sweats, lymph nodes tender 
to palpitation–generally minimal swelling noted, new sensitivities to 
food, odors, or chemicals. 
III. Exclusionary conditions: 
A. Any active medical condition that may explain the presence of chronic 
fatigue, such as: 
1. Untreated hypothyroidism 
2. Sleep apnoea 
3. Narcolepsy 
4. Malignancies 
5. Leukemia 
6. Unresolved hepatitis 
7. Multiple Sclerosis 
8. Juvenile rheumatoid arthritis 
9. Lupus erythematosus 
10. HIV/AIDS 
11. Severe obesity (BMI greater than 40) 
12. Celiac disease 
13. Lyme disease 
B. Some active psychiatric conditions that may explain the presence of chronic 
fatigue, such as: 
274 
 
1. Childhood schizophrenia or psychotic disorders 
2. Bipolar disorder 
3. Active alcohol or substance abuse–except as below: 
a) Alcohol or substance abuse that has been successfully treated and 
resolved should not be considered exclusionary. 
4. Active anorexia nervosa or bulimia nervosa–except as below: 
a) Eating disorders that have been treated and resolved should not be 
considered exclusionary. 
5. Depressive disorders 
IV. May have presence of concomitant disorders that do not adequately explain 
fatigue, and are, therefore, not necessarily exclusionary. 
1. Psychiatric diagnoses such as: 
a) School phobia 
b) Separation anxiety 
c) Anxiety disorders 
d) Somatoform disorders 
e) Depressive disorders  
2. Other conditions defined primarily by symptoms that cannot be confirmed by 
diagnostic laboratory tests, such as: 
a) Multiple food and/or chemical sensitivity 
b) Fibromyalgia 
3. Any condition under specific treatment sufficient to alleviate all symptoms 
related to that condition and for which the adequacy of treatment has been 
documented. 
4. Any condition, that was treated with definitive therapy before development of 
chronic symptomatic sequelae. 
5. Any isolated and unexplained physical examination, laboratory or imaging 
test abnormality that is insufficient to strongly suggest the existence of an 
exclusionary condition. 
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Appendix B                                                                              
Plain Language Statements and Consent Forms 
  
276 
 
  
277 
 
  
278 
 
  
279 
 
  
280 
 
  
281 
 
  
282 
 
Appendix C                                                                              
Visual Analogue Scale 
 
 
 
